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Angst door Beaudy (8 jaar) 
 
 
 
alle mensen hebben weleens een angst. soms voor een spin of voor een hond. 
deze angsten komen ergens vandaan? 
dit kan zijn door nare dingen bv: auto ongeluk of een televiesie progamma of 
net als bij mij dat ze mijn been opnieuw hebben moeten breken zonder 
verdoving en daar heb ik nu ook een angst  
van over gehouden bv: angst dat ze mijn pijn gaan doen.  
soms kunnen mensen of kinderen ook bang zijn als ze iets vreemds horen en 
dat geluid niet kennen. 
ook hebben veel kinderen de angst dat hun vader of moeder dood of weggaan. 
in heel veel gevallen kun je hier voor naar een praatdokter gaan daar proberen 
ze met je te praten  over jou angsten. 
in de hoop dat je naar een paar gesprekjes anders naar die angst gaat kijken en 
denken. 
bv: ik was in het begin ook heel bang voor het ziekenhuis en dokters. 
maar nu naar bijna een half jaar verder en elke week naar de praatdokter ben 
geweest zijn mijn angsten bijna weg.   
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Children experience many fears over the course of their development. These 
fears are normal and will disappear spontaneously. However, in some children 
these fears become persistent and intervene with daily life, which causes 
normal fears to become pathological fears or anxiety disorders. Anxiety 
disorders are often associated with social problems, school problems, low self-
esteem and an increased risk for other mental disorders such as depression and 
substance abuse (Kendall, Safford, Flannery-Schroeder, & Webb, 2004; Strauss, 
Frame, & Forehand, 1987; Strauss, Last, Hersen, & Kazdin, 1988). Evenmore, 
anxiety disorders are one of the most prevalent mental disorders worldwide. 
International prevalence rates for anxiety disorders in children range from 1.8% 
(Anderson, Williams, McGee, & Silva, 1987) to 25% (Kessler et al., 1994). 
However, when interference with daily functioning is taken into account these 
prevalence rates reduce to 5 to 10% of the children (Klein & Pine, 2002).  
Not only are anxiety disorders an enormous problem with respect to 
magnitude but also with respect to the costs associated with anxiety disorders 
and their consequences. Costs of anxiety disorders were estimated to be 63.1 
billion dollars in the USA in 1998 by extrapolating the costs of 1990 (Greenberg 
et al., 1999). In the Netherlands, health care costs of anxiety disorders across all 
ages were 180 million euro in 1999, accounting for 0.5% of the health care 
budget. More specifically, health care costs due to anxiety disorders in children 
and young adults aged 1 to 24 amounted to 21.6 million euros using a top-down 
method from existing national registrations (Polder, Takken, Meerding, 
Kommer, & Stokx, 2002). However, bottom-up or patient reported costs of 
anxiety disorders in children have not yet been examined. In chapter 2 of this 
thesis, the societal costs of clinically anxious children and adolescents referred 
for treatment will be investigated.  
 There is a need for an effective treatment that could decrease the costs 
associated with anxiety disorders. In order to determine the effectiveness of a 
certain therapy, reliable and valid methods are necessary to measure the change 
due to treatment. Besides diagnostic interviews, questionnaires can be used to 
measure treatment effects. For instance anxiety questionnaires such as the 
Screen for Child Anxiety Related Emotional Disorders Revised (SCARED-R; 
Muris, Merckelbach, Schmidt, & Mayer, 1999) can be used to detect differences 
in anxiety symptoms and to calculate the magnitude of change, the so-called 
effect sizes. The SCARED-R differentiates from other child anxiety 
questionnaires because it taps into all DSM-IV (APA, 1994) childhood anxiety 
disorders and consists of a child and parent version. Cognitions questionnaires 
like the Children’s Automatic Thought Scale (CATS; Schniering & Rapee, 2002) 
can be used to determine if a certain treatment is effective in changing 
cognitions of anxious children. The CATS has the advantage of being a 
developmentally sensitive cognition questionnaire for children measuring 
negative automatic thoughts across both internalizing and externalizing 
problems in children and adolescents. However, the SCARED was altered into a 
71-version by adding 5 social phobia items because the 66-item SCARED-R did 
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not sufficiently cover social phobia. The CATS was translated into a Dutch 
version. However, since the SCARED and CATS questionnaire were adapted, 
no psychometric properties were available. Therefore, a study was conducted to 
differentiate children with anxiety disorders from children from the general 
population with respect to their anxiety symptoms (SCARED-71) and their 
anxious cognitions (CATS). The psychometric properties of the SCARED-71 and 
the CATS will be examined in respectively chapter 3 and 4 of this thesis.   
Anxiety disorders are likely to continue into adulthood, however the 
type of anxiety disorder and the severity of the disorder vary over time (Craske, 
1997). If untreated the prognosis of anxiety disorders is quite poor (Keller et al., 
1992). Several therapies have been applied to children with anxiety disorders 
e.g. pharmacotherapy, psychodynamic therapy, Eye movement Desensitisation 
and Reprocessing (EMDR) and relaxation therapy. However, Cognitive 
Behavioural Therapy (CBT) is the only evidence-based effective treatment in 
children with anxiety disorders. Kendall was the first to develop a CBT 
program for children with anxiety disorders namely Coping cat (Kendall, Kane, 
Howard, & Siqueland, 1990). It was shown that 64% of the children was free of 
their primary diagnosis after treatment (Kendall, 1994). Since then a lot of 
variations of this CBT program, for instance group CBT, have been developed.  
Whether or not to involve parents in CBT is another issue that has been 
raised during the last years. Barrett, Dadds, and Rapee (1996) found that 
individual CBT with family management was more effective than individual 
CBT alone at post treatment and 1-year follow-up (Barrett et al., 1996). This was 
especially the case, if parents were anxious themselves (Cobham et al. 1998). 
However, four recent studies and a meta-analysis did not show an additive 
value of parental involvement (In-Albon & Schneider, in press; Nauta, Scholing, 
Emmelkamp, & Minderaa, 2001 and 2003; Siqueland, Rynn, & Diamond, 2005; 
Wood, Piacentini, Southam-Gerow, Chu, & Sigman, 2006). Chapter 5 of this 
thesis will provide an overview of CBT during the last quarter of this century.  
Recently a new family based CBT was developed, which includes both 
parents and siblings of anxious children (Bögels & Siqueland, 2006). In this 12-
session family CBT, parents, siblings and the anxious child are seen 
simultaneously. Child and parents are taught to reduce their own anxiety using 
CBT skills. Furthermore, parents learn to model, guide and reward the 
exposure of the child and dysfunctional thoughts and problematic family 
interaction are being modified. A pilot study of 17 families showed that 59% of 
the children were free of their primary anxiety disorder at 3-month follow-up 
(Bögels, & Siqueland, 2006). This pilot study was extended into a randomized 
control trial. In chapter 6, the effectiveness of this family CBT in comparison to 
an individual or child based CBT in 128 clinically anxious children and their 
families will be examined. 
In order to investigate whether family CBT or individual CBT is more 
cost-effective, a cost-effectiveness study was conducted. A cost-effectiveness 
study evaluates and compares the difference in costs related to the difference in 
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effectiveness between two treatments with the purpose of improving resource 
allocation decisions by policy makers and insurers, and consequently, to 
improve individual, societal and economical wellbeing (Knapp, 1997). This cost-
effectiveness study evaluated and compared the difference in costs and 
outcomes of individual and family CBT. To date, no studies have addressed the 
costs associated with CBT in children with anxiety disorders and subsequently, 
its cost-effectiveness. The results of the cost-effectiveness analyses will be 
presented in chapter 7. In the last chapter, a short overview and the clinical 
implications of these five studies are discussed. Future research suggestions 
and concluding remarks will be given.  
  14
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Abstract 
 
Objective: To investigate cost-of-illness in clinically anxious youth aged 8-18 in 
the Netherlands and the discriminative and convergent validity of the cost 
diary used. 
Method: A prevalence-based cost-of-illness study using a societal perspective 
was conducted. Discriminant validity was obtained by comparing costs of 
families with an anxious child (n = 118) to costs of families from the general 
population (n = 41). Bottom-up costs were derived from cost diaries, while top-
down costs were obtained from national registrations. 
Results: Costs using a bottom-up approach amounted to €2748 per family of a 
clinically referred anxious child a year, which is more than 20 million euros a 
year for the Dutch population. Costs of families with clinically anxious children 
were almost 21 times as high compared to families from the general population. 
With respect to convergent validity, costs using the bottom-up approach from 
clinically anxious children were quite comparable compared to those of top-
down data of anxious children.  
Conclusion: Clinical anxiety disorders in childhood cost the Dutch society more 
than 20 million euros a year. Based on results of discriminate and convergent 
validity, the cost diary seems a valid method in establishing cost-of-illness in 
childhood anxiety disorders. 
 
 
Keywords; anxiety disorders, cost-of-illness, children, cost diary 
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Introduction 
 
Anxiety disorders are the most common childhood mental disorders. 
Prevalence rates for children with anxiety disorders vary considerably in the 
international literature from 1.8 (Anderson, Williams, McGee, & Silva, 1987) to 
25% (Kessler et al., 1994). When impairment is taken into consideration, Klein 
and Pine (2000) estimated the prevalence rate to be between 5 to 10%. The 
yearly prevalence rate of children with a mental disorder seeking treatment in 
mental health care ranges from 1.6% (Sytema & Koopmans, 1998) to 8.1% (Leaf 
et al., 1996). 
In the Netherlands, a six-month prevalence rate of 23.5% for anxiety 
disorders was found in 13- to 18-year-old adolescents. However, when 
impairment in daily functioning was taken into account the prevalence rate 
dropped to 9.7% (Verhulst, Van der Ende, Ferdinand, & Kasius, 1997) 
Moreover, only 3.5% of the Dutch 4- to 18-year-old children with a mental 
disorder had been referred yearly to mental health care for treatment (Verhulst 
& Van der Ende, 1997).  
With respect to costs, the total costs for anxiety disorders were highest 
of all mental illnesses, namely 46.6 billion dollars, accounting for 31.5% of total 
expenditures for mental health in 1990 in the USA (Dupont et al., 1996). 
Greenberg and colleagues (1999) estimated the annual cost of anxiety disorders 
to be 63.1 billion dollars in the USA in 1998 by extrapolating the costs of 1990. 
Besides direct costs of treating anxiety disorders, also indirect costs due to 
impaired social functioning, such as financial dependence and unemployment 
are found in adults with anxiety disorders (Leon, Portera, & Weissman, 1995). 
In the Netherlands, health care costs of anxiety disorders across all ages were 
180 million euro in 1999, accounting for 0.5% of the health care budget. More 
specifically, health care costs due to anxiety disorders in 1- to 24-year-old 
children and young adults amounted to 21.6 million euros (Polder et al., 2002).  
An analysis to measure the magnitude of the costs related to illness is 
called a cost-of-illness study. A cost-of-illness study involves an estimation of 
the total economic burden, which an illness poses on society (Polder et al., 2002; 
Rice & Miller, 1995). Essentially there are two approaches to establish the cost-
of-illness, namely the bottom-up and the top-down approach.  
The bottom-up approach acquires data on patient level by means of 
registrations or self-report measures. Self-report measures contain retrospective 
cost questionnaires, retrospective cost interviews or prospective cost diaries 
(Bruijnzeels et al., 1998a; Sleed, Eccleston, Beecham, Knapp, & Jordan, 2005). The 
bottom-up approach enables one to capture resource use that is likely to vary 
from patient to patient and may not be easily extracted from existing data 
sources. Multiplying the costs per patient by the national prevalence rate results 
in the total cost-of-illness for a particular patient group. An advantage of the 
bottom-up approach is that detailed data can be obtained including non-health 
related costs, such as costs due to productivity losses and out-of-pocket costs. A 
Chapter 2 
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disadvantage of this method may be that the sample of patients used for the 
cost-of-illness calculations is not representative for the patient group, for 
example due to strict inclusion and exclusion criteria (Oostenbrink, 
Koopmanschap, & Rutten, 2005; Polder et al., 2002).  
The top-down approach gathers data on patient group level from 
existing (national) registrations. The total costs per health care sector, for 
example hospital care, are considered to be the basis from which costs can be 
deducted per patient group. An advantage of this approach is that there are no 
problems with co-morbidity, since only the primary diagnosis is taken into 
account. A disadvantage is that registrations may be incomplete and contain 
only global data, which makes it difficult to provide a detailed specification of 
the costs per patient group. Furthermore, when using a top-down approach it is 
difficult if not impossible to obtain costs outside the health care sector 
(Oostenbrink et al., 2005; Polder et al., 2002).   
Another important distinction in cost-of-illness studies is that costs can 
be determined from a prevalence-based or incidence-based perspective. In a 
prevalence-based approach, the costs of a disorder are determined for a fixed 
period of time, as a result of the prevalence of the disorder (number of cases of a 
disorder at a specific time). This period is called base period and most often 
studies investigate the annual economic burden, thus based on a year (Ament & 
Evers, 1993; Rice & Miller, 1995). A disadvantage of the prevalence-based 
approach is that it may be difficult to isolate potential differences in costs by 
stage or duration of the disorder (Greenberg et al., 1999). The incidence based 
approach estimates the lifetime costs of an illness from its onset, thus costs are 
assigned to the year in which the illness sets off (Ament & Evers, 1993; Rice & 
Miller, 1995). Incidence based studies can isolate the differences in costs by 
stage or duration of the disease. However, a disadvantage of using this 
approach is that follow up research is required. 
In this article, a prevalence-based cost-of-illness analysis was 
performed in 8- to 18-year-old children and adolescents with anxiety disorders, 
who were referred to treatment. The primary aim of this study was to establish 
the societal costs of illness in families with a clinically anxious child, using the 
bottom-up approach by means of a prospective cost diary. A secondary aim of 
this study was to investigate the discriminative validity of the prospective cost 
diary by comparing the costs related to anxiety, psychological, physical and 
other problems in families with a clinically anxious child to the same costs in 
families from the general population. The third aim of this study was to 
establish convergent validity by comparing bottom-up acquired health care 
costs obtained with the cost diaries of the clinically anxious children with top-
down acquired health care costs of children with a primary diagnosis of anxiety 
disorder.  
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Method 
 
Participants 
For the cost-of-illness study and the discriminative validity study, participants 
were clinically anxious children and children from the general population, 
respectively. The clinically anxious group consisted of 118 families with a child 
referred for community mental health treatment because of anxiety, and 
participated in a multi-centre randomized clinical trial comparing family CBT 
with individual CBT (Bodden et al., submitted). This study was conducted from 
March 2002 to November 2005, inclusion ended in March 2004. Inclusion 
criteria were (1) age 8-18, (2) a primary anxiety disorder (except for obsessive-
compulsive and post-traumatic stress disorder), (3) IQ ≥ 80, (4) at least one 
parent willing to participate. Children were excluded if suffering from (1) 
substance abuse, (2) current suicide attempts, (2) psychoses, (3) autism-
spectrum disorders, and (4) untreated Attention Deficit Hyperactivity Disorder 
(ADHD). Children using medication for their anxiety were only included if 
dosage was kept constant during treatment and follow-up.  
 There were 74 girls (63%) and 44 boys (37%), range 8-17 years (M=12.4, 
SD=2.6). Most were Caucasian (n=117, 99%) and 53 (45%) attended primary 
education. The remaining 65 (55%) attended secondary education. The mean 
number of diagnosis per child was 2.9 (SD=1.7), whereas the mean severity 
level of the primary diagnosis was 7.1 (SD=1.0). According to the compound 
diagnosis on the Anxiety Disorder Interview Schedule (ADIS; Silverman & 
Nelles, 1988) their primary anxiety diagnosis was social phobia (n=37, 31%), 
separation anxiety (n=32, 27%), generalized anxiety disorder (n=21, 18%), 
specific phobia (n=20, 17%), and panic disorder with or without agoraphobia 
(n=8, 7%). Of the 118 children, 94 (80%) had one or more co morbid anxiety 
disorder(s); separation anxiety disorder (n=20, 17%), social phobia (n=43, 36%), 
specific phobia (n=51, 43%), panic disorder (n=20, 17%), generalized anxiety 
disorder (n=42, 36%), obsessive-compulsive disorder (n=5, 4%), and post-
traumatic stress disorder (n=7, 6%). Moreover, 29 (25%) were comorbid with 
dysthymic disorder or depression, 9 (8%) with ADHD, 2 (2%) with conduct 
disorder, and 1 (1%) with oppositional defiant disorder. 
The sample from the general population consisted of a group of 41 
families who were recruited via advertisements. Children of these families were 
comparable to children from the clinically anxious group based on age, gender 
and educational level. There were 27 girls (66%) and 14 boys (34%), range 8-17 
years (M=12.5, SD=2.5). Most were Caucasian (n=40, 98%) and 16 (39%) 
attended primary school. The remaining 25 (61%) attended secondary 
education. According to the compound diagnosis on the ADIS, the prevalence 
of anxiety disorders in this sample was 12% (n=5) and 2.4% (n=1) for ADHD, 
closely resembling Dutch prevalence of anxiety disorders and ADHD, 
respectively 9.7% and 2.3% (Verhulst et al., 1997). The primary anxiety 
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diagnoses consisted of social phobia (n=1, 20%) and specific phobia (n=4, 80%) 
with a mean severity level of 4.8 (SD=0.8).  The overrepresentation of simple 
phobia and the relatively low severity rates of the anxiety disorders in the 
control group also support the “normality” of the control children. 
All children and parents received and signed an informed consent. The 
ADIS child and parent version were administered to obtain diagnostic status. 
Clinically anxious children, their siblings and parents were assessed before 
treatment and families from the general population were only measured once. 
Furthermore, all family members had to fill in a battery of questionnaires, 
among which a prospective cost diary.  
 
Prospective cost diary 
A cost diary was used to determine the resources used (Freer, 1980; Goossens, 
Rutten-van Mölken, Vlaeyen, & Van der Linden, 2000) in both the cost-of-illness 
study as in the discriminative validity study. Cost dairies were completed 
prospectively by one of the parents and covered a period of two weeks. 
Families of clinically anxious children received the cost diary 2 weeks before 
treatment and the sample of families from the general population received the 
same cost diary during their one time assessment. Each cost diary was 
presented in a booklet form with instructions and an example diary. Parents 
recorded the following resource use: visits to psychologist or psychotherapist, 
visits to the general practitioner, outpatient consultations at the hospital, 
medication, day treatment, costs of paid house help, children’s day care, after 
school care, informal care, productivity losses due to absence of work by the 
parents, loss of household activities or voluntary work, loss of leisure time, 
absence from school of the child, distance from health care facilities and out-of-
pocket expenses, such as transportation costs and monetary contributions. Also, 
parents recorded the name of the family member for whom the resource use 
was applicable (child, sibling, mother or father), as well as the reason for the 
resource use by that family member. For analysis, the reported reasons were 
grouped into (1) due to anxiety, (2) due to psychological problems, (3) due to 
physical problems, and (4) due to other reasons. 
 
Cost prices 
Costs were calculated by multiplying the resources used, obtained with the 
prospective cost diaries, by the cost price of each resource. Costs were 
calculated at 2003 euros (1€ = 0.087$, July 30th 2003). Almost all cost prices were 
obtained by using published Dutch guideline prices (Oostenbrink et al., 2005). 
However, medication prices were obtained from the Medication and aid 
Information Project database on the Internet (Board of Health Insurances, 2005) 
and were based on the Daily Defined Dosage (DDD), which indicates the mean 
medication usage per person a day with claw back and VAT (20%). An average 
cost price was calculated for medication for anxiety problems and medication 
for psychological problems.  
                                                       Societal burden of clinically anxious youth 
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 As actual cost prices for day treatment and institutionalization were not 
available, the cost prices were derived from the average of actual 
reimbursements (Board Tariff rates Health care and Care authority, 2005). The 
cost price of day care was estimated by using a shadow price based on the 
actual day care costs for children under the age of 4, derived from the Internet 
(Baby fun, 2005). To determine the costs associated with absence from school, 
actual annual tuition (National Institute of Budget information, 2005) was 
divided by the total annual hours at school, resulting in a cost price per hour of 
school absence. Productivity costs of the parents were calculated by means of 
the friction cost method, based on a mean added value of the Dutch working 
population (Oostenbrink et al., 2005). This method only takes into account 
production losses confined to the period needed (usually 90 days) to replace a 
sick employee. 
 
Cost-of-illness 
The primary aim of this study was to calculate the societal burden of illness of 
families of clinically anxious youth in The Netherlands. The cost-of-illness 
study was performed from a societal perspective and included direct health 
care costs, direct non-health care costs, indirect costs and out-of-pocket costs. 
 The costs per family over a period of two weeks were extrapolated to a 
period of 1 year (i.e. multiplied with 26) under the assumption that data 
obtained with the cost diaries were representative for that period (Goossens et 
al., 2000). Subsequently, the annual costs per family were multiplied with the 
prevalence figure of 9.7% (Verhulst et al., 1997) and the percentage of referred 
children of 3.5% (Verhulst et al., 1997), which results in a multiplication factor 
of 0.34%, to calculate the total annual societal cost-of-illness of families of 
clinically anxious children referred for treatment. It was assumed that the 
percentage of referred children with a mental disorder (3.5%) could be 
attributed to anxiety disorders as well. Furthermore, a low and high estimation 
of the cost-of-illness was calculated using the reported range of prevalence rates 
for children with anxiety disorders considering impairment and the reported 
range of percentages of children seeking treatment. As a result, a low 
multiplication factor of 0.08% (i.e. 1.6% of 5%) and a high multiplication factor 
of 0.81% (i.e. 8.1% of 10%) were used to calculate a low and high estimate of the 
societal cost-of-illness.   
 
Discriminative validity 
To determine the discriminative validity of the prospective cost diary, the 
societal costs of the 118 families of anxious children were compared to the 
societal costs of 41 families from the general population. For this purpose, all 
costs related to the child, irrespective of reason, were taken into account (i.e. 
psychological, physical or other).  For both groups, the costs per family over a 
period of two weeks were extrapolated to a period of 1 year to obtain the 
annual costs per child for both groups. It was hypothesized that costs for 
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anxiety problems were higher in the clinically anxious group compared to the 
general population but comparable between the two groups for psychological, 
physical and other problems. 
 
Convergent validity 
To establish convergent validity, health care costs per child per year obtained 
with the prospective cost diaries of 118 clinically anxious children were 
compared with the health care costs of children with a primary diagnosis of 
anxiety disorder, according to top-down registrations. For this comparison, 
only health-care costs due to anxiety of the child were considered, because the 
costs obtained with the top-down registration applied to children with a 
primary diagnosis of anxiety disorder and only consisted of costs related to the 
health care sector.  
The top-down data were obtained from a generic cost study based on 
national registrations (Polder et al., 2002). In this study, the total costs of health 
care in 1999 were assigned to diagnosis groups based on actual delivered care, 
according to distribution ratios. This was done for each of the 21 health care 
sectors, among which mental health care. Diagnosis groups were based on the 
International Statistical Classification of Diseases, injuries and causes of death 
(ICD-9; World Health Organization, 1977). The ICD-9 is divided into 17 
chapters, including chapter V, mental and behavioural disorders. Furthermore, 
a more intricate classification is used, by itemizing the chapters into 96 specific 
diagnosis groups, including anxiety disorders. All anxiety disorders are taken 
into account (ICD-9 300.0-3 and 300.5-9) (World Health Organization, 1977).  
The top-down data could not be compared directly to the group of 8 to 
18 year old children included in the bottom-up cost-of-illness analysis, because 
costs were presented for the age groups 5- to 9, 10- to 14 and 15- to 19-year-olds. 
Therefore, the assumption was made that costs were equally distributed within 
the age groups, so the corresponding ages (8-18) could be filtered out by 
averaging the costs and multiplying them by each age year (Polder et al., 2002). 
Since top-down data were based on costs in 1999, for comparison with the 
bottom-up cost-of-illness approach, costs were actualized to 2003 euros by 
using the Consumer Price Index (CPI; Central office of statistics, 2005).  
 
Statistical analysis  
Statistical analysis could only be performed on the cost-of-illness study and on 
the discriminative validity study, since top-down data were not available on 
child level. Missing items in the cost diaries were handled with the Missing 
Value Analysis of SPSS based on the regression models using available data of 
the group mean, the available data of the individual and the pattern of change 
of the group. To investigate whether data were normally distributed, a 
Kolmogorov-Smirnov test was performed.  
 Due to highly skewed cost distributions, bootstrap simulations were 
conducted in order to get insight in significant differences on subtotal and total 
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costs between families of clinically anxious children and families from the 
general population and the uncertainty surrounding these costs. The bootstrap 
method estimates the sampling distribution of a statistic through 1000 
simulations, based on sampling with replacement from the original data 
(Briggs, Wonderling, & Mooney, 1997). Bootstrap methods are increasingly 
being used for analysis of cost data, as traditional parametric and 
nonparametric statistical methods to analyse the difference in mean costs 
between groups, may be inappropriate when data are skewed (Barber & 
Thompson, 2000; Desgagné, Castilloux, Angers, & Lelorier, 1998).  
 
Results 
 
Cost-of-illness  
All resources used and costs made related to the anxiety of the child by families 
with a clinically anxious child were summed and averaged for 2 weeks and one 
year (Table 1). The mean costs per family over 2 weeks were extrapolated to a 
year and amounted to €2748 per family with a clinically anxious child. Costs 
were not normally distributed, Kolmogorov-Smirnov Z= 4.5, p < 0.01, and 
skewed to the left, indicating that a minority of families reported high costs 
related to the anxiety of the child. The most prominent were costs related to 
institutionalized treatment (26% of total costs), day treatment (23% of total 
costs), productivity loss of the parents (23% of total costs) and school absence 
(17% of total costs).  
 The total number of Dutch children aged 8 to 18 in 2003 was computed 
using data of the Central Office of Statistics (2005), and resulted in 2,175,382 
children. Multiplying this figure by 0.34% resulted in 7,385 Dutch children with 
an anxiety disorder that intervenes with daily functioning and who are referred 
to treatment. Hence, the annual societal cost-of-illness accumulated to €2,748 x 
7,385 = €20,293,958 for families of clinically anxious children referred for 
treatment in the Netherlands. The same calculation was performed using the 
low and high multiplication factors. This resulted in a low estimate of the cost-
of-illness of €4,783,839 and a high estimate of €48,436,370. 
 
Discriminative validity  
The mean total annual societal costs related to anxiety, psychological, physical 
and other reasons for families with a clinically anxious child and families from 
the general population are presented in Table 2. In the clinically anxious group, 
costs due to anxiety reasons were highest (89% of total costs), followed by costs 
due to physical reasons (6% of total costs), costs due to other reasons  (3% of 
total costs) and psychological reasons (3% of total costs). The total annual costs 
of families with clinically anxious children due to anxiety problems, 
psychological problems, physical problems and other amounted to a mean of 
€3,084 (SD=8945) per child.  
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Costs of families from the general population were highest for physical 
reasons (95% of total costs). A small proportion of costs was assigned to 
psychological reasons (5% of total costs) and other reasons (0.2% of total costs). 
Despite the fact that 5 children in the control group met criteria for an anxiety 
disorder, no costs were made concerning anxiety reasons. The total annual costs 
obtained from families of the general population amounted to a mean of €148 
(SD=523) per family. 
Costs in both groups were not normally distributed (Kolmogorov-
Smirnov Z > 1.6, p < 0.05). The bootstrapped results indicated that total societal 
costs were significantly higher in families with clinically anxious children 
compared to families from the general population. Subdividing the costs into 
reason showed significant higher costs related to anxiety and other reasons in 
families with a clinically anxious child compared to families from the general 
population. Costs related to psychological reasons were borderline significantly 
higher for the families with a clinically anxious child (see Table 2).  
 
 
Convergent validity  
The total health care costs of 8- to 18-year-old children with a primary diagnosis 
of anxiety disorder amounted to €8,018,000 in 1999 using the top-down 
approach, which augmented to €9,075,613 in 2003 when corrected with CPI. The 
total number of anxious 8- to 18-year-old children referred for treatment in 2003 
was 7,385 (i.e. 2,175,382 x 0.34%). Dividing the total health care due to anxiety in 
children costs by this number resulted in €1,229 per anxious child that was 
referred (see Table 3).  
 
 
Table 3  Direct health care costs, anxiety based per child a year based on the Bottom-up and  
top-down approach  
 
 
     Bottom-up Costs             Top-down costs 
 
 
A day of hospitalization        0.00      203 
Day treatment         0.00          1.84 
Outpatient clinic         0.00        42.51 
Categorical hospital        0.00        32.71 
Remaining         0.00          7.60  
 Subtotal Hospital care        0.00      287 
General practitioner      15.58        58.27 
Paramedical care         0.00          1.23 
 Subtotal Primary care      92.70        59.50 
Pharmaceutical help      36.49        67.50 
Mental health care   1358      785 
Management and care insurances       0.00        29.92 
 Total costs   1410    1229  
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Direct health care costs derived from the bottom-up method were used 
to compare with the top-down approach and amounted to €1,410 per referred 
anxious child (see Table 3). Total health care costs for clinically anxious children 
resulted in €10,412,187 with a low estimate of €2,453,541 and a high estimate of 
€24,842,036. Although the overall difference in total health care costs between 
the bottom-up and top-down approach per anxious child per year were about 
€180 (top-down 13% lower than bottom-up), the differences in costs per health 
care sector were considerably higher. For instance, costs of medical hospital 
care were €287 higher using the top-down approach (23% of total costs) 
compared to costs obtained with the bottom-up approach (0% of total costs). On 
the other hand, mental health care costs were €573 higher (top-down 42% lower 
than bottom-up) using the bottom-up approach (96% of total costs) compared to 
the costs obtained with the top-down approach (64% of total costs). 
 
Discussion 
 
To the authors’ knowledge, this is the first cost-of-illness study in clinically 
anxious children referred for treatment. The aim of this study was threefold. 
The first aim was to measure the societal costs of illness in clinically anxious 
children and their families, using a bottom-up approach by means of a 
prospective cost diary. The second aim was to investigate the discriminative 
validity of the prospective cost diary by comparing the costs of families with a 
clinically anxious child to the costs of families from the general population. The 
third aim of the study was to establish convergent validity by comparing 
bottom-up acquired health care costs of the clinically anxious children with top-
down acquired health care costs of children with a primary diagnosis of 
anxiety.  
 With respect to results regarding cost-of-illness, bottom-up acquired 
total societal costs for families of clinically anxious children referred for 
treatment amounted to more than €20 million per year in the Netherlands with 
a low estimation of 4.8 and a high estimation of 48 million euros, which is a 
quite broad range. Costs amounted to €2,748 per family with a clinically 
anxious child per year. These costs seem relatively low compared to costs of 
other childhood psychopathology. Knapp, Scott and Davies (1999) conducted a 
pilot study on 10 children aged 4 to 10 with conduct disorders. Cost amounted 
to €22,272 per family per year. In another study on 11 children with autism 
spectrum disorders, societal costs were €51,844 per child per year (Järbrink, 
Fombonne, & Knapp, 2003). However, it should be noticed that as these studies 
have low sample sizes, results should be considered with caution. Furthermore, 
the prevalence rate for anxiety is almost 4 times as high as conduct disorder 
(2,6%, Verhulst et al., 1997) and 39 to 44 times higher as the prevalence rate for 
autism spectrum disorders (0,22% to 0,25%, van der Gaag, Robbroeckx, Smid, & 
Verhulst, 1996).  
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In line with Knapp et al. (1999) and Järbrink et al. (2003) a large part of 
the costs in our study can be attributed to the parents’ productivity loss due to 
anxiety disorder of the child (23% of total costs). Knapp et al. (1999) found that 
per family with a child with conduct disorder the annual costs due to lost 
employment were €5,683 (30% of the total costs). Järbrink et al. (2003) showed 
that more than 50% of the total costs of children with an autism spectrum 
disorder were attributable to parents and costs related to income loss were 
€17,405 (34% of total costs). Our study also found high costs due to school 
absenteeism (17% of total costs). School absence can have long-term economic 
consequences such as decreased job opportunities or even unemployment. 
Taken together, both productivity costs of parents and school absence costs of 
the child seem very important and should be considered in future costing 
studies.  
With respect to the results regarding discriminative validity, total costs 
of families with clinically anxious children using a bottom-up approach were 
almost 21 times as high compared to costs of families from the general 
population. In line with the hypothesis, the difference in costs between families 
of clinically anxious children and families from the general population can 
largely be subscribed to the significant difference in anxiety related costs, 
showing good discriminative validity of the cost diary on anxiety related costs. 
However, significant differences were also found on costs due to other reasons. 
In the prospective cost diary, the reasons for resource use were recorded based 
on subjective judgments by the parents. However, since anxiety is an 
internalizing disorder, parents may not always be able to interpret children’s 
symptoms correctly. Therefore, they may have attributed costs mistakenly to 
non-anxiety reasons, e.g. a baby-sitter for a child old enough to stay on its own, 
if not anxious.  
With respect to convergent validity, total direct health care costs related 
to anxiety were 13% lower using a top-down approach than using a bottom-up 
approach, which seems quite comparable. However, subdividing the costs into 
several cost categories showed that costs were distributed differently among the 
cost categories. For example, bottom-up acquired mental health care costs were 
58% higher than top-down acquired mental health care costs. Furthermore, 23% 
of the total costs using a top-down approach were attributed to hospital care, 
whereas no hospital care costs were found using the bottom-up approach. 
Hence, convergent validity on total direct health care costs were quite 
comparable, while the specific cost categories differed between bottom-up and 
the top-down approach. These findings suggest that children, who are not yet 
referred for mental health care, might consume more medical hospital care. 
Therefore, from a cost-of-illness perspective, it would also be interesting to 
investigate costs of families with children with anxiety disorders, who are not 
referred for mental health treatment, using the cost diary developed for this 
study. It might well be that these families make more medical health care costs, 
as the comparison with top-down acquired data suggests. 
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This study has some limitations, which should be addressed. The first 
limitation is that the low and high multiplication factor used in this study 
caused a broad range of the societal costs of illness. This can be explained by the 
broad range of internationally reported prevalence rates and percentages of 
children seeking treatment due to differences in measurements, populations, 
etcetera. As a Dutch population was investigated, the most appropriate 
prevalence rate is 9.7% (Verhulst et al., 1997), which was obtained through the 
use of a reliable structured diagnostic interview. The same is true for the 3.5% 
of children with mental disorders seeking treatment (Verhulst et al., 1997). 
Therefore, the prevalence and referral rates used in this study seem reliable. 
The second limitation of the current study is that it can be argued that 
two-week cost diaries filled in by parents are not representative to reliably 
assess one-year bottom-up costs due to the limited time period. However, 
Goossens et al. (2000) have found that keeping a diary in a limited period 
namely one week every month, two weeks every two months or an entire year 
resulted in similar outcomes in fibromyalgia and pain patients. Another study 
of Bruijnzeels et al. (1998b) found that there was a substantial agreement 
between a 3-week cost diary and medical records concerning general 
practitioner visits of children, filled in by parents. Moreover, the inclusion 
period of this study lasted 2 years in which the cost diaries were filled out, 
therefore possible seasonal influences are ruled out.  
 The third limitation of this study is that although total health care costs 
obtained with the top-down and bottom-up method seemed quite comparable, 
the sample of children with a primary diagnosis of anxiety disorder used in the 
top-down study by Polder et al. (2002) might not be fully comparable to the 
clinically anxious children from our bottom-up approach in at least three 
respects. First, the children in the bottom-up sample were clinically anxious 
children with severe anxiety disorders. The mean number of anxiety disorders 
was 3 and the mean severity level 7, indicating severe interference with daily 
functioning. The children with a primary diagnosis of anxiety disorder in the 
top-down sample might suffer from different levels of anxiety disorders; some 
may have minor anxiety problems, while others may have severe anxiety 
problems. This kind of information was not available using the top-down data. 
Second, while the clinically anxious children in the bottom-up sample were 
awaiting CBT in a community mental health care setting, the anxious children 
in the top-down sample might be in different types and/or phases of treatment. 
Again, this kind of information was not available using the top-down data. 
Third, the clinically anxious children in the bottom-up sample were diagnosed 
using a semi-structured interview, the ADIS based on the DSM-IV (American 
Psychiatric Association, 1994). In the top-down sample, children were 
diagnosed by the doctor in attendance, who attributed the anxiety diagnosis to 
the patient based on the ICD-9 code, without a structured interview. Due to the 
classification method, the top-down estimation is possibly less reliable than the 
bottom-up cost estimation.  
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 In conclusion, this cost-of-illness study shows that the societal costs of 
families with a clinically anxious child who seek treatment amount to more 
than 20 million euros a year in the Dutch population, and were 21 times higher 
than in families of the general population. An effective treatment could 
decrease these costs on the long term. A recent cost-effectiveness study on 
family CBT versus individual CBT showed that societal costs in families with a 
clinically anxious child increased during treatment (due to total costs of 12 
sessions CBT a €1612) but decreased directly after treatment to baseline level. 
Even more, during the 1-year follow-up societal costs dropped below the costs 
at baseline (Bodden et al., submitted). Since anxiety disorders tend to last into 
adulthood (Newman et al., 1996), societal costs are likely to be higher at the 
long term. This even results in anxiety disorders accounting for the highest 
costs of all mental illnesses in adulthood in the USA (Dupont et al., 1996). 
Hence, societal costs in adults with anxiety disorders can be saved by providing 
effective treatments to children with clinical anxiety disorders.
 31
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Abstract 
 
Objective: This study investigated the diagnostic utility of the Screen for Child 
Anxiety and Related Emotional Disorders (SCARED-71), as a screening tool for 
identifying anxiety disorders in youth.  
Method: The SCARED-71 was administered to clinically referred anxious 
children (n = 138) and control children (n = 38) as well as their parents.  
Results: Results showed that the SCARED-71, child and parent report, 
differentiated clinically anxious from control children on total score and on all 
subscales. Reliable cut-off scores were established for both child and parent 
report. The parent version however had highest sensitivity and specificity and 
therefore seems the most reliable way to screen referred anxious children. Girls 
reported more anxiety symptoms than boys. Children aged 15-18 reported more 
anxiety symptoms compared to 8-14 year-olds. At subscale level, more 
symptoms of panic, generalised anxiety and social phobia were reported by the 
15-18 year-olds, while situational phobia symptoms were less reported. Parents 
reported a decrease on separation anxiety, animal and situational phobia 
symptoms as children were older. Furthermore, evidence for the discriminant 
validity across anxiety disorders was found.  
Conclusion: The SCARED-71 can be used as a screening tool to detect clinically 
anxious children and to discriminate specific anxiety disorders.  
 
 
Keywords; Anxiety disorders, Assessment, Children 
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Introduction 
 
Are self-report questionnaires actually able to reliably detect childhood anxiety 
disorders? The Spence Children’s Anxiety Scale (SCAS; Spence, 1998), Revised 
Child Anxiety and Depression Scale (RCADS; Chorpita et al., 2000) and Screen 
for Child Anxiety and Related Emotional Disorders (SCARED; Birmaher et al., 
1997) seem to have potential for detecting anxiety problems in youths. An 
advantage of the SCARED-R(evised) (Muris et al., 1999a) is that it taps into all 
DSM-IV childhood anxiety disorders. Still, interviews such as the Anxiety 
Disorder Interview Schedule (ADIS; Silverman & Nelles, 1988), the Diagnostic 
Interview Schedule (DISC; NIMH, 1992) and the Child version of the Structural 
Clinical Interview of DSM (KSCID; Hien et al., 1998) are necessary to establish 
an anxiety disorder classification. However, interviews are time-consuming, 
costly, and require trained professionals. With reliable cut-off scores, 
questionnaires like the SCARED-R might be helpful to screen for anxiety 
disorders and to differentiate nonclinical from clinically anxious children.  
 Evidence for the discriminant validity of the 66-item SCARED-R was 
obtained by differentiating between children with anxiety disorders, disruptive 
behaviour disorders, and mood disorders (Muris et al., 2003; Muris & 
Steerneman, 2001). Furthermore, the chance of having an anxiety disorders was 
9 times higher for children scoring high on the SCARED as compared to 
children with low scores (Muris et al., 2001). Using the original 38-item 
SCARED, Birmaher and colleagues (1997) found that anxiety-disordered youth 
also displayed significantly higher anxiety scores than children with other 
psychiatric disorders.  
 In order to differentiate children with severe and subclinical anxiety 
problems, reliable cut-off scores have to be obtained. Cut-off scores are useful in 
prevention research to identify children at high risk for anxiety problems. 
Furthermore, in therapy outcome studies, cut-off scores can be employed to 
determine whether treatment was successful in such way that a child has 
reached a subclinical level of anxiety. Muris et al. (2000) determined a cut-off 
point of 33 for the SCARED-R by means of discriminant analysis between 
subclinical and low anxious youth. However, it remains unclear whether this 
cut-off score holds for clinically anxious youth.  
 Two demographic factors are important when investigating anxiety in 
children, namely gender and age. Several studies have shown that girls report 
higher levels of anxiety than boys (e.g., Castellanos & Hunter, 1999; Craske, 
1997). Girls might report more anxiety symptoms because of gender 
stereotyping. That is, it is culturally more accepted that girls display anxiety 
symptoms. In addition, parental rearing styles may contribute to the fact that 
girls are allowed to display more anxiety. Moreover, girls’ coping behaviour is 
more characterised by rumination and worry, whereas in boys active, problem-
oriented coping is more often used which is usually associated with less anxiety 
(Craske, 1997). Girls reported higher levels of anxiety symptoms on the 
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SCARED-R as compared to boys in both a nonclinical as a clinical sample, and a 
similar trend was found on the parent version (Muris et al., 2003; Muris et al., 
1999a; Muris et al., 1999b).  
 It is generally assumed that anxiety decreases as children become older 
(Bernstein et al., 1996; Castellanos & Hunter, 1999). Initially, as children reach a 
certain level of cognitive development, their ability to perceive situations as 
potentially dangerous increases. With increasing age, however, the child gets a 
better understanding of these situations and learns to control them, which 
reduces anxiety (Ollendick et al., 1991). Studies using the SCARED-R with 
nonclinical children generally reveal no substantial age effects (e.g., Muris et al., 
1998). In clinically anxious youths, symptoms of panic disorder and generalised 
anxiety increased with age, whereas symptoms of specific phobias and 
separation anxiety decreased, as children were older (Muris et al., 2003). 
 Three studies have examined whether the SCARED is able to reliably 
detect specific anxiety disorders in youths. Muris and colleagues (2000) found 
that children with subclinical specific phobia, generalised anxiety and 
separation anxiety symptoms on the DISC had significantly higher scores on the 
corresponding SCARED-66 subscale than children without such symptoms. 
Due to a small sample size, only the aforementioned subscales could be 
analysed. In another study by Muris and colleagues (2001), generalised anxiety 
disorder and separation anxiety disorder as classified by means of the KSCID 
were best predicted by high scores on the corresponding SCARED-R subscales 
in a non-clinical sample. Sensitivity and specificity scores were found to be 
modest to satisfactory. The social phobia subscale, however, had little 
predictive value, and other anxiety disorders were not investigated. In a study 
with clinically anxious children (Muris et al., 2003), further support for the 
predictive value of the SCARED-R was obtained. 
 This is the first study to investigate the psychometric properties of the 
SCARED-71 in a clinical population using both child and parent report. The 
SCARED-R did not sufficiently cover social phobia, therefore this subscale was 
enlarged by adding 5 extra items. The first goal was to examine the internal 
consistency of the SCARED-71. Special attention will be devoted to the altered 
social phobia subscale to investigate whether its reliability has improved. 
Second, the discriminant validity was investigated by comparing scores of 
clinical and nonclinical children and cut off scores were determined. Third, 
since several studies have shown that age and gender influence anxiety, effects 
of these demographic variables were also explored.  Finally, the discriminant 
validity for detecting specific anxiety disorders will be investigated. 
 
Method 
 
Participants 
Participants were clinically anxious (n=138) and control children (n=38). The 
clinically anxious children were referred for treatment and participated in a 
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multi-centre randomized clinical trial comparing family with individual CBT 
(Bodden et al., submitted). Children were included, if their age was 8 to 18 
(M=12.5, SD=2.7), suffered from a primary anxiety diagnosis except for 
obsessive-compulsive disorder (OCD) and posttraumatic stress disorder 
(PTSD), and had an IQ ≥ 80. Children were excluded if they suffered from 
substance abuse, suicide attempts, psychoses, autism spectrum disorders, and 
untreated attention deficit hyperactivity disorder (ADHD). There were 83 (60%) 
girls and 55 (40%) boys. Almost half (44%) of the children attended primary 
school, the remaining 77 (56%) attended secondary education. Of the parents, 
136 mothers and 124 fathers participated.  
 The control sample consisted of children from the general population 
who were recruited via advertisements and were comparable to the clinically 
anxious group based on age, F(1,174) = 0.0, p > .1 and gender, χ2 = 0.1, p > .1. 
Non-clinical children ranged in age from 8-18 (M=12.4, SD = 2.6). There were 24 
(63%) girls and 14 (37%) boys. Primary education was attended by 15 (40%) 
children and 23 (60%) attended secondary education. All mothers (n=38) and 
fathers (n=38) participated.  
The ADIS child (C) and parent (P) version were conducted to obtain 
diagnostic status. Primary and comorbid compound diagnosis of the clinically 
anxious children are shown in Table 1. In the control group, 5% (n=2) had an 
anxiety disorder and 3% (n=1) ADHD.  
 
 
Table 1  Primary and co-morbid diagnoses of the clinically anxious children on the ADIS (n = 138) 
 
                    
     Primary diagnosis                      Comorbid diagnosis               
        ADIS-C          ADIS-P            ADIS-C       ADIS-P                    
   N % N  %  N  % N          % 
Diagnosis 
No anxiety disorder     6   4%   0   0%   0   0%   0        0% 
Social phobia  37 27% 43 31% 36 26% 41      30% 
Separation anxiety  disorder 26 19% 32 23% 20 14% 19      14% 
Specific phobia  34 25% 27 20% 38 28% 53      38% 
Generalised anxiety disorder 25 18% 25 18% 22 16% 40      29% 
Panic disorder  10   7% 11   8% 13   9% 11        8% 
Obsessive-compulsive disorder        5   4%   5        4% 
Posttraumatic stress disorder       4   3%   6        4% 
Depressive and/or dysthymic disorder    15 11% 26      19% 
Attention-deficit hyperactivity disorder        3   2%   9        7% 
Conduct disorder        0   0%   2        1% 
Pervasive developmental disorder      0   0%   1        1% 
Oppositional Defiant Disorder      0   0%   2        1% 
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Assessments 
SCARED-71 
In this study, the SCARED-71 was used. The original 38-item SCARED 
measures separation anxiety, generalised anxiety disorder, panic disorder, 
social phobia and school phobia symptoms (Birmaher et al., 1997). Muris and 
colleagues (1999a) added items for measuring symptoms of specific phobia, 
OCD and PTSD. These alterations resulted in a 66-item questionnaire, the 
SCARED-R, which taps symptoms of all anxiety disorders as listed in the DSM-
IV (APA, 1994). 
 The SCARED-R is a reliable and valid questionnaire. The internal 
consistency of the total score is good in a nonclinical population (ranges from 
α=.91 to α=.95) but slightly lower in a clinical sample (Muris, et al., 1999b, Muris 
et al., 2003, Muris & Steerneman, 2001). The test-retest validity is satisfactory 
(Muris, et al, 1999b) and the concurrent validity is good (Muris et al., 1998). 
Finally, the treatment sensitivity of the SCARED-R has proven to be adequate 
(Muris et al., 1999c). 
Despite the good psychometric properties of the SCARED-66, the social 
phobia subscale of the SCARED-R only consists of four items, which can be 
regarded as rather insufficient compared to the other subscales. Further, these 
four items all refer to fear of interaction with unfamiliar people. However, 
socially phobic children often also fear encounters with familiar people and 
social performance situations (Bögels & van Melick, 2004). To overcome this 
shortcoming, 5 social phobia items were added, based on items of the SCAS and 
the Social Phobia and Anxiety Inventory for Children (SPAIC; Beidel et al., 
1995). On the SCARED-71, children and parents have to indicate how 
frequently the child experiences each anxiety symptom using a 3-point Likert 
scale indicating almost never (0), sometimes (1) and often (2).  
ADIS 
In both samples, a semi-structured diagnostic interview was conducted, namely 
the ADIS. This interview is specifically designed to measure anxiety disorders 
in 7-17 year-olds. For each diagnosis a severity score can be obtained that 
ranges between 0 and 8, with 4 or higher indicating a clinical diagnosis. The 
ADIS-C/P possesses good inter-rater (Silverman & Nelles, 1998) and high test-
retest reliability (Silverman & Eisen, 1992).  The research assistants who 
performed the ADIS interviews in our study videotaped 4 of their interviews, 
which were then re-rated by 2 trained psychology students. The mean inter-
rater agreement (kappa) was 0.89 for the ADIS-C and 0.83 for the ADIS-P. 
 
Procedure 
All children and parents signed an informed consent. Clinically anxious 
children were assessed before and after treatment and at follow-up. Families 
from the general population were measured once and received a financial 
reward afterwards. All family members filled out a battery of questionnaires, 
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including the SCARED-71. Children were assisted if necessary by a research 
assistant.  
 
Analysis 
Missing data were extrapolated using the missing value analysis of SPSS based 
on regression models using available data of the group mean, the available data 
of the individual and the pattern of change of the group. The SCARED-71 
scores of father and mother were averaged. Group differences on total SCARED 
scores were analyzed by means of the Analyses of (Co)Variance (AN(C)OVA). 
To evaluate differences on the subscales, a Multivariate ANCOVA 
(MANCOVA) was carried out. A discriminant analysis was performed to 
predict the diagnoses of the specific anxiety disorders. In addition, cut-off 
scores were established using ROC curve analysis. 
 
Results 
 
Internal consistency 
Firstly, internal consistency coefficients were computed separately for the child, 
mother and father version using the total sample. Cronbach’s alpha coefficients 
were high, indicating a high degree of homogeneity. The internal consistencies 
of the subscales were moderate to high, with Cronbach’s alpha values ranging 
from .64 (situational-environmental phobia; child version) to .93 (animal 
phobia; father version). The internal consistency coefficients of the extended 
social phobia subscale were all high: .85 for child, .91 for mother and .89 for 
father report (see Table 2).  
 
Table 2  Cronbach’s alpha values on the SCARED-71 total and subscales scores for the child (n = 
176), mother (n = 174) and father version (n = 155)  
 
      Child  Mother  Father 
Subscale     
 Panic disorder   .88  .88  .86 
 Generalised anxiety Disorder  .87  .87  .87 
 Social phobia    .85  .91  .89 
 Separation anxiety disorder  .81  .86  .84 
 Obsessive-compulsive disorder  .74  .77  .70 
 Posttraumatic stress Disorder  .82  .84  .80 
 Animal phobia   .87  .92  .93
 Blood-injection-Injury phobia  .74  .80  .83 
 Situational-environmental phobia .64  .66  .67 
Total score    .95  .96                 .95 
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Discriminant Validity 
The discriminant validity of the SCARED-71 was examined by comparing total 
scores of clinically anxious youths with those of control youths by means of an 
ANCOVA with gender and age as covariates. Results indicated that clinically 
anxious children reported significantly more anxiety symptoms than control 
children, F(1,172) = 58.8, p < .01, pooled effectsize = 1.6. A MANCOVA with the 
subscales as dependent variables revealed a main effect for group as well, 
FHotelling(9,164) = 6.9, p < .01. Follow-up ANOVAs showed that anxious children 
exhibited significantly higher levels of anxiety symptoms on all subscales as 
compared to control children, all F(1,172) > 9.8, p < .01 (see Table 3). 
 In line with these results, the parents of clinically anxious children 
reported higher levels of anxiety symptoms in their children than the parents of 
control youth, F(1,172) = 123.8, p <. 01, pooled effectsize = 2.4. Again, this 
pattern was found across individual subscales, FHotelling(9,164) = 17.5, p <. 01, 
indicating that according to their parents, clinically anxious children exhibited 
higher levels of all anxiety symptoms as compared to control children, as all 
F(1,172) > 11.4, p < .01 (see Table 3). 
 
 
Table 3  Mean SCARED-71 scores and standard deviations in the clinically anxious sample (children 
n = 138, mothers n = 136 and fathers n = 124) and the control sample (children n = 38, mothers n = 38 
and fathers n = 38) 
 
     Clinically anxious       Control        l                    
      M         SD         M        SD    F 
Child version         
Panic disorder     7.4   5.7    2.1   2.7 31.1 
Generalised anxiety disorder     7.8   4.5    3.7   3.2 26.9 
Social phobia      8.2   4.5    4.3   3.2 24.6 
Separation anxiety disorder      8.2   5.1    3.2   2.4 34.0 
Obsessive compulsive disorder   6.2   3.6    2.9   2.0 29.4 
Posttraumatic stress disorder      2.3   2.4    1.0   1.3   9.7 
Animal phobia     1.6   2.0    0.3   0.7 14.2 
Blood-injection-Injury phobia      4.4   3.3    2.6   2.3 10.2 
Situational-environmental phobia    3.5   2.5    1.6   1.6 20.9 
Total score                49.6 22.3  21.7 12.2 54.7 
 
Parent version Combined        
Panic disorder   6.5   4.8    0.6   0.9 55.9 
Generalised anxiety disorder    8.6   3.7    2.6   2.0 92.8 
Social phobia    8.6   4.4    2.8   2.3 62.5 
Separation anxiety disorder    9.4   4.8    1.8   1.5 93.5 
Obsessive compulsive disorder 4.8   2.9    1.0   0.9 62.5 
Posttraumatic stress disorder    2.4   2.1    0.5   0.7 31.1 
Animal phobia   1.3   1.8    0.3   0.8 11.1 
Blood-injection-Injury phobia    4.2   3.3    1.9   2.4 16.6 
Situational-environmental phobia   3.2   2.2    1.0   1.1 32.6 
Total score     49.0 19.7  12.6   7.7 123.8 
Note: all  ps < 0.01 
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Gender 
To test gender effects on the total SCARED-71, an ANCOVA was carried out 
with group and age as covariates. Girls reported more anxiety symptoms (M = 
46.3, SD = 24.4) compared to boys (M = 39.2, SD = 21.5), F(1,172) = 4.7, p < .05, 
pooled effectsize = 0.3. No interaction effects with group, F(1,168) = 0.6 or age, 
F(1,168) = 0.0 were found. Across subscales, no significant differences between 
boys and girls were found, FHotelling(9,164) = 1.6, p >. 1. Furthermore, no 
significant group by gender and age by gender interaction effects were 
revealed, respectively FHotelling(9,160) = 0.6, p > .1 and FHotelling(9,160) = 0.7, p > .1. 
Parents reported no differences between boys and girls on either the total score, 
F(1,172) = 1.0, p > .1 or the subscales, FHotelling(9,164) = 1.3, p > .1. 
 
Age 
In order to examine age effects corrected for gender and group, an ANCOVA 
was carried out in which age was categorised into 3 groups, namely 8-11, 12-14, 
and 15-18 year-olds. A significant age effect was found, F (1,172) = 3.8, p = .05. 
Further comparisons between the three age groups showed that in particular 
15-18 year-olds differed from 8-11 year-olds, F(1,113) = 5.7, p < .05 and 12-14 
year-olds, F(1,103) = 11.8, p < .01. The 8-11 year-olds and 12-14 year-olds did not 
differ significantly, F(1,130) = 1.4, p > .05. No interaction effect with group, 
F(1,168) = 0.0 was found. 
 A MANCOVA performed on the subscales also showed a significant 
age effect, FHotelling(9,164) = 11.6, p < .01. Follow-up ANOVAs showed age 
differences on the subscales panic, F(1,172) = 22.4, p < .01, generalised anxiety, 
F(1,172) = 26.7, p < .01, social phobia, F(1,172) = 21.1, p < .01 and situational 
phobia, F(1,172) = 11.9, p < .01. For all anxiety disorders except for situational 
phobia, a similar pattern was found: that is 8-11 and 12-14 year-olds did not 
differ significantly, all F(1,130) < 1.5, p > .05), whereas the highest scores were 
found for 15-18-year-olds compared to 8-11 year-olds, all F(1,113) > 21.7, p < .01, 
and compared to 12-14 year-olds, all F(1,103) > 12.4, p < .01. Scores on 
situational phobia appeared to decrease with age and differed significantly 
between 8-11 and 15-18 years-old, F(1,113) > 9.1, p < .01. No interaction effect of 
age by group was found, FHotelling(9,160) = 0.3. 
No age differences were found for the total parent scores, F(1,172) = 1.3, 
p > .1. Also, no interaction effect with group was found, F(1,168) = 0.0. 
However, for the subscales, differences between age groups did emerge, 
FHotelling(9,164) = 6.1, p < .01. Follow-up ANOVAs showed that with increasing 
age, parents reported lower scores on their children’s symptoms of separation 
anxiety, F(1,172) = 7.2, p < .01, animal phobia, F(1,172) = 4.9, p < .05, and 
situational phobia, F(1,172) = 27.6, p < .01. Again, no interaction effect with 
group was found, FHotelling(9,160) = 0.2. 
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Cut-off scores  
In order to differentiate between clinically anxious and control children by 
means of the SCARED-71 total score, cut-off scores were established. This cut-
off score was obtained by determining the maximum sensitivity and specificity 
score of the SCARED-71 for predicting any ADIS anxiety diagnosis by means of 
ROC curve analysis. The optimal cut-off score for the total SCARED-71 child 
version was 30. The sensitivity was 0.78, which indicates that 78% of the 
children who score above the cut-off part on the scale were classified as having 
an anxiety disorder, and really suffered from significant anxiety problems. 
There were 22% false negatives: these children were not detected by the 
SCARED-71 as potentially having an anxiety disorder but actually displayed 
serious anxiety complaints. The specificity of the SCARED-71 child version was 
0.76, which means that 76% of the children who scored below the cut-off part 
were not classified as having an anxiety disorder and indeed did not have 
anxiety problems. There were 24% false positives, which refer to youths 
classified by the SCARED-71 child version as possibly having an anxiety 
disorder, but actually do not display serious anxiety complaints. For the parent 
version, the optimal cut-off score was 21. Sensitivity and specificity were both 
0.92. The parent and child version combined revealed a cut-off score of 27, with 
sensitivity of 0.89 and specificity of 0.90. In Table 4, cut off scores for various 
gender and informant groups are shown.  
 
 
Table 4  Total SCARED-71 cut-off scores based on the clinically anxious sample (children n = 138, 
mothers n = 136 and fathers n = 124) and the control sample (children n = 38, mothers n = 38 and 
fathers n = 38) 
 
             Cut-off score                        Sensitivity                                 Specificity  
Child version  30   0.78   0.76 
Child version-boys  27   0.71   0.69 
Child version-girls  31   0.82   0.80 
Parent version combined 21   0.92   0.92 
Parent version-mother 25   0.85   0.87 
Parent version-father 22   0.88   0.87 
Combined child and parent  27   0.89   0.90 
 
 
Discriminant analysis 
In order to investigate whether specific anxiety diagnoses were best predicted 
by their corresponding SCARED-71 subscale, a discriminant classification 
analysis was carried out only using data of clinically referred youth. Children 
with a primary diagnosis of OCD and PTSD were not included, therefore these 
disorders were not taken into account. The results demonstrated that panic 
disorder, social phobia, separation anxiety disorder and specific phobia as 
measured with the ADIS-C were best predicted by their corresponding subscale 
of the SCARED-71 child version, all ps < .05. The corresponding subscale of the 
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SCARED-71 had the highest loading factor on the standardised canonical 
discriminant function. The subscale generalised anxiety was found to be a 
borderline significant predictor for the resembling ADIS-C diagnosis. 
Sensitivity and specificity scores were moderate to high for all subscales, 
indicating satisfactory to good classification.  
 Anxiety disorders as obtained with the ADIS-P were best predicted by 
their corresponding subscale on the SCARED-71 parent version, all ps < .05. The 
highest standardised canonical discriminant function coefficient of each 
subscale resembled the concerned anxiety diagnosis. The sensitivity and 
specificity scores of the subscales were moderate to high (see Table 5).  
 
 
Table 5  Discriminant classification of the SCARED-71 in clinically anxious children self-report (n = 
138) and parent-report (n = 138)  
 
      + Dis         - Dis     Wilks’  SCDF Sens      Spec 
   M (SD)  M (SD)  Lambda     
Child version         
Panic   11.8 (7.0)  6.5 (5.0)  .84* 1.04 0.70 0.79 
Generalised anxiety   9.3 (4.6)  7.0 (4.3)  .88** 0.87 0.64 0.69 
Social phobia  10.0 (4.2)  7.1 (4.4)  .70* 1.12 0.75 0.75 
Separation anxiety 12.3 (4.8)  6.1 (3.9)  .57* 0.78 0.80 0.85 
Specific Phobia  
 Animal   2.0 (2.2)  1.2 (1.8)  .83* 0.33 0.67 0.71 
 Medical   5.4 (3.4)  3.4 (2.9)  .83* 0.40 0.67 0.71 
 Situational   4.3 (2.6)  2.7 (2.2)  .83* 0.43 0.67 0.71 
 
Parent version         
Panic   10.5 (5.5)  5.7 (4.3)  .74* 0.98 0.68 0.78 
Generalised anxiety 10.5 (3.2)  6.9 (3.2)  .70* 1.04 0.78 0.81 
Social phobia  10.7 (3.6)  5.5 (3.6)  .60* 0.86 0.81 0.81 
Separation anxiety 12.8 (4.5)  7.4 (3.7)  .58* 0.96 0.78 0.84 
Specific Phobia 
 Animal   1.7 (2.2)  1.3 (1.8)  .66* 0.15 0.74 0.83 
 Medical   5.4 (3.4)  4.2 (3.3)  .66* 0.41 0.74 0.83 
 Situational   4.1 (2.6)  3.2 (2.2)  .66* 0.70 0.74 0.83 
Note: + Dis = with specific anxiety disorder; - Dis = without specific anxiety disorder; SCDF = 
Standardised Canonical Discriminant Function Coefficient; Sens. = Sensitivity, and Spec. = 
Specificity, * p < 0.05 
 
 
Discussion 
 
The current study examined the diagnostic utility of the SCARED-71 in both 
clinically anxious and control youths and their parents. The main results can be 
summarised as follows. First, the SCARED-71 possessed good internal 
consistency. Second, in line with the hypothesis, the child and parent version of 
the SCARED-71 differentiated clinically anxious from normal children on the 
total score and on all subscales. Third, girls reported more anxiety symptoms 
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than boys, but only on self-report. Fourth, children aged 15-18 reported a higher 
degree of anxious symptoms as compared to 8-14 year-olds. At subscale level, 
children reported more panic, generalised anxiety disorder and social phobia 
symptoms with older age groups, while situational phobia symptoms were 
lower in the older age groups. Parents reported more anxiety symptoms 
relating to separation anxiety, animal phobia and situational phobia, as children 
were older. Fifth, reliable cut-off scores were obtained. Finally, the SCARED-71 
discriminated across various anxiety disorders.  
The internal consistencies of the SCARED-71 child and parent version 
were, in line with research of Muris and colleagues (e.g. Muris et al, 2003), high 
except for situational-environmental phobia. The latter subscale consists of a 
wide variety of stimuli like height, thunder and darkness, which is likely to 
decrease homogeneity. The Cronbach’s alpha scores on the subscale social 
phobia were slightly higher, compared to SCARED-R studies (Muris et al, 
1999b; Muris et al., 2003), therefore the altered social phobia subscale seems 
more reliable.  
The child and parent version of the SCARED-71 differentiated clinically 
anxious from non-clinical children on the total score and on all subscales. This 
finding is in line with earlier studies using different SCARED versions (Muris et 
al., 2003; Muris et al., 2001). More over, previous research has shown that the 
DSM-based scale can differentiate between children with anxiety disorders and 
children with psychiatric disorders (Birmaher et al., 1997), disruptive disorders 
(Muris & Steerneman, 2001) and mood disorders (Muris et al., 2003). Hence, the 
majority of the data support the notion that the SCARED and its revisions have 
good discriminant validity.  
 In both clinical and control sample, girls reported higher levels of 
anxiety symptoms on the total SCARED-71 than boys. This finding is in line 
with previous studies showing that girls report more anxiety than boys (e.g., 
Castellanos & Hunter, 1999; Craske, 1997). Girls might report more anxiety 
symptoms because of gender stereotyping, cultural acceptance, parenting styles 
which promote anxiety in girls more and the more internalising coping style of 
girls which results in more anxiety (Craske, 1997). A study of Pierce and 
Kirkpatrick (1992) showed that when male students are given instructions that 
their truthfulness will be measured by means of changes in heart rate, their 
fears on a fear schedule increased while no such increase was found in female 
students. This implies that males as do boys may fill in fear and anxiety 
questionnaires in a cultural desirable way. 
 In line with other studies using different questionnaires, no gender 
differences were observed when using the parent version of the SCARED-71 in 
both the clinical and the control group (Straus & Last, 1993; Last et al., 1992). 
The lack of gender difference in parent report in the clinical group can be 
explained by the fact that parents perceive the anxiety symptoms of girls as 
normal and therefore are not inclined to search treatment unless the anxiety is 
very severe. If boys display anxiety symptoms parents might be more prone to 
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seek help. Therefore, the difference in gender might be less pronounced than in 
a normal sample (Craske, 1997).  
With respect to age, the finding that self-reported anxiety is higher in 
15-18 year-old clinically anxious children compared to 8-11 and 12-14 year-olds, 
is remarkable. From a clinical practice point of view, this finding can be 
explained by the fact that under the age of 12, parents are usually the ones who 
bring their child to a mental health care facility. The impact of the child’s 
anxiety will be better noticed by the parents than by the child itself. When the 
child researches puberty, he or she becomes more autonomous and will react 
against its parents and institutions like mental health care centres. Also the 
child might be afraid of reactions of peers and of stigmatising, which increases 
the threshold value for an older child to go to a mental health care centre. 
Therefore, only the teenagers with self-experienced severe anxiety symptoms 
may agree with referral for mental health care. The same age pattern was found 
for the control children, 15 to 18-year olds reported the highest anxiety 
symptoms. This could be explained by the fact that these adolescents are in a 
period of their lives in which they are approaching important life changes like 
independent living and work, which is found to increase anxiety (e.g. Caspi, 
Elder, & Bem, 1988). Perhaps, adolescents aged 15 to 18 might also fill in 
questionnaires less social desirable. A larger sample and a longitudinal design 
are necessary to further investigate this age effect. 
 At subscale level, more symptoms of panic, generalised anxiety and 
social phobia symptoms were reported by the 15-18 year old children, while 
situational phobia symptoms were less reported. Parents reported more anxiety 
symptoms relating to separation anxiety, animal phobia and situational phobia, 
in the 8-11 year olds. This is in line with the reported age of onset of anxiety 
disorders with the earliest mean age of onset for separation anxiety and specific 
phobia, while the age of onset for social phobia is approximately 10 years and 
the onset of generalised anxiety disorder is found to range between 10.8 to 13.4 
years. Panic disorder and agoraphobia are often only found in adolescence 
(Castellanos & Hunter, 1999; Craske, 1997). In line, a study examining physical 
and social evaluative fears separately showed that physical fears decreased 
with age, whereas social-evaluative fears increased with age (Westenberg et al., 
2004).  
 The difference in age effect between child and parent report for 
different anxiety disorders can be explained by the fact that parents can observe 
anxious behaviour related to separation anxiety and phobia more clearly than 
that of more internalising anxiety disorders as generalised anxiety disorder. 
Besides this, separation anxiety is also likely to intervene with parents’ 
functioning, while social phobia and generalised anxiety mostly hampers the 
child’s functioning. 
The cut-off scores of the SCARED-71, obtained in this study, can be 
useful for research and clinical practice to detect clinically anxious children and 
to evaluate high end state functioning in treatment studies. Sensitivity and 
Chapter 3 
 44
specificity scores were reasonably high, reflecting a reliable identification of 
children possibly having an anxiety disorder. The highest sensitivity and 
specificity scores in our study were found for the parent version. With a cut-off 
score of 21, the parent version seems to be the most reliable way to screen 
clinically referred anxious children, because the percentage of false positives 
and false negatives is the smallest compared to the child version or the 
combined version. This finding might be in line with aforementioned point that 
parents are usually the ones who bring the child to mental health care while the 
child might not want treatment or think its’ anxiety problems are not severe 
enough.      
 In the clinical sample, anxiety disorders were best predicted by the 
corresponding SCARED-71 subscale. This indicates that in general, subscales 
scores are a reliable indicator of the persistent clinical diagnoses. Only 
generalised anxiety symptoms reported by children were a borderline 
significant predictor of actual diagnosis. This can be explained by the fact that 
symptoms of generalised anxiety are less specific and show the same features as 
other anxiety disorders symptoms, which causes overlap with other anxiety 
disorders.   
 This study had some limitations. First, children with OCD and PTSD as 
a primary disorder were not included, therefore discriminant classification 
could not be obtained for these disorders. Second, age effects were measured 
cross sectional, while a longitudinal study is preferred to measure such effects. 
Third, most children were Caucasian, therefore ethnicity could not be taken into 
account and results can only be generalised to a Caucasian population. Fourth, 
although this study shows that the SCARED-71 is a good instrument to screen 
for anxiety disorders in children, no conclusions can be drawn related to other 
anxiety questionnaires. Hence, future research should compare the SCARED-71 
to other anxiety questionnaires like the SCAS and RCADS to investigate which 
questionnaire is most reliable and valid to detect children with clinically 
anxious problems.   
This study has shown that the SCARED-71 can be used as a screening 
tool in research and clinical practice. The SCARED-71 total score cannot only 
discriminate between control and clinically anxious children, there is also 
evidence for the discriminate validity of the SCARED-71 subscales across 
anxiety disorders.  
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Abstract 
 
This study examined the frequency of negative automatic thoughts concerning 
physical threat, social threat, personal failure and hostile intent in clinically 
anxious (n=139) and control children (n=61) by means of the Children’s 
Automatic Thoughts Scale (CATS; Schniering & Rapee, 2002). In line with the 
hypothesis, it was found that clinically anxious children reported more negative 
automatic thoughts compared to control children. On subscale level, clinically 
anxious children reported more negative automatic thoughts relating to 
physical threat, social threat and personal failure than control children, whereas 
no difference on the report of negative thoughts concerning hostile intent was 
found. Girls reported more negative thoughts on the subscale social threat, 
whereas boys reported more thoughts on hostile intent. In 15-18 year-olds, the 
highest frequency of negative automatic thoughts was found, compared to 8-11 
and 12-14 year-olds. The two latter did not differ significantly on frequency of 
negative thoughts. Some evidence for content specificity of automatic thought 
patterns was found, that is separation anxiety was best predicted by the 
physical threat subscale, social phobia was best predicted by social threat and 
depression was best predicted by the personal failure subscale of the CATS. 
 
Keywords; Anxiety disorders, Children, Cognitive assessment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative automatic thinking and anxiety in youth    
 47
Introduction 
 
The vast majority of effectiveness studies on Cognitive Behavioural Therapy 
(CBT) in children with anxiety disorders use anxiety questionnaires or 
interviews to measure change in anxiety symptoms, but do not measure 
possible changes in anxious children’s cognitions. As a result, it is unknown 
whether the demonstrated effects on anxiety are related to change in cognitions. 
To investigate whether cognition is an important mediator for change, reliable 
and valid assessment instruments are essential. 
 There are several self-report measures designed to assess dysfunctional 
thinking in children with anxiety and depression problems, e.g. the Negative 
Affect Self Statement Questionnaire (NASSQ; Ronan, Kendall & Rowe, 1994) 
and the Children’s Thoughts Questionnaire (CTQ; Marien & Bell, 2004). 
However, these questionnaires do not measure thoughts across internalizing 
and externalizing problems. Schniering and Rapee (2002) have developed the 
Children’s Automatic Thought Scale (CATS), which is a developmentally 
sensitive self-report measure designed to assess a wide range of negative 
automatic thoughts across internalizing and externalizing problems in children 
and adolescents, aged 7-16. The CATS consists of four distinct but related 
subscales namely physical threat, social threat, personal failure and hostile 
intent, which load onto one higher order factor. 
 Some studies have addressed the issue if anxious children can be 
characterised by having more negative thoughts compared to children from the 
general population. Most of them found that high anxious children report more 
negative cognitions than low anxious children (e.g. Ronan, Rowe & Kendall, 
1988; Zatz & Chassin, 1983). In line, results of Schniering and Rapee (2002) 
showed that anxious, depressed and behavioural disordered children reported 
significantly more negative automatic thoughts on the CATS than children from 
a community sample. On the CATS subscale level, anxious children had higher 
scores for physical threat, social threat and personal failure compared to the 
community children, whereas no difference was found on hostile intent. In 
another line of cognition research namely free recall, anxious children 
expressed more negative than neutral and positive thoughts related to an 
ambiguous situation, whereas control children expressed equal numbers of 
negative, neutral and positive thoughts (Bögels & Zigterman, 2000). Kendall 
(1984) has called this phenomenon, the power of nonnegative thinking, which 
implies that a lower frequency of negative cognitions instead of the presence of 
positive cognitions differentiates normal children from maladaptive children. 
Hence the amount of negative cognitions seems to be larger in children with 
anxiety disorders than in children without anxiety disorders.  
 Two factors are important when investigating cognition in children, 
namely gender and age. In general, anxiety and mood disorders are more 
frequent in girls, whereas disruptive behaviours are more frequent in boys 
(Verhulst, Van der Ende, Ferdinand, & Kasius, 1997). However, Schniering and 
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Rapee (2002; 2004a; 2004b) did not find a gender effect on the CATS total score in 
a community sample. Although, on subscale level, boys reported more hostile 
intent thoughts, while girls reported significantly more automatic thoughts on 
personal failure and social threat (Schniering & Rapee, 2002). The latter finding 
is in line with Campbell and Rapee (2004) who found that social threat 
cognitions were more frequent in girls. 
 It remains unclear whether negative thinking is related to age. Weems, 
Berman, Silverman, and Saavedra (2001) found a stronger association of 
cognitive distortions and anxiety in 12-17 year-olds compared to 6-11 year-olds. 
Also, results of several studies show that older children tend to have more 
catastrophising and personal cognitions (Prins, 2002). In contrast, no age 
difference was revealed on the CATS in a community sample (Schniering & 
Rapee, 2002; 2004a; 2004b). Similar results were shown in a study on loss and 
threat cognitions (Ambrose & Rholes, 1993). These inconsistent results warrant 
further investigation of the effect of age on cognitions in anxious children. 
 The content of the CATS subscales is based on Beck’s cognitive 
specificity model of anxiety. This model implies that thoughts are organised 
into distinct cognitive contents. These contents are specifically related to the 
expression of certain psychopathology. Thoughts on failure, loss and 
deprivation are associated with depression, whereas threat, danger and 
unpredictability are associated with anxiety and thoughts of being wronged are 
associated with anger (Beck, Brown, Steer, Eidelson, & Riskind, 1987; Beck & 
Clark, 1988). 
 Schniering and Rapee (2002; 2004a) found some evidence for the 
cognitive content-specificity of the CATS. Anxiety disorders were associated 
with social threat, depression associated with personal failure and behavioural 
disorders with hostile intent. However, in one study, physical threat was 
associated with anxiety disorders (Schniering & Rapee, 2002), but not in another 
study (Schniering & Rapee, 2004a). Furthermore, depressed children reported 
more automatic thoughts on personal failure than did anxious, normal and 
disruptive children (Schniering & Rapee, 2004a). The finding that anxiety is 
related to threat cognitions and depression is associated with personal failure 
cognitions is in line with other studies (Ambrose & Rholes, 1993; Jolly 1993; 
Jolly & Dykman, 1994; Marien & Bell, 2004). However, some studies did not 
find evidence for the cognitive specificity hypothesis (Epkins, 1996; Ronan & 
Kendall, 1997).  
 Also within anxiety disorders there is some evidence for content 
specificity. A study by Bögels, Snieder and Kindt (2003) showed that separation 
anxious children interpreted ambiguous stories in line with their fear compared 
to social phobic children and generalised anxious children. Social phobic 
children overestimated the danger of rejection compared to separation anxious 
children but not when compared to generalised anxious children. No support 
for the content-specificity hypothesis was found for generalised anxiety. Results 
of a study on social phobia showed that children with social phobia had a 
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higher level of negative self-talk regarding social evaluative situations 
compared to non-anxious children (Spence, Donovan & Brechman-Toussaint, 
1999). Further research seems necessary to further explore the content 
specificity hypothesis within anxiety disorders in order to enhance effectiveness 
of cognitive behaviour therapy by targeting specific thoughts. 
The main purpose of this study was to investigate the utility of the 
CATS to measure negative automatic thoughts in a clinically anxious and 
control sample. Firstly, consistent with the results of Schniering and Rapee 
(2002) it was predicted that clinically anxious children have more negative 
automatic thoughts on the total score, and on the subscales physical threat, 
social threat, and personal failure in comparison to the control sample. 
Secondly, it was hypothesised that girls have more negative thoughts on social 
threat and personal failure, while boys report more thoughts on hostile intent. 
Thirdly, gender and age differences are investigated. Fourthly, we investigated 
whether children with different types of anxiety disorders can be characterised 
by different types of automatic thoughts. As separation anxiety is being 
described as “worry that something might happen to them or to a significant 
other” (DSM-IV, APA, 1994), we hypothesised that separation anxiety in 
children would be predicted by the physical threat subscale. Social phobia is 
predicted to be related to the social threat subscale of the CATS. It is further 
hypothesised that panic disorder and specific phobia are best predicted by high 
scores on physical threat. Generalised anxiety disorder is predicted to be related 
to physical threat, social threat and personal failure, since these areas are all 
associated with worry. Fifthly, according to the cognitive specificity model, it 
was predicted that anxious children with comorbid depression would have 
higher scores on personal failure than anxious children without comorbid 
depression. 
 
Method 
 
Participants 
Participants were clinically anxious children (n = 139) and control (n = 61) 
children. The clinical sample consisted of referred children and adolescents who 
took part of a multi-centre randomized clinical trial comparing family CBT with 
individual CBT (Bodden et al., submitted). Children were included if they were 
8-18 years old, suffered from a primary anxiety diagnosis (other than obsessive 
compulsive disorder and post-traumatic stress disorder), and had an 
intelligence coefficient of ≥ 80. Children were excluded if they suffered from 
substance abuse, current suicide attempts, psychoses, autism spectrum 
disorders and untreated attention deficit hyperactivity disorder. There were 82 
(59%) girls and 57 (41%) boys, with a mean age of 12.5 (SD = 2.7). Sixty children 
(43%) attended primary education. The remaining 79 (57%) attended secondary 
education.   
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 The control sample consisted of children from the general population 
who were recruited via advertisements in newspapers and local stores and 
received a financial reward of €50 for their participation. Control children were 
comparable to the clinically anxious group based on age, F (1,198) = .67, p > .1 
and gender, χ2 = 2.9, p > .1. The age of the control children ranged from 8-18 
years (M = 12.2, SD = 2.6). There were 28 (46%) girls and 33 (54%) boys.  
Primary education was attended by 24 (39%) children and 37 (61%) received 
secondary education.  
To obtain diagnostic status, both child and parent version of the 
Anxiety Disorder Interview Schedule (ADIS c/p; Silverman & Nelles, 1988) 
were assessed. Primary and comorbid compound diagnosis of the clinical 
anxious children are outlined in Table 1. In control children, the prevalence of 
anxiety disorders was 3% (2 out of 61) and 2% (1 out of 61) for Attention Deficit 
Hyperactivity Disorder.  
 
 
Table 1  Primary and comorbid diagnosis of the clinical sample on the compound ADIS (n = 139) 
 
     Primary diagnosis  Comorbid diagnosis  
    N %  N % 
Diagnosis    
Social phobia   46 33%  48 35%  
Separation anxiety disorder  34 25%  24 17%  
Specific phobia   24 17%  58 42%  
Generalised anxiety disorder  24 17%  46 33%  
Panic disorder   11   8%  24 17%  
Obsessive-compulsive disorder        6   4%  
Posttraumatic stress disorder         6   4%  
Depressive and/or dysthymic disorder    26 19%  
Attention Deficit Hyperactivity disorder     11   8%  
Conduct Disorder        1     1% 
Oppositional Defiant Disorder      1   1% 
Pervasive Developmental Disorder      1   1% 
 
 
Measures 
 CATS 
All participants completed a translation of the Children’s Automatic Thought 
Scale (CATS; Schniering & Rapee, 2002). Children and adolescents have to 
indicate on a 5-point scale, the frequency with which they have experienced 
each thought over the past week. The scale ranges from not at all (0) to all the 
time (4). The 40 items are summed to provide a total score, with high scores 
reflecting a greater frequency of negative automatic thoughts. The CATS 
consists of 4 subscales: physical threat (e.g. “I’m going to get hurt”), social 
threat (e.g. “I look like an idiot”), personal failure (e.g. “I am worthless”) and 
hostile intent (e.g. “Most people are against me”). The CATS has a good internal 
consistency and test-retest reliability (Schniering & Rapee, 2002, 2004b).  
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ADIS 
In both samples, a semi structured diagnostic interview was administered, 
namely the ADIS child and parent version. This interview is specifically 
designed to measure anxiety disorders, depression and externalising disorders 
in 7-17 year-olds. Each diagnosis has a severity score that ranges between 0 and 
8, with a score of 4 or higher indicating a clinical diagnosis. The child and 
parent version were combined into a compound summary. The ADIS-C/P 
possesses good inter-rater (Silverman & Nelles, 1998) and high test-retest 
reliability (Silverman & Eisen, 1992).  Research assistants in our study had to 
videotape 4 own interviews, which were re-rated by 2 trained students. The 
mean inter-rater agreement for diagnoses (kappa) was 0.89 for the ADIS-C and 
0.83 for the ADIS-P. 
 
Procedure 
All children and parents received and signed an informed consent. Clinically 
anxious children were assessed before treatment and families from the general 
population were measured once. The ADIS interviews with parents and child 
were conducted by a research assistant. Furthermore, all family members filled 
out a battery of questionnaires, including the CATS. All children were assisted 
by a research assistant if necessary.  
 
Analysis 
Missing data were predicted using the missing value analysis of SPSS based on 
regression models using available data of the group mean, the available data of 
the individual and the pattern of change of the group. Differences on the total 
CATS score were calculated by ANCOVA. To measure differences on the 
subscales, a MANCOVA was carried out. Discriminant analyses were carried 
out to investigate content specificity within anxiety disorders. 
 
Results 
 
Internal consistency 
Firstly, the internal consistency was calculated using the total sample of 200 
children and adolescents. The Cronbach’s alpha coefficient for the total CATS 
score was .94 in the total sample, which indicates a high degree of homogeneity. 
The internal consistencies for the subscales were also high, with alphas of .85 
for physical threat, .90 for social threat, .92 for personal failure and .82 for 
hostile intent. 
 
Clinical versus control 
To test whether the clinical and control group differed, an ANCOVA was 
carried out, with a correction for gender and age. It was revealed that clinically 
anxious children reported significantly more negative automatic thoughts than 
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children from the general population, F (1, 196) = 10.5, p < .01, pooled effectsize = 
0.6. Means can be found in Table 2. 
 
 
Table 2  Mean CATS Scores and Standard Deviations in the clinical (n = 139) and control sample (n 
= 61)  
 
    Clinical sample   Control sample  
    M     SD      M     SD     F      
Physical threat           5.8   6.7    2.4   3.4  12.9* 
Social threat    8.6   7.9    4.2   4.1  14.8* 
Personal failure        8.6   8.2    3.4   4.3  10.3*  
Hostile intent          7.7   6.9    7.9   5.9    0.0  
Total CATS score       29.3 24.2  18.0 13.6  10.5*  
Note:   * = p < 0.01 
 
 
A MANCOVA with the four subscales as dependent variables, revealed 
a main effect for group as well, FHotelling (4, 193) = 6.4, p < .01. Follow-up 
ANOVAs showed that the clinically anxious group reported more thoughts on 
physical threat, F (1, 196) = 12.9, p < .01, pooled effectsize = 0.7, social threat, F (1, 
196) = 14.8, p < .01, pooled effectsize = 0.7 and personal failure, F (1, 196) = 10.3, p 
< .01, pooled effectsize = 0.8 compared to children from the general population 
but no difference on hostile intent occurred, F (1, 196) = 0.0 (see Table 2).  
 
Gender effect 
An ANCOVA was carried out, to test whether gender influenced the total score 
of negative automatic thoughts, corrected for group and age. No main effect for 
gender was found, F (1, 196) = 0.5, p > .1. Also, no interaction effects with 
group, F (1, 192) = 0.2, p > .1 or age were found, F (1, 192) = 0.3, p > .1. Means 
can be found in Table 3. 
 However, across the four subscales, gender did influence the degree of 
negative automatic thoughts, FHotelling (4, 193) = 3.9, p < .01. Girls reported a 
significant higher degree of negative automatic thoughts related to social threat 
compared to boys, F (1, 196) = 4.1,  p < .05, whereas boys report more negative 
automatic thoughts on hostile intent than girls, F (1, 196) = 3.9 p = .05. No 
significant difference between boys and girls was found on the physical threat 
subscale, F (1, 196) = 1.1, p > .1 and on personal failure, F (1, 196) = 1.3, p > .1 
(see Table 3). Furthermore, no significant group by gender and age by gender 
interaction effects occurred, respectively FHotelling (4, 189) = 0.5, p > .1 and 
FHotelling (4, 189) = 0.6, p > .1 (see Table 3). 
 
 
 
Negative automatic thinking and anxiety in youth    
 53
Table 3  Mean CATS Scores and Standard Deviations for boys (n = 90) and girls (n = 110)  
 
            Boys                   Girls           
    M     SD     M     SD     F      
Physical threat           4.0   5.5    5.3   6.5  1.1  
Social threat    5.4   5.4    8.8   8.2  4.1** 
Personal failure       4.7   6.3    7.2   8.1  1.3  
Hostile intent          8.9   6.7    6.8   6.5  3.9**  
Total CATS score       23.0 19.1  28.1 24.2  0.5  
Note:  ** = p  < 0.05 
 
  
Age effect  
In order to examine age effects corrected for gender and group, an ANCOVA 
was carried out with age categorised into 3 age groups, namely 8-11, 12-14 and 
15-18 year-olds. A significant age effect corrected for gender and group was 
found, F (1, 196) = 6.2, p < .05. Further analysis between the 3 age groups 
showed that only 15-18 year-olds reported significantly higher levels of 
automatic thoughts compared to 8-11, F (1, 128) = 9.2, p < .01 and 12-14 year-
olds, F (1, 117) = 19.2, p < .01. The 8-11 and 12-14 year-olds did not differ 
significantly, F (1, 149) = 2.6, p > .05. Again, no interaction effect with group, F 
(1, 192) = 0.1, p > .1 was found. Means can be found in Table 4. 
 
 
Table 4  Mean CATS Scores and Standard Deviations for age 8-11 (n =81), 12-14 (n = 70) and 15-18 (n 
= 49)  
 
    8-11 year old 12-14 year old 15-18 year old  
    M   SD   M  SD   M   SD    F      
Physical threat      5.4   6.5   2.5   3.4   6.9   7.3   0.1 
Social threat      5.2   5.3   6.6   6.5 11.6   9.1   19.9* 
Personal failure         4.9   6.2   4.1   4.7 10.0   1.4  13.6* 
Hostile intent      8.9   6.9   6.4   6.0   7.9    6.8   0.4 
Total score        24.3 20.3 19.5 15.7 37.3  28.2   6.2** 
Note:   * = p < 0.01 and ** = p < 0.05 
  
 
Across the four subscales, a significant age effect was found, F (4, 193) = 
8.1, p < .01. Children aged 15 to 18, reported more negative thoughts concerning 
social threat, F (1, 196) = 19.9, p <. 01 and personal failure, F (1, 196) = 13.6, p < 
.01 but not concerning physical threat, F (1, 196) = 0.1, p > .1 and hostile intent,  
F (1, 196) = 0.4, p > .05. Both the subscales social threat and personal failure 
showed a linear pattern; scores increase as age increases (see Table 4). 
Furthermore, no significant group by age interaction effect was revealed, 
FHotelling (8, 372) = 0.1, p > .05. 
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Are different anxiety disorders associated with different cognitions? 
In order to investigate whether having a specific anxiety disorder can be 
predicted by having automatic thoughts concerning a specific subscale, a 
discriminant analysis was carried out. The primary diagnosis was used, since 
this diagnosis caused the most interference with daily functioning and will 
therefore be associated with more frequent automatic thoughts related to that 
anxiety. In line with the hypotheses, separation anxiety disorder (n = 34) was 
best predicted by the physical threat subscale with a standardised canonical 
discriminant function coefficient (scdfc) of 1.10, followed by social threat (scdfc 
= -.62), personal failure (scdfc = -.40) and hostile intent (scdfc = .28), Wilks’ 
Lambda = .90, p < .01. Also in line with expectations, social phobia (n = 46) was 
best predicted by the social threat subscale of the CATS with a standardised 
canonical discriminant function coefficient of 1.35, followed by physical threat 
(scdfc = -.72), personal failure (scdfc = -.42) and hostile intent (scdfc = -.21), 
Wilks’ Lambda = .84, p < .01. In contrast to our hypotheses, specific phobia (n = 
24) and panic disorder (n = 11) were not predicted by the physical threat 
subscale, respectively Wilks’ Lambda = .97, p > .05 and Wilks’ Lambda = .94, p > 
.05. In line with expectations, generalised anxiety disorder (n = 24) was not 
predicted by a specific subscale, Wilks’ Lambda = .97, p > .05. 
 
Do children with comorbid depression have more thoughts on personal failure? 
To investigate the hypothesis that clinically anxious children with comorbid 
depression have a significantly higher score on the CATS subscale personal 
failure, the group of clinically anxious children was divided into a group 
without depressive disorder and/or dysthymic disorder (n = 113) and a group 
with depressive disorder and/or dysthymic disorder (n = 26). Children with 
depression and/or dysthymic disorder (M = 11.7, SD = 10.4) reported 
significantly more negative automatic thoughts on personal failure than 
children without depression and/or dysthymic disorder (M = 6.2, SD = 7.2),  
F (1, 137) = 10.2, p < .01. Children with depression and/or dysthymic disorder 
(M = 11.8, SD = 9.4) also reported significantly higher levels of automatic 
thoughts on social threat than children without depression and/or dysthymic 
disorder (M = 7.8, SD = 7.4), F (1, 137) = 5.6, p < .05. No difference was found on 
physical threat, F (1, 137) = 0.0, p > .05 and hostile intent, F (1, 137) = 0.2, p > .01. 
The discriminant analysis showed that depression was predicted by high scores 
on personal failure (scdfc = 1.44), followed by physical threat (scdfc = -.98), 
social threat (scdfc = -.10) and hostile intent (scdfc = .03), Wilks’ Lambda = .87,  
p < .01. 
 
Discussion 
 
The aim of this study was to investigate the utility of the CATS to measure 
negative automatic thoughts in clinically anxious and control youths. The main 
results can be summarised as follows. The first finding of this study is that, in 
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line with our hypothesis and Schniering and Rapee (2002), clinically anxious 
children reported more negative automatic thoughts compared to control 
children on the total score and on the subscales physical threat, social threat and 
personal failure. Secondly, girls reported more negative automatic thoughts on 
the subscale social threat, whereas boys reported more thoughts concerning 
hostile intent. Thirdly, 15-18 year-olds reported the highest frequency of 
negative automatic thoughts, compared to 8-11 and 12-14 year-olds. The latter 
two did not differ. Fourthly, children with separation anxiety reported more 
thoughts concerning physical threat, while children with social phobia as 
primary anxiety disorder reported more thoughts on social threat. Fifthly, 
anxious children with comorbid depression had higher scores on personal 
failure than children without comorbid depression. 
 The finding that anxious children reported a higher frequency of 
negative anxiety related thoughts (total CATS score) is in line with different 
studies, some using the same methodology to measure cognitions for example 
by means of self report (Ronan, et al., 1988), and some using different 
methodology like interpretations of ambiguous situations (Bögels & Zigterman, 
2000).  
 On subscale level, clinically anxious children report more negative 
automatic thoughts concerning physical threat and social threat compared to 
control children. This finding is consistent with Beck’s cognitive specificity 
model, which states that threat is more related to anxiety (Beck et al, 1987; Beck 
& Clark, 1988). No difference on the hostile intent subscale was found, which is 
also consistent with the cognitive specificity model. Hostile intent is more 
associated with externalising disorders.  
 In line with the hypothesis and the findings of Schniering and Rapee 
(2002), high scores on the personal failure subscale in the clinically anxious 
group were found. This can be explained by the fact that thoughts on personal 
failure might not be specific for depression. Marien and Bell (2004) suggest a 
cognitive overlap between anxiety and depression, which is called negative 
cognitivity. Negative cognitivity is a general negative cognitive bias 
characterised by negative thoughts like negative self-evaluation, prediction of 
negative outcomes, and a negative interpretation bias. Also a study by Jolly 
(1993) showed that anxious cognitive content correlated to clinician and self-
report anxiety symptoms but also correlated to self-reported depressive 
symptoms.  
 Jolly and Dykman (1994) found evidence for a more cognitive level of 
the tripartite model, in which a general distress factor is considered as a shared 
feature for depression and anxiety but also anxiety and depression are seen as 
having unique characteristics (Clark & Watson, 1991). In adolescents, anxious 
cognitions were associated with anxiety, depressive cognitions were associated 
with depression and both were also associated with more general cognitions. 
Ambrose and Rholes (1993) showed that the severity of anxious cognitions have 
an influence on the overlap of depressive cognitions in anxious children. At 
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some level of severity, threat cognitions encourage depressive symptoms and 
the association of anxious cognitions and anxious symptoms becomes less 
strong. Hence, in children with high threat cognitions also depression-related 
cognitions are prevalent. Even more, 19% of the clinically anxious children had 
comorbid depression, which might cause the increase in negative automatic 
thoughts concerning personal failure in anxious children. 
 Girls had higher scores on social threat, while boys reported more 
negative thoughts on hostile intent. This could be due to gender role 
stereotyping, in which boys are not culturally allowed to report anxious 
thoughts. A study of Pierce and Kirkpatrick (1992) showed that when male 
students are given instructions that their truthfulness could be measured by 
means of changes in heart rate, their fears on a fear schedule increased while no 
such increase was found in female students. This implies that males as do boys 
fill in the questionnaire in a cultural desirable way. Girls are also more 
concerned with others’ opinions of them because they want to be “liked” 
(Rosenberg & Simmons, 1975) thereby they might have more negative thoughts 
on the social threat subscale. This is also in line with Campbell and Rapee 
(1994), who showed that social threat thoughts were more prevalent in girls. 
Furthermore, internalising problems are more prevalent in girls, while 
externalising problems are more prevalent in boys (Verhulst et al., 1997), which 
might result in more corresponding cognitions of respectively social threat and 
hostile intent. In contrast to Schniering and Rapee (2002) no difference on the 
personal failure subscale was found between boys and girls. In conclusion, 
there are gender differences in thoughts of clinically anxious children. 
 The finding that 15-18 year-olds report more negative automatic 
thoughts than 8-14 year-olds on the total CATS score, social threat, and personal 
failure can be explained by Piaget’s theory. Piaget (1987) proposed three 
different stages of reasoning. First, the preoperational stage (1,5-7 year-olds), in 
which children generate a limited number of possible solutions. Second, the 
concrete operational stage (7-11 year-olds), in which children are able to 
generate several possibilities and are able to perform deductive reasoning. 
Third, the formal operation stage (>11 year-olds), in which children are able to 
anticipate an unlimited number of possibilities and perform deductive 
reasoning. Thus, with increasing age, the child’s cognitive skills develop and 
the child will form more possible outcomes, increasing the risk of having more 
negative cognitions. The older children also reported more negative thoughts 
on personal failure. This is in line with Brady and Kendall (1992) who showed 
that younger children often solely have anxiety, while older children have 
anxiety with comorbid depression. The fact that social threat cognitions 
increased, is in line with the fact that the onset of social anxiety commonly 
occurs in early to mid adolescence (Bernstein, Borchardt, & Perwien, 1996). Due 
to the cognitive development of anxious children, thoughts increase in number 
and severity.  
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 Some evidence for diagnostic specificity of the type of negative 
automatic thoughts within specific anxiety disorders was found. Children with 
separation anxiety disorder and social phobia had higher scores on respectively 
physical threat and social threat than children without these primary diagnoses. 
These two findings are consistent with the corresponding DSM-IV criteria of the 
diagnosis (APA, 1994). The fact that we did find evidence for the specificity of 
negative thoughts in children with social phobia and children with separation 
anxiety might suggest that the effectiveness of cognitive behaviour therapy can 
be enhanced by targeting these specific thoughts when the child is diagnosed 
with separation anxiety or social phobia. Contrary to our hypothesis, we did 
not find that children with specific phobia and panic disorder had more 
negative thoughts on physical threat compared to children without those 
disorders. As for children with generalised anxiety disorder we did not find 
higher scores on all the subscales compared to children without generalised 
anxiety disorder. This is in line with the study by Bögels et al. (2003), who 
found that children with generalised anxiety symptoms did not report more 
interpretations consistent with the content of their fear.  
 Clinically anxious children with comorbid depression had a higher 
score on the subscale personal failure. Several studies show that depressed 
children have more thoughts related to personal failure than non-depressed 
children (Kaslow, Stark, Printz, Livingston & Tsai, 1992). The latter finding is 
also consistent with Beck’s cognitive specificity model (Beck et al., 1987; Beck & 
Clark, 1988) and other studies showing that depression is associated with 
cognitions concerning personal failure (Ambrose & Rholes, 1993; Jolly 1993; 
Marien & Bell, 2004). The higher frequency of social threat thoughts can be 
explained by the fact that depressive children often withdraw from peers, 
thereby increasing anxiety to interact with peers (de Wit, 2000). Taken together, 
this research and previous literature shows that children with (comorbid) 
depression have more personal failure thoughts. 
 The limitations of this study are that we did not include a sample of 
children with externalising disorders, nor did we include children with 
depression as primary diagnosis. Furthermore, this study was cross sectional 
instead of longitudinal. When anxious and non-anxious children are followed 
throughout their development on their automatic thoughts related to threat, 
one might find different results.    
 The finding that negative automatic thoughts are more prevalent in 
clinical children stresses the importance of changing negative cognitions during 
treatment. Mifsud and Rapee (2005) already demonstrated that a significant 
change on the CATS was found after a school based cognitive intervention. 
Future studies should assess cognitions in effectiveness studies as well, to not 
only compare effects related to anxiety but also related to cognitions. 
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Introduction 
 
Anxiety disorders are the most prevalent disorders in children, cause 
interference with daily functioning of the child and if untreated the prognosis of 
an anxiety disorder is quite poor (Keller, et al., 1992). Of 725 children aged 6 to 
19 year-olds, 14% were found to have an anxiety disorder (past or present), of 
which 66% still had an anxiety disorder after approximately 4 years duration 
(Keller et al., 1992). Moreover, other research has shown that children with 
anxiety disorders still met diagnostic criteria up to 8 years after the onset of the 
anxiety disorder (Kovacs & Devlin, 1998).  
Diverse treatments for children with anxiety disorders exist for instance 
pharmacotherapy, Cognitive Behavioural Therapy (CBT), Psychodynamic 
Therapy, Eye Movement Desensitisation and Reprocessing (EMDR) and 
Relaxation Therapy. However, Cognitive Behavioural Therapy (CBT) is the only 
evidence-based treatment in children with anxiety disorders. This chapter 
contains a review regarding CBT throughout the last twenty years. The 
components, the history and the diverse variations of CBT will be discussed. 
Even more, a table with randomised control trials will be provided.   
In the last quarter of this century, a substantial number of randomised 
control trials were conducted to study the effectiveness of CBT. CBT includes a 
range of therapeutic techniques based on the principle that thoughts, feelings 
and behaviour are closely related. CBT includes a combination of different 
techniques to recognise and alter distorted thoughts that anxious children and 
adolescents experience prior to or in a feared situation. It is assumed that these 
distorted cognitions (overestimation of negative events or danger and inability 
to cope with threat) lead to anxiety and maladaptive behaviour like avoidance. 
By modifying these cognitions, behaviour will change as well. Furthermore, 
CBT consists of techniques to change behaviour. The most commonly used 
technique is exposure in vivo. This real life exposure consists of approaching 
the feared stimuli or situation gradually from least to most fearful. So far, CBT 
is proven to be the only efficacious treatment for children with anxiety 
disorders.   
 
Components of CBT 
CBT for children with anxiety disorder has basically 5 components; psycho 
education, somatic management skills, cognitive restructuring, exposure and 
relapse prevention. Psycho education provides information about anxiety and 
the feared stimuli. Somatic management provides techniques to reduce 
autonomic arousal and related physiological responses by making the child 
aware of its reaction to anxiety and to control these reactions. Furthermore, 
relaxation training, often a combination of progressive muscle relaxation, deep 
breathing and cognitive imagery, is used.  
Cognitive restructuring focuses on identifying maladaptive thoughts 
and teaching the child a more coping focused thinking. Behaviour experiments 
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can help to challenge maladaptive thoughts. In behavioural experiments, 
evidence is collected as a support for or against a certain hypothesis the child 
has concerning its anxiety. Exposure involves a gradual approach towards a 
feared stimuli or situation so anxiety can decrease, this is called extinction. 
Through recurrent exposure, the link between the feared stimulus and the 
anxiety reaction will weaken. Often an anxiety hierarchy is generated with 
anxious situations or stimuli that gradually increase in severity from low to 
most fearful.  
Relapse prevention methods provide consolidating and generalising 
principles to maintain treatment effects over time. Furthermore, a commonly 
used technique in CBT is modelling. Modelling involves demonstrating 
courageous behaviour in a fearful situation so the child can imitate this desired 
coping behaviour in reaction to its own anxiety.   
 
Pioneers in CBT  
In contrary to adult anxiety literature, treatment studies involving children with 
anxiety disorders were not conducted until late in the 20th century. In 1988, 
King, Hamilton and Ollendick concluded that behavioural techniques were 
effective in specific childhood fears and phobias. A year later, Kane and Kendall 
(1989) conducted a pilot study in which 16 to 20 sessions CBT were given to 4 
children aged 9 to13 with overanxious disorder. Both post treatment as follow-
up data showed a decline on parent, clinician and child report questionnaires.  
Dadds, Heard and Rapee (1992) were the first to report preliminary 
results on a treatment with parental involvement. In their study, a 12-session 
family anxiety management training was given parallel to child CBT. Children 
aged 7 to 14 with overanxious disorder (n = 10) and separation anxiety disorder 
(n = 4) were randomised to CBT with family management (n = 7) or the waitlist 
condition (n = 7). Child CBT with family anxiety management was found to be 
more effective (70% free of anxiety disorders) than the waitlist condition (0% 
free of anxiety disorders) (Dadds et al., 1992). 
From this point on, diverse protocols were developed and randomised 
control trials were conducted for children with anxiety disorders. CBT was 
given in individual (child alone) CBT format or group CBT format. Additionally 
family components were included throughout the development of CBT for 
anxiety disorders in children. This family component was given parallel to child 
CBT. Recently, family CBT was developed involving both children and parents 
simultaneously in treatment. Outcome measures usually reflect the percentage 
of children free from any anxiety diagnosis (adf) or the percentage of children 
free from their primary anxiety diagnosis or the most intervening diagnosis 
(pdf). An overview of these RCT’s can be found in Table 1.  
 
Individual CBT 
Kendall was the first to develop a CBT program for children with anxiety 
disorders namely Coping cat (Kendall, Kane, Howard, & Siqueland, 1990). This 
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program involves 16 to 20, 60-minute weekly sessions for children aged 7 to 13. 
The program consists of a treatment manual for the therapist and a workbook 
for the child. Both are developed especially for children with a primary 
diagnosis of separation anxiety disorder, generalised anxiety disorder or social 
phobia. The main principles are recognising anxious feelings and physiological 
reactions to anxiety, identifying and challenging cognitions in anxiety-
provoking situations, developing coping strategies with the fearful situation 
(coping self-talk), exposure and evaluating performance. The FEAR acronym is 
used; F-Feeling frightened?; E-Expecting bad things to happen; A-Actions and 
attitudes that help; and R-Results and rewards (Kendall et al., 1990).  
Kendall was also the first to publish data on Individual CBT. His study 
showed that Individual CBT (64% pdf) is more effective compared to waitlist 
(5% pdf) (Kendall, 1994). Barrett adapted Kendall’s coping cat into Coping Koala 
(Barrett, Dadds & Rapee, 1996), which focuses more on exposure and cognitive 
restructuring. This adapted version was also effective in treating children with 
anxiety disorders with percentages ranging from 57% (post treatment) to 71% (1 
year follow-up) free of anxiety diagnosis (Barrett et al., 1996). Even more, this 
protocol has been translated in other languages, including a Dutch protocol 
called “De dappere kat” by Nauta, Scholing, Emmelkamp and Minderaa (2001). 
Another individualised CBT is Social Effect Therapy (SET-C; Beidel, 
Turner, & Morris, 2000), which was developed specifically for children with 
social phobia. The treatment involves reduction of social anxiety, improvement 
of social skills and an increase of participation in social activities. The 
components consist of education, social skills training, peer generalisation 
experiences (practice acquired social skills in different natural settings) and 
exposure in vivo. SET-C combines child alone and group sessions. This 
treatment was proven to be effective (67% pdf), even up to 6 months follow-up 
(85% pdf) (Beidel et al., 2000). 
 
Individual CBT with parents 
In 1996, Howard and Kendall extended the Coping Cat protocol to a family 
based CBT. In a pilot study with 6 children with overanxious disorder and 
separation anxiety disorder, it was found that this treatment was effective, 
indicated by the fact that 83% did not fulfil criteria of any anxiety diagnosis 
(Howard & Kendall, 1996). 
Barrett et al. (1996) tested the additive efficacy of additional family 
anxiety management combined with the Coping Koala protocol for child CBT 
(Heard, Dadds, & Rapee, 1991 in Barrett et al., 1996). Family anxiety 
management involves education of the parents in contingency management to 
reinforce coping and courageous behaviour and ignore anxious behaviour, it 
teaches parents to cope with their own anxiety and model positive or adaptive 
coping in stressful situations (management of own anxiety), and parents receive 
a training in communication and problem solving skills, so they are better able 
to work as a team. This intervention consists of 12 sessions and can be given in 
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a parent group format (Barrett, 1998) or a combination session with first, the 
child alone, followed by child and parents together. At post treatment 
individual CBT combined with family management (84% adf) was more 
effective than individual CBT alone (57% adf). However, at 6 months follow-up 
this effect disappeared. Again, at 1-year follow-up, an additive value of 
individual CBT with family management was shown (Barrett et al., 1996).  
Besides working with parents, sometimes teachers are involved. A 
Parent and teacher training (King et al, 1998) was given to parents of children 
with school refusal. It involves parent sessions and school personnel 
consultation. Parents receive 5 sessions in behaviour management strategies 
focussed on school attendance, are taught to use positive reinforcement and 
received cognitive therapy. School personal consultation consisted of discussing 
the treatment plan, facilitating the child’s return and teaching positive 
reinforcement with school personnel (King et al., 1998). Two studies of King et 
al. (1998 and 1999) have shown that individual CBT with parent/teacher 
training was effective in the percentage of children with school refusal meeting 
the criterion of 90% school attendance.  
Exposure based contingency management (Silverman, Kurtines, Weems, et 
al., 1999) was developed to facilitate exposure by using contingency 
management techniques for parents. Parents were taught behavioural strategies 
like positive reinforcement and reward to help the child with the exposure. 
Contingency management (55% adf) was found to be as effective as a control 
educational support (56% adf) and less effective as self control exposure (88% 
adf) (Silverman, Kurtines, Weems, et al., 1999). 
Nauta et al. (2001) developed a 7-session Cognitive parenting program 
focusing on parents’ behaviour, thoughts and feelings regarding their anxious 
child. This program was given additionally to child CBT. Sessions consisted of 
providing psycho education, behavioural advice and parenting skills, problem 
solving skills and targeting parents’ thoughts about their anxious child. No 
additive value of this parenting program was found (Nauta et al. 2001; Nauta, 
Scholing, Emmelkamp, & Minderaa, 2003).  
Not only protocols but also books are used in treatment studies. The 
book Keys to parenting your anxious child (Manassis, 1996 in Manassis et al., 2002) 
is used in different studies using a group therapy for parents. It contains 
strategies to educate and help parents cope with their child’s anxiety (Manassis 
et al., 2002). 
 
Individual CBT with anxious parents  
Cobham, Dadds and Spence (1998) conducted a study to investigate whether 
individual CBT with parental involvement is more effective when parents are 
anxious themselves. Parents had to have a State Trait Anxiety Inventory (STAI: 
Spielberger, 1973) score of 40 or higher to be labelled as anxious. They 
developed an intervention named Parental anxiety management (Cobham et al., 
1998). This intervention consists of 4 parent sessions in combination with 10 
CBT Overview 
 65
sessions of child CBT (Coping Koala). The sessions involved psycho education, 
cognitive restructuring, relaxation training, and contingence management. It 
was found that in the short term, individual CBT with parental involvement 
was more effective when parents were anxious themselves. At follow-up the 
additive value of parental involvement disappeared. Children with non-
anxious parents were treated equally well with individual CBT or individual 
CBT with parental involvement both at short term as at long term follow-up 
(Cobham et al., 1998).  
 
Group CBT 
Barrett adapted and extended Kandall’s Coping Cat into a group format of 
Coping Koala (Barrett, 1998). This format showed to be effective at post 
treatment and 1-year follow-up (respectively 56% and 6%% adf). Another group 
format was developed by Flannery-Schroeder and Kendall (2000) using the 
Coping Cat protocol. At post treatment, group CBT (50% pdf) was not 
significantly more effective than individual CBT (73% pdf). Also, at 3-month 
follow-up, the percentage children free of their primary anxiety disorder did 
not differ significantly, group CBT 53% and individual CBT 79% (Flannery-
Schroeder & Kendall, 2000). 
 
Group CBT with parents 
Barrett (1998) tested the additive efficacy of additional family anxiety management 
combined with the Coping Koala group version. Group CBT with family 
management was equally effective as solely group CBT both at post treatment 
and at 1-year follow-up (Barrett, 1998). Another group version of the Coping 
Cat workbook was developed namely, the Coping Bear workbook (Manassis, 
Avery, Butalia, & Mendlowitz, 2004). 
Spence, Donovan, and Brechman-Toussaint (2000) specifically 
developed a group CBT with parental involvement for children with social phobia. 
The program involves social skills training, relaxation techniques, social 
problem solving, positive self-instruction, cognitive challenging and exposure 
(social skills practice in “games” session). Parental involvement consisted of 
modelling, reinforcing social skills and encouraging the child to socially 
interact. Parents observed the child’s group session through a one-way screen. 
Furthermore, parents received handouts and group training sessions. Group 
CBT with parental involvement (88% pdf) was more effective than solely group 
CBT (58% pdf) at post treatment. At 1-year follow-up, group CBT with parental 
involvement (88%) was trend significant more effective than group CBT (53%), 
indicating an almost significant finding (Spence et al., 2000). 
In 2000, Barrett and colleagues further refined family based group CBT, 
which was called Friends (Barrett, Lowry-Webster, & Turner, 2000 in Shortt, 
Barrett, & Fox,. 2001). Friends is a acronym for strategies which are taught; F- 
Feeling worried?; R- Relax and feel good; I-Inner thoughts/I can do it; E-
Explore solutions and coping plans; N-Nice work so reward yourself; D-Don’t 
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forget to practice; and S-Stay calm, you know how to cope now. The Friends 
program also teaches children to think of their body as friend (the body shows 
the child when it’s anxious), to be their own friend (try hard and reward 
themselves), to make friends (social support) and to talk to their friends in 
difficult situations. There are two developmentally sensitive versions; one for 
children aged 6 to 11 and one for youth aged 12 to 16. The parents are involved 
in a group format by teaching them cognitive restructuring and to cope with 
their own anxiety, reinforcement strategies, partner support training and to 
engage in social activities. This parent training can be given either in 4, 1½-hour 
sessions or 10 sessions of 40 minutes parallel to the child sessions. The Friends 
program with parental involvement was effective; 69% of the children was free 
of all their anxieties at post treatment. At 1-year follow-up, this percentage was 
68% (Short et al., 2001). Currently, a study is investigating the effectiveness of 
the FRIENDS program in Dutch children. Results have not been published yet 
(Treffers, Ferdinand, Van Widenfelt, Utens, Liber & van der Leeden, personal 
communication). 
Facing your fears (Cobham, 2003) is another group CBT program, which 
consists of 6 sessions. Both child and parent are present in the beginning and 
end of the sessions. This program contains of two steps namely helpful 
thoughts and brave behaviours. This program was given specifically to non-
anxious parents. At post treatment, no child was free of its anxiety disorder. At 
3-month follow-up, 80% was free of their anxiety disorders. This percentage 
even climbed to 100% (adf) at 1-year follow-up (Cobham, 2003). 
Family CBT  
Two studies did include the parents in the child sessions, so the child and 
parents were simultaneously involved in the treatment. The Attachment based 
family therapy of Siqueland, Rynn and Diamond (2005) focuses on family 
interaction like parental beliefs about anxiety, overprotection and psychological 
control. The main goal of therapy is to encourage his or her autonomy. Three to 
four sessions are alone with the adolescent to establish the child’s autonomy. 
Parents are taught CBT skills to help their child and not to cope with their own 
fear. This treatment was not found to be more effective than individual CBT 
alone (Siqueland et al., 2005). 
In a study of Wood, Piacentini, Southam-Gerow, Chu, and Sigman 
(2006) a family based CBT program named the Building confidence program was 
used. This therapy focuses on parental communication, more specifically 
intrusiveness and autonomy granting. This program combines child CBT 
techniques like skills training and exposure with parent training. Sessions were 
divided in three parts; child alone (15 to 30 minutes), parents alone (25-30 
minutes) and parents and child together (10 to 15 minutes). The family based 
building confidence program (79%) was equally effective compared to 
individual CBT (53%) at post treatment (Wood et al., 2006).    
Recently, a new family CBT was developed, including both parents and 
siblings of anxious children (Bögels & Siqueland, 2006).  In this family CBT, 
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child and parents are taught to reduce their own anxiety using CBT skills. The 
therapist guides the parents to be co therapists of the child by modelling 
courageous behaviour and guiding the exposure of the child. Dysfunctional 
thoughts of parents on parenting (“I have to be available to my child all the 
time”), the anxious child (“My child is vulnerable”), and the safety of the child’s 
world (“The world is full of anger”) are targeted. The child’s thoughts 
concerning the parents (“I’m not allowed to bother my parents with my 
anxiety”) and about using anxiety as means of communication are challenged. 
Furthermore, family interaction is modified by improving communication and 
problem solving with the goal of granting more autonomy to the child. Parental 
conflict and communication problems about handling their anxious child are 
also addressed. A pilot study using this family CBT showed that 59% of the 17 
children were free of their primary anxiety disorder at 3-month follow-up 
(Bögels & Siqueland, 2006).    
 
Parent CBT 
Cool kids is a group CBT program solely for parents and was developed by 
Lyneham et al. (2003 in Thienemann, Moore, & Tompkins, 2006). This treatment 
was based on Kendall’s Coping Cat and the workbooks used are additional to 
“Helping you anxious child” (Rapee, Spence, Cobham, & Wignall, 2000). 
Elements of this therapy are psycho education, parenting strategies, exposure 
(“stepladders”), problem solving, mindfulness techniques, and social skills 
training. Parents learn skills to help their child with their anxiety as lay 
therapists (Thienemann et al., 2006).  
 
Control conditions 
In most RCT studies, the control group consists of a waitlist group. However 
four studies used an active control group. The first is Educational support therapy 
(Last, Hansen, & Franco, 1998), which is an attention placebo control and 
involves a combination of educational presentations and supportive 
psychotherapy. Children also have to keep a daily diary. Last et al. (1998) found 
that educational support (50%) was found to be equally effective as individual 
CBT (65% adf). The second, Exposure based cognitive self-control (Silverman, 
Kurtines, Weems, et al., 1999) is a non-active control condition in which 
children and parents were given education about anxiety and treatment and 
received therapeutic support. However, no exposure was given. Contingency 
management (55% adf) was found to be as effective as educational support 
(56% adf) (Silverman, Kurtines, Weems, et al., 1999). 
The third, Testbusters (Beidel, et al. 2000) is an active but non-specific 
intervention including individual and group sessions. Testbusters is a program 
to develop good study-skills and test-taking strategies. Testbusters (5% pdf) 
was found to be less effective than social effect therapy (67% pdf) (Beidel et al. 
2000). Fourth, Muris, Meesters, & van Melick (2002) used emotional disclosure 
as a control condition. Children had to keep a diary in which they wrote down 
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their thoughts and feeling concerning threatening situations. It was found that 
group CBT (80% within normal range of Revised Child Anxiety and Depression 
Scale; Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000) was more effective 
compared to emotional disclosure (40% within normal range of RCADS) (Muris 
et al., 2002).  
 
Other treatments 
Some studies have investigated a specific ingredient of CBT namely exposure. 
In the following studies only questionnaire results were obtained, therefore 
they are not included in Table 1. Menzies and Clarke (1993) investigated the 
efficacy of 3 sessions in vivo exposure, vicarious exposure, in vivo exposure 
combined with vicarious exposure or waitlist. In vicarious exposure, the child 
observes a model (therapist) interacting in water-related activities for 15 
minutes. Participants were 48 children aged 3 to 8 with water phobia. At post 
treatment, the combination of in vivo exposure and vicarious exposure was 
equally effective as in vivo exposure. However, both were more effective than 
vicarious exposure and waitlist. Vicarious learning was more efficacious than 
waitlist. At 12-week follow-up, the combination of in vivo exposure and 
vicarious exposure was more effective than in vivo exposure, which was more 
efficacious than vicarious exposure on questionnaires and a behaviour rating 
scale. 
Cornwall, Spence, and Schotte (1996) found that a 6-session emotive 
imagery was more efficacious than a 20-week waitlist on self-report, parent 
report and a behavioural observation in children (n = 24) with darkness phobia, 
aged 7 to 10. Muris, Merckelbach, Holdrinet, and Sijsenaar (1998) compared 2,5 
hours Eye Movement Desensitisation and Reprocessing (EMDR), exposure and 
computerised exposure. EMDR was given using the protocol of Shapiro (1995 in 
Muris et al., 1998) for specific phobia. The goal of EMDR is desensitisation of 
aversive experiences using horizontal eye movements during negative 
images/thoughts or feelings. The computerised CBT involved confrontation 
with spiders on a computer screen. Children aged 8 to 17 with spider phobia 
were included. After Exposure (n = 9), an improvement on all measures was 
found. Children treated with EMDR (n = 9) showed improvement on self-
reported spider fear. Computerised exposure (n = 8) showed a non-significant 
improvement. Therefore it was concluded that exposure was more efficacious 
than EMDR, which was more efficacious than computerised CBT. In a second 
phase all children received 1,5 hours exposure (Muris et al., 1998).  
Ost, Svensson, Hellström, and Lindwall (2001) showed that a 1-session 
exposure (n = 21) was equally effective as exposure with the parent present (for 
instance as a model) (n = 20). Both were more effective than a waitlist condition 
(n = 19) in children with phobias, aged 7 to17 (Ost et al., 2001).  
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Concluding remarks 
This overview shows that CBT is effective in treating children with anxiety 
disorders. Not only at the short term but even up to 9 years follow-up, the 
percentage of children free of their primary anxiety disorder is quite high 
(Kendall, Safford, Flannery-Schroeder, & Webb, 2004). Both individual CBT and 
group CBT are effective compared to a waitlist condition. Two studies show 
that individual CBT and group CBT are equally effective (Flannery-Schroeder & 
Kendall, 2000; Muris, Mayer, Bartelds, Tierney, & Bogie, 2001), whereas one 
study showed that individual CBT is more effective. However the latter study, 
only presented results based on questionnaires (Manassis et al., 2002). 
With respect to parental involvement, results are more inconsistent. 
Individual CBT with family management was found to be more effective than 
individual CBT alone at post treatment and 1-year follow-up (Barrett et al., 
1996) and if parents were anxious themselves (Cobham et al., 1998). However, 
in 4 studies no additive value of parental involvement (Nauta et al., 2001 and 
2003), family attachment based therapy (Siqueland et al., 2005) or family based 
CBT (Wood et al., 2006) was found. Combined with group CBT, no surplus 
value of family management at the short term (Barrett, 1998) or long term 
(Barrett et al., 2001) was found. Even more combined parent and child groups 
were not significantly more effective than child group CBT alone (Mendlowitz 
et al., 1999). Spence et al. (2000) found that parental involvement with group 
CBT was more effective at post treatment, however at 1-year follow-up this 
effect was found to be borderline significant. Taken together, results suggest 
that the majority of studies show that parental involvement is not more 
effective than solely individual CBT. Correspondingly, a recent meta-analysis 
by In-Albon and Schneider (in press) showed almost no difference between 
child and family CBT. 
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Abstract 
 
The efficacy of child-focused versus family-focused Cognitive Behavioural 
Therapy (CBT) for clinically anxious children and adolescents was evaluated, in 
particular in relation to parental anxiety disorders and the child’s age. Families 
(n=128) were randomly assigned to individual or family CBT and evaluated at 
pre-treatment, post-treatment and 3-month follow-up. Twenty-five families 
were measured before and after a wait-list period. None of these wait-list 
children recovered from their anxiety disorders. In contrast, 41% of the children 
receiving treatment no longer met criteria for any anxiety disorder after 
treatment with continued improvement of 52% at three-month follow-up. In 
contrast with expectations, significantly more children were free of all anxiety 
disorders in individual (53%) compared to family (28%) CBT at post-treatment, 
whereas at three-month follow-up, the superior effect of individual CBT was no 
longer significant. Contrary to expectations, when parents themselves had 
anxiety disorders, family CBT was not more effective than individual CBT. 
Finally, family CBT was not more effective in younger and individual CBT not 
more beneficial in older children, as was expected. Overall, individual CBT 
seems slightly more effective than family CBT.  
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Introduction 
 
CBT is an efficacious treatment for children and adolescents with anxiety 
disorders. A systemic review of 22 randomised controlled trials (RCT) by 
Cartwright-Hatton, Roberts, Chitsabesan, Fothergill, & Harrington (2004) found 
an overall remission rate of 56.5% for CBT and 34.8% for control conditions. 
Similar results were found in a review of James, Soler, & Weatherall (2005), 56% 
for CBT and 28% for controls. A meta-analysis showed mean overall treatment 
effect sizes of d = .84 for CBT versus d = .13 for waitlist (In-Albon & Schneider, 
in press). Following treatment, 70.4% of children were free of anxiety disorders, 
compared to 14% after waitlist.  
Anxiety disorders run in families. In addition to genetic factors, 
environmental factors such as anxious modelling, parental conflict, maladaptive 
family functioning, parenting styles and parental beliefs are associated with 
child anxiety (Bögels, & Brechman-Toussaint, in press). This suggests that, 
although the exact nature of transmission is not well understood, parents 
should be involved in their anxious child’s treatment.  
However, evidence for the additive value of parental involvement is 
inconsistent. Barrett, Dadds, & Rapee (1996) found that individual CBT with 
additional family management was more effective than CBT alone. However, 
group CBT plus family management was not superior (Barrett, 1998). Similarly, 
children with social phobia benefited more from group CBT plus parent 
training than group CBT alone, but at 12-month follow-up this effect was no 
longer significant (Spence, Donovan, & Brechman-Toussaint, 2000). Other 
group CBT studies (Barrett, Duffy, Dadds, & Rapee, 2001; Mendlowitz, et al., 
1999) as well as other individual CBT studies (Nauta, Scholing, Emmelkamp, & 
Minderaa, 2001; Nauta, Scholing, Emmelkamp, & Minderaa, 2003) did not show 
a superior effect of family involvement. A recent study comparing family-
focused CBT with child-focused CBT did find family CBT to have an additional 
benefit based on questionnaire results, however the percentage of anxiety free 
children did not differ significantly between family CBT (79%) and individual 
CBT (53%) (Wood, Piacentini, Southam-Gerow, Chu & Sigman, 2006). 
Correspondingly, In-Albon and Schneider (in press) reported almost no 
difference between child and family CBT in their meta-analyses.  
Parental anxiety can cause or maintain child anxiety by reinforcing 
avoidance, anxious modelling, and confirmation of threat interpretations 
(Ginsburg, & Schlossberg, 2002). Therefore, parental involvement seems most 
important when parents are anxious themselves. Indeed, parental anxiety 
management enhanced the efficacy of CBT for anxious children if one of the 
parents had high trait anxiety (Cobham, Dadds, & Spence, 1998). Furthermore, 
phobic children benefited more from treatment with modelling by the mother if 
the mother was treated as well, but only if the mother was phobic (Windheuser, 
1977). These studies suggest that if parents are anxious themselves, parental 
involvement may enhance CBT efficacy. 
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 The age of the child is another relevant issue in considering efficacy of 
child versus family CBT. Family factors are more influential for young children, 
whereas older children are more autonomy seeking, which reduces family 
influence and increases the influence of peers (Hudson, Kendall, Coles, Robin, 
& Webb, 2002). Therefore, older children might benefit more from individual 
CBT, and young children more from family CBT. This idea was supported by 
Barrett et al. (1996), who found a higher percentage of children aged 7-10, free 
of any diagnosis after CBT plus family management (100%) than after CBT 
alone  (56%), whereas in children aged 11 to 14 no difference was found (both 
60% free of any disorder). Hence, this study suggests family CBT to be more 
beneficial in younger children. 
Several factors may have contributed to lack of support for the 
hypothesized additive effect of family CBT.  First, most studies have involved 
parents by using some kind of parent training which was given additionally to 
child CBT. Such an approach implies that most therapeutic change is still 
delivered by the therapist and not by the parents using “transfer of control” of 
CBT skills (Ginsburg, Silverman, & Kurtines, 1995). Second, the reviewed 
studies did not involve siblings and are therefore no “true” family treatments. 
Sibling involvement may affect the whole family structure, and free the anxious 
child from the position of a “scapegoat”. Third, several studies recruited 
children by means of advertisements. These children and their families might 
have less severe problems and therefore might not need additional family 
treatment.  
In this randomised controlled trial, family CBT was given based on the 
transfer of control principles including both parents and siblings of clinically 
referred youth, aged 8 to 18, with severe anxiety disorders. It was hypothesised 
that; (I) CBT is more beneficial than waitlist, (II) family CBT is more effective 
than child CBT, especially if  (III) parents suffer from anxiety disorders 
themselves, and (IV) young children benefit more from family CBT, whereas 
older children benefit more from individual CBT.  
 
Method 
 
Participants 
Participants were 128 children, referred to eight participating Dutch childhood 
mental health care centres. Families were randomly assigned to individual CBT 
(n = 64) or family CBT (n = 64). Twenty-five families were assigned to a natural 
8-12 week wait-list. Inclusion criteria were (1) age 8 to 18, (2) primary anxiety 
disorder (except OCD and PTSD), (3) IQ ≥ 80, (4) at least one parent willing to 
participate. Children were excluded if suffering from (1) substance abuse, (2) 
current suicide attempts, (2) psychoses, (3) autism spectrum disorders, (4) 
untreated attention deficit hyperactivity disorder, and (5) if they used 
medication for their anxiety, unless they stopped medication before treatment 
or dosage was kept constant during treatment and follow-up.  
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There were 76 girls (59%) and 52 boys (41%), from 8 to 17 years (M = 
12.4, SD = 2.7). Most were Caucasian (n = 126, 98%) and 58 (45%) attended 
primary school. The remaining 70 (55%) attended high schools, of low 16 (23%), 
average 21 (30%) and high 25 (36%) academic level. In addition, 8 (11%) 
followed vocational training.  
Participants were assessed using a semi-structured interview, the 
Anxiety Disorder Interview Schedule for DSM-IV, child and parent version 
(Silverman, & Nelles, 1988). The mean number of diagnoses per child was 2.9 
(SD = 1.7), 104 (81%) had co-morbid anxiety disorders, and the mean severity 
level of the primary diagnosis was 7.1 (SD = 1.0) (see Table 1).  
 
 
Table 1  Children’s primary and co morbid compound diagnosis based on the ADIS (n = 128) 
 
     Primary diagnosis  Comorbid diagnosis 
    N %  N %     
Diagnosis  
Social phobia   41 32%  45 35% 
Separation anxiety disorder  34 27%  21 16% 
Generalised anxiety disorder  23 18%  45 35% 
Specific phobia   21 16%  54 42% 
Panic disorder       9   7%  20 16% 
Dysthymic disorder     23 18% 
Attention deficit Hyperactivity disorder   10   8% 
Posttraumatic-stress disorder       8   6% 
Depressive disorder       8   6% 
Obsessive-compulsive disorder       6   5%   
Conduct disorder        2   2% 
Oppositional defiant disorder       1   1% 
Note: Children with OCD and PTSS as primary anxiety disorders were not included in this study 
 
 
Of the parents, 117 (91%) fathers and 126 (98%) mothers participated of 
whom one mother (1%) and one father (1%) were adoption parents and 3 (3%) 
fathers were stepfathers. Two mothers (2%) did not participate due to death (1) 
and maternal social phobia (1). Eleven fathers did not participate due to; death 
(5), homelessness (1), language problems (1), drugs use (1) and lack of 
motivation (3). Maternal and paternal mean age was respectively, 41.8 (SD = 
4.8) and 45.0 (SD = 5.1) years. Both biological parents were assessed, using the 
ADIS adult interview (DiNardo, Brown, & Barlow, 1994). In 39% (n = 50) of the 
families, at least one parent had a current anxiety disorder. One family in family 
CBT was excluded from questionnaire-analysis due to incomplete data. 
 
Design and Procedure 
At intake, families who met the inclusion criteria received and signed informed 
consent. Research assistants blind to treatment condition conducted the ADIS-
interviews and questionnaire assessments at pre-treatment, post-treatment and 
3-month follow-up. Following the pre-treatment assessment of parents, families 
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with and without an anxiety-disordered parent were randomly assigned to 
family or individual CBT. The active treatment conditions consisted of weekly 
sessions, which lasted for maximum 90 minutes. During the 3-month follow-up 
period, the therapist called the families twice, but no other treatment was given. 
At 3-month follow-up, the ADIS-C and ADIS-P were re-administered and all 
family members filled in the questionnaires. After the assessment, the therapist 
informed the family about their results and if necessary informed them about 
further treatment possibilities. Twenty-five families were assigned to an 8 to 12 
week waitlist and were given a reduced battery of questionnaires and the ADIS-
C and P before and after wait-list. Afterwards 76% (n = 19) were randomly 
assigned to individual or family CBT and the remaining 6 families received 
treatment as usual because the trial had finished (see Graph 1). 
 
 
Graph 1  Flow chart of the randomisation and dropout rates of the included children  
 
147 Included 
128 Randomized for treatment 
12 dropped-out during pre-treatment or before 
randomization  
6 waitlist only  
19 waitlist then randomized for treatment 
64 allocated to individual CBT 64 allocated to family CBT 
62 completed individual CBT 
2 discontinued individual CBT 
52 completed family CBT 
12 discontinued family CBT 
Individual CBT 
59 completed the 3-month fu assessment  
3 dropouts at 3-month fu  
Family CBT 
50 completed the 3-month fu assessment  
2 dropouts at 3-month fu  
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Assessments 
Interviews                                 
Children’s diagnostic status was assessed using the ADIS-C and ADIS-P. The 
ADIS-C/P is a semi-structured diagnostic interview measuring anxiety 
disorders and other DSM-IV childhood psychopathology. Each diagnosis is 
rated on severity ranging from 0 to 8, 4 indicating a clinical diagnosis. Child 
and parents ratings are combined in a compound summary. The ADIS-C/P 
possesses good inter-rater (Silverman, & Nelles, 1988) and high test-retest 
reliability (Silverman, & Eisen, 1992). Parental anxiety diagnoses were obtained 
by the ADIS adult version (DiNardo et al., 1994). Brown, DiNardo, Lehman, & 
Campbell, 2001) which possesses good to excellent reliability. 
Questionnaires 
The Screen for Child Anxiety Related Emotional Disorders, child and parent 
report were administered to assess the child’s anxiety symptoms. The validity 
and reliability of SCARED-71, in which the subscale social phobia is enlarged, is 
satisfactory (Bodden, Bögels, & Muris, submitted). Furthermore, the well-
established State Trait Anxiety Inventory (Spielberger, 1973) child and parent 
version and the Child Behaviour Checklist (Achenbach, & Edelbrock, 1983) 
were administered. Children completed the Children’s Automatic Thought 
Scale (Schniering, & Rapee, 2002), to measure negative self-statements across 
both internalizing and externalizing problems. The CATS consists of 4 
subscales: physical threat, social threat, personal failure and hostile intent. The 
CATS possesses good internal consistency and satisfactory test-retest reliability 
(Schniering, & Rapee, 2002).   
 
Therapists, research assistants, and treatment/assessment integrity 
Therapists (psychotherapists, behavioural therapists, or health care 
psychologists) were trained by Lynn Siqueland and Susan Bögels, used a 
detailed session-to-session protocol, and had weekly group supervision by a 
local expert. All therapy sessions were audio taped. Afterwards, one audiotape 
per treatment was randomly selected and reviewed by two trained 
psychologists to assess treatment integrity. Treatment integrity check indicated 
perfect agreement on condition (Individual or Family CBT), ICC = 1.00. A scale 
was construed to assess achievement of treatment goals per session separately 
for individual and family CBT. Interrater agreement for obtained therapy goals 
was .92 for individual CBT and .84 for family CBT. Therapy goals were largely 
obtained (M = 2.4, SD = 0.7 for Individual CBT and M = 2.5, SD = 0.6 for family 
CBT on a scale of 0 = not obtained, 1 = a bit, 2 = satisfactory, 3 = good.  
Research assistants were trained in the ADIS and rated four gold 
standard videotapes provided by the Child and Adolescent Anxiety Disorder 
Clinic of the Temple University in Philadelphia, USA. Their ratings had to 
match the diagnoses given by the experienced interviewers from Temple. 
Moreover, each research assistant videotaped 4 of his/her own interviews, 
which were re-rated by 2 trained students. The mean inter-rater agreement for 
diagnoses (kappa) was 0.89 for the ADIS-C and 0.83 for the ADIS-P. 
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Therapies 
Both therapies consisted of 13 sessions and had its’ own therapist manual and 
patient workbooks. Both therapies began with one introduction session in 
which family functioning was assessed and principles of CBT were introduced.  
Individual CBT 
Individual CBT was loosely based on Kendall’s Coping Cat (Kendall, 1994). The 
focus was on (1) psycho education and registration of fear, (2) cognitive 
restructuring and behaviour experiments, (3) exposure in vivo by means of a 
fear hierarchy and reinforcement and (4) relapse prevention. Parents were 
involved as little as possible, in order to maximise treatment differences. At the 
start of treatment they were informed about CBT, at session 4 they were 
involved in the fear hierarchy and reward system and in the last session the 
therapy results were shared with the parents.  
Family CBT 
Family CBT (Bögels, & Siqueland, 2006) was developed based on earlier work 
of Siqueland and Diamond (1998), Ginsburg et al. (1995) and Barrett et al. 
(1996). Three sessions are with the child alone, 2 with child and parents, 5 
sessions with parents alone and 3 sessions involve the whole family, including 
siblings. The focus of family CBT is threefold; (1) family CBT includes dyadic 
sessions, in which both child AND parents are taught to reduce their own 
anxiety using CBT skills. Parents learn to model courageous behaviour and 
guide and reward the exposure of the child; (2) modifying parental 
dysfunctional beliefs about parenting, the anxious child, the safety of the child’s 
world and their role as parents and modifying the child’s dysfunctional beliefs 
about the parents and about using anxiety as means of communication; (3) 
modifying problematic family interaction by improving communication and 
problem solving. One major focus is to grant autonomy to the child. Parental 
conflict and communication problems about handling their anxious child are 
addressed in a session alone with the parents. A pilot study of 17 families 
showed that 59% of the children were free of their primary anxiety disorder at 
3-month follow-up (Bögels, & Siqueland, 2006).    
 
Data analysis  
All analyses were done using the intent to treat principle, including the children 
who started treatment but dropped-out. Missing data were predicted using the 
missing value analysis of SPSS based on regression models using available data 
of the group mean, the available data of the individual and the pattern of 
change of the group. For treatment-dropouts and follow-up-dropouts, last 
assessments were carried forward, assuming no change. The percentage of 
children free of all anxiety disorders was used as the primary outcome measure, 
since the primary diagnosis is less stable (Costello, Mustillo, Erkanli, Keeler, & 
Angold, 2003). Mother and father scores were aggregated for SCARED, STAI 
and CBCL. Effect sizes were calculated by dividing the change score by the 
standard deviation of change. To measure whether the scores of the anxious 
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child fell within the range of the normal population, cut-off scores for SCARED, 
STAI and CBCL were applied. Binary logistic analysis was used to analyze 
nominal data (free of anxiety disorders and below cut-off point). Ordinal data 
(questionnaires) were analysed by ANOVAs using change scores (pre minus 
post or follow up). 
 
Results 
 
Pre-treatment comparison  
No differences at pre-treatment occurred across family versus individual CBT 
and waitlist versus CBT with respect to demographic variables; age, gender, 
marital status, child and parent’s education level and psychopathology 
(number and severity of diagnoses), all F (1,126)’s < 3.8, p > 0.1, x2 (1, n = 128) = 
0.6, p > 0.1 for gender and x2 (1, n = 128) = 3.7, p > 0.1 for parental marital status.  
 
Treatment effectiveness  
After the 3-month waiting period, 100% of the 25-waitlisted children still 
suffered from an anxiety disorder. In contrary, at post-treatment, 52 (41%) 
children were free of all anxiety disorders, x2 = 15.4, p < 0.01, and 71 (56%) free 
of their primary anxiety diagnosis. At 3-month follow-up, these figures were 66 
(52%) and 86 (67%), respectively. Only 14 (11%) children did not benefit from 
treatment, that is, no decline of severity of anxiety diagnoses. Overall, no 
significant time effect was found on the questionnaires after waitlist, F Hot. (5, 
20) = 1.6, p > 0.1. 
 
Family versus individual CBT  
Diagnostic interview  
Binary logistic regression revealed a main effect for condition at post-treatment, 
corrected for parental anxiety and age, Wald (1) = 9.9, p < 0.01, OR = 3.7. Of the 
64 children in individual CBT, 53% no longer met criteria for any anxiety 
disorder compared to 28% in family CBT. At 3-month follow-up, these figures 
were no longer significantly different, respectively 56% and 47%, Wald (1) = 1.2, 
p > 0.1 (see Table 2). The similar results were found when using the data of 
families who completed treatment. Of the 62 children who completed 
individual CBT, 55% no longer met criteria for any anxiety disorder, whereas 
33% no longer suffered from any anxiety disorder after completing family CBT, 
Wald (1) = 7.6, p < 0.01, OR = 3.4. At 3-month follow-up, the percentages were 
58% for individual CBT and 54% for family CBT, Wald (1) = 0.3, p > 0.1. 
At post-treatment and follow-up, the predicted interaction effect 
between condition and parental anxiety was not found, all Wald (1) < 1.0, p > 
0.1. Hence family CBT was not more efficacious if parents suffered from anxiety 
disorders. However, a main effect for parental anxiety was found at post-
treatment Wald (1) =10.0, p<0.01, OR = 4.0, and at 3-month follow-up, Wald (1) 
= 4.3, p < 0.05, OR = 2.2. If neither parent suffered from an anxiety disorder, 40 
(51%) children at post-treatment and 46 (59%) at follow-up no longer met 
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criteria for any anxiety disorder compared to 12 (24%) and 20 (40%) children of 
which one or both parents had anxiety disorders.  
The expected interaction effect between age and condition did not occur 
at post-treatment and follow-up, all Wald (1) < 0.4, p > 0.1. Thus, family CBT 
was not more effective for young children and individual CBT was not more 
effective for adolescents. In spite of this, a main effect for age occurred at post-
treatment (but not at follow-up), Wald (1) = 7.1, p < 0.01, OR = 1.2.  Older 
children benefited less from CBT than younger children as computed using the 
biserial correlation between age and presence of an anxiety disorder, Rb = Rpb√ 
proportion anxiety * proportion no anxiety/ y (ordinate)= .19 √0.406 * 
0.594/.3876 = 24. 
 
 
Table 2  Percentage anxiety disorder and primary anxiety disorder free children after individual (n 
= 64) and family CBT (n = 64) 
 
    Post treatment        3-month follow-up 
   Individual CBT Family CBT Individual  CBT  Family CBT     
  N  %  N %            N % N   %   
ADIS 
Free of  
anxiety disorder  34 53% 18 28% 36 56%  30       47%  
Free of Primary  
anxiety disorder  45 70%  26 41%  47 73%  39   61% 
 
 
Questionnaires  
No main effects were found on pre-post change scores for either treatment 
condition, F Hot. (6, 110) = .05, p > 0.1, child’s age, F Hot. (54, 650) = .50, p > 0.10 
or parental anxiety, F Hot. (6, 110) =.01, p > 0.1 as measured by the SCARED, 
STAI, CATS and CBCL internalizing scale. No interaction effects occurred 
between treatment condition and parental anxiety, F Hot. (6,86) < 0.1, p > 0.1 or 
child’s age, F Hot. (48, 506) < 0.6, p > 0.1, indicating no support for the 
hypotheses that family CBT is more effective if parents suffer from anxiety 
disorders and that family CBT is more effective in young children. However, a 
significant interaction of age by parental anxiety was found, F Hot. (54, 506) = 
1.5, p < 0.05, on the STAI-C, F (9, 91) = 2.4, p < 0.05, STAI-P F (9, 91) = 2.4, p < 
0.05, and CBCL internalizing scale, F (9, 91) = 2.2, p < 0.05. A simple inspection 
of means revealed a pattern indicating that of the parents without anxiety 
disorders, a higher percentage of younger children (9 to 12) benefited from 
treatment compared to parents who had anxiety disorders. The older children 
(13-17) improved irrespective of parental anxiety.  
The pre-follow-up MANOVA revealed no significant main effects for condition, 
parental anxiety, both F Hot. (6, 110)’s < 0.9, p > 0.1 or the child’s age, F Hot. (54, 
650) = .53, p > 0.1. One significant overall interaction was found, treatment 
condition by parental anxiety, F Hot. (6, 86) = 2.2, p < 0.05. Post-hoc ANOVAs 
showed that all six variables contributed to the interaction. Inspecting the   
Individual versus family CBT 
 85
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Ta
bl
e 
3 
 M
ea
n 
sc
or
es
, s
ta
nd
ar
d 
de
vi
at
io
ns
 a
nd
 e
ffe
ct
 s
iz
es
 (d
) f
or
 c
hi
ld
 (n
 =
 1
27
) a
nd
 p
ar
en
t (
n 
= 
12
7)
 q
ue
st
io
nn
ai
re
s 
 
 
 
 
 
 
 
 
 
 
   
   
   
  P
re
-tr
ea
tm
en
t  
   
   
   
   
   
   
  P
os
t t
re
at
m
en
t  
   
   
 
   
   
3-
m
on
th
 fo
llo
w
-u
p 
   
   
   
d  
pr
e-
po
st
   
  
d 
pr
e-
3m
on
th
 fu
 
Sc
al
e 
 
In
d 
C
BT
 
Fa
m
 C
BT
  
In
d 
C
BT
   
Fa
m
 C
BT
  
In
d 
C
BT
   
Fa
m
 C
BT
   
   
  
In
d 
Fa
m
   
In
d 
Fa
m
 
 SC
A
R
ED
-C
 
47
.6
 (2
0.
2)
 
51
.3
 (2
3.
3)
 
29
.9
 (1
7.
8)
 
37
.7
 (2
4.
1)
 
26
.3
 (1
8.
3)
 
 29
.3
 (2
2.
0)
   
 
1.
03
 
0.
53
 
1.
07
 
0.
89
 
SC
A
R
ED
-P
 
45
.8
 (1
7.
2)
 
49
.3
 (2
0.
8)
 
29
.1
 (1
2.
4)
 
33
.8
 (2
0.
3)
 
23
.8
 (1
2.
6)
   
30
.0
 (2
0.
1)
  
 
1.
06
 
0.
94
 
1.
39
 
1.
03
 
ST
A
I-C
  
36
.1
 (7
.9
) 
39
.1
 (8
.3
) 
29
.1
 (7
.1
) 
33
.6
 (9
.2
) 
28
.3
 (7
.3
) 
30
.9
 (8
.9
) 
 
 
1.
01
 
0.
58
 
1.
07
 
0.
88
 
ST
A
I-P
 
39
.5
 (6
.7
) 
39
.9
 (7
.7
)  
 
32
.0
 (6
.0
) 
33
.8
 (7
.8
) 
30
.4
 (6
.1
) 
31
.8
 (7
.9
) 
 
 
1.
08
 
0.
95
 
1.
37
 
1.
16
 
C
BC
L-
In
t. 
18
.0
 (8
.2
) 
18
.3
 (9
.5
) 
  9
.6
 (5
.6
) 
11
.8
 (8
.5
) 
  8
.0
 (5
.6
) 
 10
.7
 (8
.1
)  
 
 
1.
03
 
0.
86
 
1.
22
 
0.
92
 
C
A
TS
   
25
.6
 (2
0.
4)
 
34
.5
 (2
7.
5)
 
16
.1
 (1
6.
2)
 
24
.3
 (2
2.
7)
 
16
.0
 (1
7.
9)
 
20
.4
 (2
0.
5)
  
 
0.
59
 
0.
40
 
0.
49
 
0.
56
 
N
ot
e: 
O
ne
 fa
m
ily
 d
id
 n
ot
 co
m
pl
et
e q
ue
st
io
nn
ai
re
s 
  
Chapter 6 
86
means showed that, in contrast to our hypothesis, if parents do not suffer from 
anxiety disorders, family CBT was more beneficial, whereas if parents had an 
anxiety disorder, individual CBT was more effective. Treatment effect sizes (see 
Table 3) were generally high, increased at follow-up, were higher for individual 
CBT than family CBT, and higher for parent reports compared to child reports. 
 
Clinical significant change 
Cut-off scores obtained from literature were used to assess the percentage of 
children falling into the normal range (CATS; Bodden, & Bögels, submitted, 
SCARED; Bodden et al., submitted, STAI; Bakker, van Wieringen, van der 
Ploeg, & Spielberger, 1989 and CBCL; Verhulst, van der Ende, & Koot, 1996), 
see Table 4. No pre-treatment differences on cut-off scores existed, all Wald (1) 
< 2.9, p > 0.1. A main effect for treatment type was found on post-treatment cut-
off scores of STAI-C, corrected for pre-treatment cut-off scores, Wald (1) = 3.9, p 
< 0.05, OR = 5.4, indicating that significantly more children fell into the normal 
range after individual than after family CBT; 97% versus 83%. Furthermore, a 
main effect of parental anxiety on CATS was found, Wald (1) =5.9, p < 0.05, OR 
= 2.8. If parents had no anxiety disorders 74% of their children fell below the 
cut-off point of the CATS compared to 48% if parents suffered from anxiety 
disorders. Interestingly, an interaction effect of treatment by parental anxiety 
occurred on SCARED-C, Wald (1) = 3.6, p = 0.057, OR = 4.6. Inspection of this 
interaction showed that in contrast to the hypothesis, if parents suffered from 
anxiety disorders, more children fell into the normal range with regard to 
anxiety symptoms after individual CBT (46%) compared to family CBT (19%). If 
parents did not suffer from an anxiety disorder, the percentages were 55% for 
individual CBT and 62% for family CBT. Neither a main effect for child’s age 
nor an interaction effect for child’s age by condition was found. 
 
 
Table 4  Percentages of children underneath the cut-off point of the questionnaires after individual 
and family CBT 
 
                Post treatment                3-month follow-up   
      Ind CBT       Fam CBT      Ind CBT      Fam CBT      
  N  % N % N % N        %    
Scale 
SCARED  
 Child 33 52% 28 44% 43 67% 39 62%
 Parent 19 30% 23 37% 30 47% 24        38% 
STAI   
 Child  62 97% 53 83% 62 97% 58        91% 
 Parent 62 97% 57 89% 63 98% 61        95% 
CBCL-Int. 56 88% 50 78% 58 91% 48       75% 
CATS  47 73% 34 54% 46 72% 39        62% 
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 Using follow-up cut-off scores, a main effect for treatment condition 
was found on CBCL internalizing scale, Wald (1) = 7.4, p < 0.01, OR = 4.8, 
showing a beneficial effect for individual (91%) compared to family (75%) CBT. 
The interaction effect of treatment by parental anxiety remained on SCARED-C, 
Wald (1) = 4.7, p < 0.05, OR = 5.5, showing beneficial effects for individual CBT 
(75%) compared to individual CBT (46%) if parents had anxiety disorders. If 
parents did not suffer from an anxiety disorder, the percentages were 63% for 
individual CBT and 73% for family CBT. Again, no main effect of child’s age or 
interaction effect of child’s age by condition occurred. 
 
Discussion 
 
The present study investigated the effects of family CBT compared to 
individual CBT in clinically anxious children. The main results can be 
summarised as: (I) CBT was more effective than wait-list; (II) individual CBT 
was more effective than family CBT at post-treatment; (III) at follow-up, family 
CBT and individual CBT were equally effective; (IV) both treatments were less 
effective if parents suffered from anxiety disorders themselves both at post-
treatment and follow-up; and (V) both treatments were more effective in 
younger children at post-treatment.  
Contrary to hypothesis, we found no added effect of family CBT. 
Unexpectedly, the reverse was found, namely individual CBT was more 
beneficial at post-treatment. The finding that family involvement does not add 
to the effectiveness of individual CBT is consistent with the majority of studies 
evaluating this question (In-Albon, & Schnieder, in press), but this is the first 
study showing individual CBT to be more effective.  Several explanations can be 
given. First, individual CBT might be more autonomy encouraging to the 
anxious child than family CBT because the child receives therapy and the 
possible success alone. Second, the number of family therapy sessions might 
have been insufficient to address all the topics thoroughly: parental anxiety, 
family functioning and communication, as well as the child’s anxiety. These 
topics may need more time to be fully covered. Third, since family CBT works 
by means of transfer of control, most information and guidelines are given 
through the parents. As such, distortions can occur in the transfer of 
information from parent to child. Since therapists are thoroughly trained in CBT 
principles they may be more capable of coaching children. Note that this was 
the first RCT in which almost no individual CBT was given to the child in the 
family condition. Fourth, it may have been difficult to fully engage and 
motivate parents and siblings in family CBT because they were not the ones 
referred to treatment. Fifth, parents might be more defensive in family CBT 
since they might feel blamed for the child’s anxiety.  
At 3-month follow-up, family CBT and individual CBT were equally 
effective, mainly because family CBT “catches up”. This can be explained by the 
process of Sowing and Reaping (Nauta et al., 2003). During family treatment the 
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parents learned training skills (sowing), which can be used to master the child’s 
anxiety after treatment (reaping). 
 With respect to overall effectiveness, both treatments appeared highly 
efficacious (individual CBT 56% and family CBT 47% free of all anxiety 
disorders at 3-month follow-up) and compare well with the overall remission 
rate of 57% from a meta-analysis of CBT for childhood anxiety disorders 
(Cartwright-Hatton et al., 2004). Note that some studies included in this meta-
analysis recruited children predominantly by means of advertisements, who are 
less severe anxious and therefore may easier meet the stringent criterion of free 
of all anxiety disorders (Weisz, Weiss, Han, Granger, & Morton, 1995), and did 
not include dropouts. In addition, ratings of severity of the anxiety disorders in 
our sample indicated that only 14 children (11%) did not improve. In addition, 
the average effect size was rather high, 1.2 for individual CBT and 1.1 for family 
CBT. In comparison, In-Albon and Schneider (in press) found an overall effect 
size of .84 for CBT, suggesting that even the less effective therapy in this study, 
family CBT, was highly efficacious.  
 In contrast to our hypothesis and to Cobham et al. (1998), family CBT 
was not more effective if parents suffered from anxiety disorders. In contrast, 
questionnaire results showed family CBT to be more effective if parents had no 
anxiety disorders. A more general finding was that CBT was less effective if 
parents suffer from anxiety disorders. It has been proposed that parental 
psychopathology may hinder the process of transfer of control of CBT skills 
from parents to child (Ginsburg et al., 1995). Parents with current anxiety 
disorders might have been too anxious to transmit CBT to their child. Since 20% 
of the anxiety disordered mothers suffered from co-morbid depression, 
maternal depression might have also contributed to the less beneficial child 
outcomes, in line with previous research (Southam-Gerow, Kendall, & 
Weersing, 2001). Research into the effects of parental treatment of anxiety 
disorders on child outcomes might shed more light on this issue. 
 Also, in contrast to our hypothesis and Barrett et al. (1996), we did not 
find that younger children benefited more from family CBT and older children 
more from individual CBT. However, child age influenced treatment outcome 
in general. Consistent with Southam-Gerow et al. (2001) and Hudson et al. 
(2002), in our study CBT was less effective in older children (13 years and 
older). Several explanations for the less beneficial outcomes for adolescents in 
our study can be given. First, the same therapy workbooks were applied for 
children and adolescents and therefore may not have been developmentally 
sensitive. Some exercises may have been too childish and as a consequence 
adolescents might not have fully engaged in therapy, reducing efficacy. Second, 
adolescents function more independent and are less cooperative so therapeutic 
alliance is more difficult to establish (Hudson et al., 2002). Third, and most 
likely, adolescents may have established more persistent negative cognitive and 
behavioural patterns (e.g. avoidance) due to the longer duration of anxiety 
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symptoms in comparison with younger children. Therefore, it might be more 
difficult to change these patterns.   
Interestingly, 86% of the treatment-dropouts were in the family CBT 
condition. Inspection of reasons for dropout in family CBT suggests that in 
some cases it was hard to motivate family members, since the child’s anxiety 
was seen as the primary focus of treatment. Post-hoc analyses of pre-treatment 
differences between family CBT completers versus dropouts were carried out to 
further investigate reasons for family treatment-dropout. No differences were 
found regarding the following child characteristics; age, gender, number and 
severeness of anxiety disorder. Families did not differ on parental anxiety 
disorder, parental psychopathology, number of children, and social economic 
status. However, the percentage of broken homes was higher (36%) in family 
CBT dropouts than in family CBT completers (14%), χ2 (1) = 3.2, p = 0.08. 
Furthermore, the percentage of housewives was significantly higher in the 
dropout-group (73%) compared to the completer group (28%), χ2 (1) = 8.2, p < 
0.05. Hence, more complexity in families and less employment of mothers 
occurred to be associated with family treatment-dropout.  A highly speculative 
explanation is that being a housewife is associated with more overprotection of 
the anxious child and more resistance to change. Clearly, more research is 
necessary to understand treatment-dropout during family treatment.  
 This study has several limitations. First, although CBT was more 
effective than waitlist, this might not provide enough evidence for its’ efficacy. 
Two studies indicate that CBT is not superior to educational support (Last, 
Hansen, & Franco, 1998; Silverman et al., 1999). Second, families were randomly 
assigned to family CBT. Perhaps family CBT will be more beneficial if given 
based on either family preference or impairment in family functioning.  
 
Clinical Implications 
This study has shown that individual CBT is more effective than family CBT, at 
least in the short term. Taking into consideration the majority of literature, 
indicating that parental involvement does not add to the effects of child CBT, 
one can question whether involving parents in therapy is needed. Family CBT is 
less feasible and is also expected to be more costly due to invested treatment 
time of family members. Some of this study’s results suggest that the clinical 
intuition to involve parents especially if they are anxious may not be best 
practice. For “healthy” parents family CBT does seem an alternative to child-
focused CBT.  
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Abstract 
 
Objective: To investigate the cost-effectiveness of family Cognitive Behaviour 
Therapy (CBT) compared with individual CBT. 
Design: Clinically anxious children referred to treatment were randomly 
assigned to family or individual CBT and were assessed at pre-treatment, post 
treatment, 3-months and 1-year after treatment. 
Outcome measures: Cost-effectiveness ratios were calculated expressing the 
incremental costs per anxiety-free child and the incremental costs per Quality 
Adjusted Life Year (QALY) for the referred child.  
Results: Both societal costs and effectiveness were not significantly different 
between individual and family CBT. However, the point estimates of the cost-
effectiveness ratios resulted in dominance for individual CBT, indicating that 
individual CBT is more effective and less costly compared to family CBT. These 
results were confirmed by bootstrap analyses and cost-effectiveness 
acceptability curves. Several secondary and sensitivity analyses showed that 
results were robust.   
Conclusion: It can be concluded that family CBT is not a cost-effective treatment, 
compared to individual CBT.  
                                                       Cost-effectiveness of family versus individual CBT 
 93
Introduction 
 
Mental illnesses cause a high burden on society. Of all mental illnesses, the total 
costs are highest for anxiety disorders, namely 46.6 billion dollars in the USA, 
accounting for 31.5% of total expenditures for mental health in 1990 (Dupont et 
al., 1996). In the Netherlands, the costs of anxiety were 180 million euro in 1999, 
accounting for 0.5% of the health care budget. More specifically, health care 
costs due to anxiety disorders in children and young adults aged 1 to 24 
amounted to 21.6 million euros (Polder, Takken, Meerding, Kommer, & Stokx, 
2002).  
Anxiety disorders affect 5 to 15% of children and adolescents 
(Bernstein, Borchardt, & Perwien, 1996). In the Dutch population, a six-month 
prevalence rate of 23.5% was found among 13- to 18-year-olds, when 
impairment in daily functioning was taken into account the rate dropped to 
9.7% (Verhulst, van der Ende, Ferdinand, & Kasius, 1997). Anxiety disorders 
substantially influence quality of life of the child and are a burden for the 
family and society, resulting in high costs (Leon, Portera, & Weissman, 1995).  
Research on the effectiveness of treatments of childhood anxiety 
disorders focuses mostly on cognitive behavioural therapy (CBT) and 
demonstrates that CBT is efficacious (Cartwright-Hatton, Roberts, Chitsabesan, 
Fothergill, & Harrington, 2004; In-Albon & Schneider, in press). Evidence for 
the added value of parental involvement in CBT is inconsistent. For instance, 
Barrett, Dadds, and Rapee (1996) found that individual CBT with additional 
family management was more effective than CBT alone. In contrast, a recent 
study of Nauta, Scholing, Emmelkamp, and Minderaa (2003) and a recent meta-
analysis (In-Albon & Schneider, in press) did not show a superior effect of 
parental involvement. Recently, a new family based CBT was developed, which 
includes both parents and siblings of anxious children (Bögels & Siqueland, 
2006).  In this family CBT, child and parents are taught to reduce their own 
anxiety using CBT skills. Furthermore, parents learn to model, guide and 
reward the exposure of the child and dysfunctional thoughts and problematic 
family interaction are being modified.  
Several authors (Fals-Stewart, Yates, & Klostermann, 2005; Steinglass, 
1996) have argued the need for economic evaluations of family treatment 
because of their potential cost advantages. Due to the multiplier effect, the 
positive effects of treating a family member may also transfer to other family 
members. Besides, by providing a more stable family environment, the chance 
that positive treatment effects will be undone when the child returns to the 
family will be reduced. 
A cost-effectiveness analysis is a method to evaluate and compare 
outcomes and costs of interventions (Drummond, O’Brien, Stoddart, & 
Torrance, 1997; Gold, Siegel, Russell, & Weinstein, 1996) with the aim to 
improve resource allocation decisions by policy makers and insurers, and 
consequently, to improve individual, societal and economical wellbeing 
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(Knapp, 1997). To date, no studies have addressed the costs associated with 
CBT in children with anxiety disorders and subsequently, its cost-effectiveness.  
 Offering a cost-effective treatment to children with anxiety disorders is 
expected to reduce the costs associated with the consequences of anxiety 
disorders. On the short term it is expected that the child and family’s health, 
quality of life and parental time released will improve. Society as a whole may 
benefit from better social functioning, less usage of services and increased 
productivity of the parents. On the long term, effective interventions may 
prevent self-induced illness, improve attainment of education, and improve 
social functioning. The expected benefits for society in the long run concern less 
crime rates, less alcohol and drug abuse, less social care usage, better earning 
potential for the child, less unemployment of the child as an adult, and less 
health care usage (Greenberg et al., 1999; Knapp, 1997; Leon et al, 1995; 
Marciniak, Lage, Landbloom, Dunayevich, & Bowman, 2004; Tudor Edwards & 
Thalanany, 2001). All together, the ultimate savings that can be achieved by 
investing in a cost-effective treatment for children with anxiety disorders may 
be substantial.  
 The aim of this study was to compare family CBT to individual CBT 
with respect to the costs, effects and cost-effectiveness. The incremental cost-
effectiveness ratios were expressed as the cost per anxiety-free child and the 
cost per Quality Adjusted Life Year of the referred child, with a time horizon of 
15 months.        
 
Method 
 
Study design 
A multi-centre randomized clinical trial was performed comparing family CBT 
with individual CBT (Bodden et al., submitted). Inclusion criteria were (1) age 8 
to 18, (2) primary anxiety disorder (except for OCD and PTSD), (3) IQ ≥ 80, and 
(4) at least one parent willing to participate. Children were excluded if suffering 
from (1) substance abuse, (2) current suicide attempts, (2) psychoses, (3) autism 
spectrum disorders, (4) untreated attention deficit hyperactivity disorder. 
Children were also excluded if they used medication for anxiety, unless they 
stopped medication or dosage was kept constant during treatment and follow-
up. After checking the inclusion and exclusion criteria, the child and parents 
received and signed an informed consent.  
After baseline assessment (pre-treatment), which consisted of the 
Anxiety Disorder Interview Schedule parent-, adult- and child-version to obtain 
child and parental psychopathology, and a battery of questionnaires including 
the EuroQol, families were randomly assigned to 12-sessions individual CBT or 
family CBT. Directly after treatment (post-treatment), 3-months (follow-up 1) 
and 12-months (follow-up 2) after treatment, research assistants who were 
unaware of the treatment condition conducted the follow-up measurements 
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which consisted of the ADIS parent- and child-version and several 
questionnaires.  
 
Cost-analysis 
The cost analysis was, according to Dutch guidelines (Oostenbrink, 
Koopmanschap, & Rutten, 2005), performed from a societal perspective and 
included direct health care costs, direct non-health care costs, indirect costs and 
out-of-pocket costs. Costs were calculated by multiplying the real resources 
used by the cost price of each resource used. This approach is also known as 
‘micro-costing’ which is a detailed inventory and measurement of resources 
consumed (Jacobs & Roos, 1990). Costs were collected and calculated at 2003 
euros (1€ = 0,087$, July 30th 2003) and were discounted at 4% after 12 months 
following randomization (Oostenbrink et al., 2005).  
 Resources used were determined by means of cost diaries (Drummond 
et al., 1997; Freer, 1980; Goossens, Rutten-van Mölken, Vlaeyen, & van der 
Linden, 2000), which were completed prospectively for five times by one of the 
parents of the anxious child over a period of 2 weeks each; at pre-treatment (2 
weeks before treatment), during treatment, at post-treatment, at 3-month 
follow-up and 1-year follow-up. Each cost diary was presented in a booklet 
form with instructions and an example diary. Parents recorded the resources 
used (see Table 3) and the name of the family member for whom the resource 
use was applicable (child, sibling, mother or father), as well as the reason for the 
resource use. For analysis, the reported reasons were grouped into (1) due to 
anxiety, (2) due to psychological problems, (3) due to physical problems, and (4) 
due to other reasons.  For the main cost-effectiveness analysis, only resource use 
related to anxiety of the child was considered. 
 Almost all cost prices were obtained by using published Dutch 
guideline prices (Oostenbrink et al., 2005). Medication prices were obtained 
from the Medication and aid Information Project database on the Internet 
(Board of health insurances, 2005) and were based on the Daily Defined Dosage 
(DDD), which indicates the mean medication usage per adult a day with claw 
back and Value Added Tax (20%). An average cost price was calculated for 
anxiety medication and medication for psychological problems, used in the 
secondary analysis. As actual cost prices for day treatment were not available, 
the cost price was derived from the average of actual reimbursements (Board 
Tariff rates Health care and Care authority, 2005). The cost price of day care was 
estimated by using a shadow price based on the actual day care costs for 
children under the age of 4 (Babyfun, 2005). To determine the costs associated 
with absence from school, actual annual tuition (National Institute of Budget 
information, 2005) was divided by the total annual hours at school, resulting in 
a cost price per hour of school absence. Productivity costs of the parents were 
calculated by means of the friction cost method, based on a mean added value 
of the Dutch working population (Oostenbrink et al., 2005). The friction costs 
method only takes into account production losses confined to the period 
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needed (usually 90 days) to replace a sick employee. All cost prices per unit of 
resource use are presented in Table 3. 
 
Effectiveness 
ADIS 
Children’s diagnosis was assessed using a semi-structured interview the ADIS, 
which is specifically designed to measure anxiety disorders and other 
psychopathology in children and adolescents (Silverman & Nelles, 1988). Each 
diagnosis is rated on severity ranging from 0 to 8, 4 indicating a clinical 
diagnosis. The scores of both child (ADIS-c) and parents (ADIS-p) on child 
anxiety were combined in a compound summary. Siblings’ anxiety diagnoses 
were obtained in the same way. The ADIS-c/p has a good inter-rater 
(Silverman & Nelles, 1988) and test-retest reliability (Silverman & Eisen, 1992). 
Parental anxiety diagnoses were obtained by the ADIS adult-version (DiNardo, 
Brown, & Barlow, 1994), which has a good to excellent inter-rater reliability on 
the majority of diagnoses (Brown, DiNardo, Lehman, & Campbell, 2001).  
EuroQoL (EQ-5D) 
The EQ-5D is a generic health-related quality of life instrument (EuroQolgroup, 
1990). The EQ-5D contains 5 dimensions of health-related quality of life, namely 
mobility, self-care, daily activities, pain/discomfort and depression/anxiety. 
Each dimension can be rated at three levels: no problems, some problems and 
major problems. The 5 dimensions can be summed into a health state. Utility 
values can be calculated for these health states, using preferences elicited from a 
general population, the so-called Dolan algorithm (Dolan, 1997). The utility 
values derived from the Dolan algorithm were used to compute Quality 
Adjusted Life Years (QALYs). The maximum number of QALYs that can be 
reached with a time horizon of 15 months is 1.25. Furthermore, the EQ-5D 
consists of a visual analogue scale (VAS) ranging from zero (worst imaginable 
health state) to 100 (best imaginable health state). The reliability and validity of 
the EQ-5D has been established (Brooks with the EuroQol group, 1996). The 
EQ-5D used in this study, was filled in by the child, mother and father, 
concerning the child’s quality of life. Mother and father scores were averaged 
into one proxy score because they correlated highly. The proxy score was used 
for the cost per QALY analysis. The proxy version of the EQ-5D has good 
construct validity and convergent validity (Stolk, Busschbach, & Vogels, 2000).  
 
Cost-effectiveness analysis 
In cost-effectiveness analysis, the difference in costs is related to the difference 
in effectiveness, resulting in an Incremental Cost-Effectiveness Ratio (ICER). In 
this study effectiveness was expressed as (1) the proportion of anxiety-free 
children and based on (2) QALYs. The ICERs expressed (1) the incremental 
costs per anxiety-free child and (2) the incremental costs per QALY. The time 
horizon of the cost-effectiveness analysis was 15 months. 
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Statistical analysis 
Data were analyzed according to the intention-to-treat principle. Missing items 
in the cost diaries were handled with the Missing Value Analysis of SPSS based 
on regression models using available data of the group mean, of the individual 
and the pattern of change of the group. During treatment 8 families in family 
CBT and 1 family in individual CBT dropped-out, of which respectively 4 and 1 
refused further measurements. Another 4 families in individual CBT and 1 in 
family CBT refused the measurements at follow-up. Costs and effectiveness 
data of these families were estimated using the last-observation-carried-
forward-method (LOCF-method). Cost data were interpolated to a period of 15 
months under the assumption that data obtained with the cost diaries were 
representative for the periods in between.  
 To investigate whether data were normally distributed a Kolmogorov-
Smirnov test was performed. If cost and quality of life data were not normally 
distributed, the non-parametric Mann Whitney U test was used to test for 
significant differences. Binary logistic regression was used to assess differences 
in the percentage of anxiety free children.  
 In order to get insight in the uncertainty surrounding subtotal and total 
costs and due to highly skewed cost distributions, bootstrap simulations were 
conducted. The bootstrap method estimates the sampling distribution of a 
statistic through a large number of simulations, based on sampling with 
replacement (Briggs, Wonderling, & Mooney, 1997). The results based on 1000 
bootstrap replications of the costs for family CBT and individual CBT were 
used to calculate 95% confidence intervals (95% CI) around the cost-differences, 
based on the 2.5th and 97.5th percentiles. Bootstrap simulations were also 
conducted in order to quantify the uncertainty around the ICER (Efron & 
Tibshirani, 1993), yielding information about the joint distribution of cost and 
effect differences. The bootstrapped cost-effectiveness ratios were subsequently 
plotted in a cost-effectiveness plane, in which the vertical line reflects the 
difference in costs and the horizontal line reflects the difference in effectiveness. 
The choice of treatment depends on the maximum amount of money that 
society is prepared to pay for a gain in effectiveness, which is called the ceiling 
ratio. Therefore, the bootstrapped ICERs were depicted in a cost-effectiveness 
acceptability curve showing the probability that family CBT is cost-effective 
using a range of ceiling ratios. Finally, several secondary analyses were 
conducted to investigate the robustness of the results for changing several 
parameters.  
 
Results 
 
Participants 
In total 128 children participated in the RCT. At pre-treatment, two children 
from the individual CBT group received clinical treatment and were 
institutionalized. Since the costs associated with clinical treatment were 
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extremely high, persisted over time and were not attributable to treatment 
condition, these 2 children were excluded from the cost-effectiveness analysis. 
Furthermore, 3 (2%) families in individual CBT and 7 (6%) families in family 
CBT did not fill in the pre-treatment cost diary. Since this information is 
necessary for interpreting follow-up cost data, these families were excluded 
from the analysis. Therefore, results with respect to the costs and cost-
effectiveness analysis are presented for 116 children, of which 59 were 
randomized to individual CBT and 57 to family CBT.  
The children consisted of 72 girls (62%) and 44 boys (38%), from 8 to 17 
years (M = 12.3, SD = 2.6). Most were Caucasian (n = 115, 99%) and 53 (46%) 
attended primary school. The remaining 63 (54%) attended secondary 
education, of average (31, 49%) and high (24, 38%) and specialized (8, 12%) 
educational level. The mean number of diagnosis per child was 2.9 (SD = 1.6), 
whereas the mean severity level of the primary diagnosis was 7.1 (SD = 1.0) (see 
Table 1).  
 
 
Table 1  Primary and co morbid compound diagnosis (pre-treatment) based on the ADIS (n = 116) 
 
     Primary diagnosis  Comorbid diagnosis 
    N %  N %  
Diagnosis  
Social phobia   36 31%  42 36%  
Separation anxiety disorder  32 28%  20 17%  
Specific phobia   20 17%  47 41%  
Generalized anxiety disorder  20 17%  41 35%  
Panic disorder     8   7%  18 16%  
Obsessive-compulsive disorder         5   4%   
Posttraumatic-stress disorder          5   4%  
Dysthymic disorder     19 16% 
Depressive disorder         6   5% 
Attention deficit Hyperactivity disorder       9   8% 
Conduct disorder          2   2% 
Oppositional defiant disorder           1   1% 
 
 
Of the parents, 110 (95%) fathers and 115 (99%) mothers participated. 
Maternal and paternal mean age was respectively, 41.8 (SD = 4.9) and 44.9 (SD 
= 5.1) years. Both parents were diagnosed, using the ADIS adult interview (26). 
In 41% (n = 47) of the families, at least one parent had a current anxiety 
disorder.  
Demographic and socio-economic characteristics between individual 
CBT and family CBT were highly comparable. No statistically significant 
differences were found regarding the following child characteristics; age, 
educational level (both F<3.0, p > 0.05) and gender, x2 (1, n = 116) = .83, p > 0.05. 
Also no differences were found on the following parental characteristics; age, 
educational level, job level, family income, hours of work, hours of volunteer 
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work, hours of house hold activities, and hours of leisure time, all F<3.6 and p > 
0.05. 
 
Cost-analysis 
At pre-treatment, costs in both groups were not normally distributed 
(Kolmogorov-Smirnov Z >2.2, p < 0.00). Most families reported no or few costs 
associated with anxiety of the child. Total societal costs were slightly, but not 
significantly, higher for individual CBT compared to family CBT (see Table 2). 
A Mann-Whitney test showed no significant differences between the two 
groups at pre-treatment on subtotal and total societal costs (all U >1673, p > .1). 
The bootstrap analysis also showed no significant differences between the two 
conditions (see Table 2). 
 
 
Table 2  Baseline subtotal costs and total societal costs for individual CBT (n = 59) and family CBT (n 
= 57) 
 
    Ind CBT costs Fam CBT costs Incremental costs (95% CI)  
Cost category  
Direct health care costs             17.02 (125)                34.65 (178)                  17.63 
  Bootstrapped  16.67 (16.0) 33.35 (23.4)  16.68 (-32 - +69) 
Direct non-health care costs   4.13 (26.7)       0.89 (4.7)   -3.24 
  Bootstrapped    4.12 (3.4)   0.91 (0.6)   -3.21 (-11 - +2) 
Indirect costs  54.82 (249) 37.18 (132) -17.64 
 Bootstrapped  55.52 (30.8) 35.82 (17.1) -19.70 (-93 - +39) 
Out-of-pocket costs    7.86 (54.1)   0.09 (0.5)     -7.77 
  Bootstrapped    7.77 (7.1)   0.09 (0.1)   -7.68 (-23 - 0) 
Total societal costs  83.83 (280)    72.80 (263)  -11.02  
 Bootstrapped 84.21 (35.9)    73.79 (35.8)  -10.42 (-105 - +93)  
Note: Ind CBT = Individual CBT; Fam CBT = Family CBT 
 
 
Although not statistically significant, direct health care costs at pre-
treatment were higher for family CBT. This can be explained by the fact that, 
out of 3 children in day treatment at pre-treatment, 2 were randomized for 
family CBT. With respect to the indirect costs, the most prominent cost-
differences were present for absence from paid work, absence from school and 
loss of leisure time, although these differences were not significant. Three 
parents in individual CBT reported productivity loss, compared to 2 parents in 
family CBT. At pre-treatment, costs due to absence from school were higher in 
family CBT due to 6 children reporting relatively more hours of school absence 
(M hours = 44.5), compared to 8 children in individual CBT(M hours = 25.9). 
Loss of leisure time was slightly more reported in family CBT.  
 Results of the cost analysis over 15 months are summarized in Table 3. 
No statistically significant differences on subtotal and total societal costs per 
anxious child were found, Mann-Whitney U >1485, p > .26. The same finding 
was revealed using bootstrapped results. The mean total societal costs  
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amounted to €2751.39 (SD=  4774) for individual CBT and €3051 (SD = 4582) for 
family CBT. This resulted in an incremental cost-difference of €299, meaning 
that family CBT, although not significant, is more costly than individual CBT. 
Comparable to the pre-treatment situation, costs due to day treatment, leisure 
time and school absence were higher in family CBT and costs due to absence 
from paid work were higher in individual CBT. Graph 1 displays the mean total 
societal costs per cost diary without interpolation. Compared to the pre-
treatment costs, costs increased during treatment and dropped immediately 
after treatment, ultimately resulting in lower costs compared to pre-treatment. 
Moreover, the graph shows that the cost patterns were highly comparable for 
individual and family CBT. 
 
 
Graph 1  Mean total societal costs for individual CBT and family CBT per cost diary of 2 weeks 
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Effectiveness 
 ADIS   
Directly after treatment, the proportion of anxiety free children was 0.54 for 
individual CBT and 0.28 for family CBT. At 3-month follow-up, these figures 
were 0.58 and 0.47 respectively. The proportions of anxiety-free children at 1-
year follow-up were 0.68 and 0.53 for respectively individual CBT and family 
CBT, which was not significantly different, Wald (1) = 2.8, p = 0.1, OR = 0.5.  
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EQ-5D  
Results of the EQ-5D at pre-treatment are presented in Table 4. In general, 
children with anxiety disorders had no problems with mobility, self-care, and 
pain. The scores on the ‘daily activities’ and ‘mood’ dimensions were slightly 
higher compared to the other dimensions. Although both the VAS value and 
the utility value were slightly higher for individual CBT compared to family 
CBT, results were not statistically significantly different between individual 
CBT and family CBT at pre-treatment (all Mann Whitney U > 1486, p > .09). 
 In general, the scores on the ‘mobility’, ‘self-care’ and ‘pain’ dimensions 
remained fairly stable over time, whereas the scores on the ‘daily activities’ and 
‘mood’ dimensions decreased (see Table 4), resulting in increasing utility values 
over time. Comparable to the pre-treatment situation, utility values and VAS 
values at post-treatment, 3-month follow-up and 1-year follow-up were slightly 
higher in the individual CBT condition compared to family CBT. The number of  
QALYs was 1.18 for individual and 1.15 for family CBT (Mann Whitney U = 
1526, p > .10).  
 
Cost-effectiveness analysis 
 
The ICER based on the costs per anxiety-free child indicated inferiority for 
family CBT, as total societal costs for family CBT are €299 higher and 
effectiveness is 0.15 lower (see Table 5). The bootstrapped cost-effectiveness 
ratios were plotted in a cost-effectiveness plane (Graph 2a), showing that 60% of 
cost-effectiveness ratios are situated in the northwest (inferior) quadrant. This 
indicates that there is a 60% probability that family CBT is both more costly and 
less effective compared to individual CBT. Thirty-five percent of the ICERs 
were located in the southwest quadrant, indicating that family CBT is less costly 
but also less effective. The northeast quadrant contained 4% of the ratios, 
showing that family CBT is more costly and more effective. The remaining 2% 
of the ratios were in the southeast quadrant indicating lower costs and higher 
effectiveness for family CBT, resulting in dominance for family CBT.  
 Graph 2b shows the cost-effectiveness acceptability curve for the 
percentage of anxiety-free children. For example, using a ceiling ratio of €2500 
per anxiety-free child, the probability that family CBT is cost-effective is 24%. 
The probability that family CBT is cost-effective decreases from 24% to 4% with 
increasing the ceiling ratio from €2500 to €37500. 
 
The ICER based on the cost per QALY also indicated inferiority for family CBT, 
as total societal costs were €299.13 higher and the number of QALYs was 0.02 
effectiveness ratios for the incremental costs per QALY. Fifty-seven percent of 
the ratios were in the northwest quadrant revealing that family CBT is more 
costly and less effective compared to individual CBT, and thus inferior. Thirty- 
Costs per anxiety-free child 
lower for family CBT (see Table 5). Graph 3a shows the bootstrapped cost-
Cost per QALY  
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Graph 2a  Cost-effectiveness plane for costs per anxiety-free child for family CBT versus individual 
CBT  
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Graph 2b  Cost-effectiveness acceptability curve for the costs per anxiety-free child for family CBT 
versus individual CBT 
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Graph 3a  Cost-effectiveness plane for the costs per QALY for family CBT versus individual CBT  
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Graph 3b  Cost-effectiveness acceptability curve for the costs per QALY for family CBT versus 
individual CBT  
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three percent of the ICERs were located in the southwest quadrant, which 
indicates lower costs and less QALYs. The northeast quadrant had 5% of the 
ratios, showing more QALYs and higher costs. The remaining 6% of the ICERs 
were in the southeast quadrant indicating lower costs and more QALYs.  
 Graph 3b displays the acceptability curve for bootstrapped incremental 
costs per QALY. The probability that family CBT is cost-effective decreases 
from 36% to 19% by increasing the ceiling ratio from € 2500 to € 37500.    
 
Secondary cost-effectiveness analyses 
Five secondary analyses were conducted, of which results are presented in 
Table 5. In the first analysis, pre-treatment differences with respect to the utility 
values between family CBT and individual CBT, although not significant, were 
corrected for by using regression analysis, as recommended by Manca, 
Hawkins and Sculpher (2005). For each EQ-5D measurement, a regression 
analysis was conducted with the child’s age and gender, treatment condition 
and pre-treatment utility value as independent variables. The dependant 
variable was the utility value per EQ-5D measurement (post-treatment, 3-
month follow-up, and 1-year follow-up). All analyses showed that the utility 
value at pre-treatment influenced the utility values over time, although the 
influence decreased. Per child, a corrected utility value per measurement was 
calculated by subtracting the pre-treatment utility value, multiplied with the 
corresponding beta, from the utility value per measurement. The corrected 
utility values were used to calculate corrected QALYs.  
At pre-treatment, also cost differences were present between family and 
individual CBT. Analogous to the procedure described above, cost differences 
at pre-treatment were corrected for by means of regression analysis. All 
regression analyses showed that costs at pre-treatment influenced the costs over 
time, but the influence decreased. Per child, the corrected costs per cost diary 
were calculated by subtracting the pre-treatment costs, multiplied by the 
corresponding beta, from the costs per cost diary for that child.  
In the second analysis, costs related to psychological problems of the 
child were included in the cost-analysis. In the main analysis, only anxiety 
related costs were included, based on subjective judgments by the parents. 
However, since anxiety is an internalizing disorder, it is possible that parents 
were not always able to interpret the symptoms correctly. Therefore, they may 
have attributed symptoms mistakenly to other psychological reasons, like 
depression, while in fact they were an expression of anxiety. Therefore, costs 
due to psychological reasons were also included in the cost-analysis.   
The third analysis concerned the cost-effectiveness per anxiety-free 
family, by including not only the costs related to anxiety of the child but also 
costs related to anxiety of other family members. In order to be considered as an 
‘anxiety-free family’, father, mother, anxious child and siblings had to be 
anxiety free on the ADIS at 1-year follow-up.  
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The fourth and fifth analyses were sensitivity analyses to test the 
robustness of the results. The fourth analysis concerned the cost price for one 
hour of school absence, which was based on parent contributions and grants 
from the government. However, continuing absence from school may result in 
loss of a whole school year, and, as a consequence, starting a career later in life. 
Therefore, costs due to school absence were put on par with productivity costs 
due to loss of unpaid work, which is €8.30 per hour (Oostenbrink et al., 2005). 
Sixth, the cost price of day treatment was based on national reimbursements. 
Currently, all health care institutions are performing cost price calculations in 
light of a new Dutch financing system based on diagnosis-treatment 
combinations. Preliminarily results suggest that the actual cost prices are higher 
than the national reimbursements. Therefore, the cost price of day treatment 
was raised with 50%, resulting in €144 per child per day (see Table 5).  
 All secondary analyses revealed that family CBT remained more costly 
and less effective, indicating inferiority for family CBT. Hence, results with 
respect to cost-effectiveness were highly robust for changing several 
parameters.  
 
Discussion 
 
To our knowledge, this is the first cost-effectiveness study in children with 
anxiety disorders. The cost-effectiveness analysis was conducted according to 
recently published international guidelines for trial-based economic evaluations 
(Ramsey et al., 2005). Although both societal costs and effectiveness were not 
statistically significantly different between family CBT and individual CBT, the 
point estimates of the cost-effectiveness ratios, expressing the costs per anxiety-
free child and the costs per QALY, both indicated dominance for individual 
CBT. These results were confirmed by the bootstrap analyses, showing for both 
effectiveness measures that the largest part of the bootstrapped ICERs was in 
the quadrant where family CBT is inferior. Based on the bootstrapped results, 
the cost-effectiveness acceptability curves indicated that family CBT is not cost-
effective compared to individual CBT, irrespective of the chosen ceiling ratio. 
Finally, several secondary and sensitivity analyses revealed that the cost-
effectiveness results were robust. Therefore, it can be concluded that family 
CBT is not a cost-effective treatment, compared to individual CBT.   
 With respect to the effectiveness of CBT as measured by the ADIS, both 
treatments were highly effective (individual CBT 68% and family CBT 53%) and 
compare well with an overall remission rate of 57% in a meta-analysis of CBT 
for childhood anxiety disorders (Cartwright-Hatton et al., 2004). Note that some 
studies included in this meta-analysis recruited children predominantly by 
means of advertisements, who are less severe anxious and therefore may easier 
meet the stringent criterion of free of all anxiety disorders, and did not include 
dropouts. The finding that family involvement did not add to the effectiveness 
of individual CBT is consistent with a recent meta-analysis showing no 
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difference between child CBT and family focused CBT (In-Albon & Schneider, 
in press).  Also, effectiveness as measured by the QALY was not significantly 
different between individual and family CBT. However, utility values increased 
with 0.08 and 0.11 for respectively individual and family CBT, showing 
improvement in health-related quality of life for both groups. These 
improvements exceed the minimally important difference of 0.03 (Marra et al., 
2005) of the EQ-5D, indicating that this instrument is sensitive to changes in 
anxiety.  
 Although health-related quality of life improved after CBT, the impact 
of children’s anxiety on general quality of life seems marginal, considering that 
utility scores at pre-treatment were relatively high in both groups. This can be 
explained by the fact that parents reported mainly problems on the ‘daily 
activities’ and ‘mood’ dimensions. Also, only 6% of the anxious children had 
major problems on the mood dimension, while 50% had some problems and 
44% had no problems on the mood dimension at pre-treatment. The fact that 
44% reported no problems on the EQ-5D ‘mood’ dimension can possibly be 
explained by the fact that the definition of this dimension contains both anxiety 
and depression. In this study, only 5% children had co-morbid depression. 
Moreover, the Dolan transformation puts the least of weight on the ‘mood’ and 
‘daily activities’ dimensions, as a consequence of which utility values were 
higher than expected. Finally, the relatively high utility values can also be 
explained by a ceiling effect, which has been found frequently in studies using 
the EQ-5D in relatively healthy populations (Brazier, Roberts, Tsuchiya, & 
Busschbach, 2004; de Wit, Busschbach, & de Charro, 2000). Furthermore, low 
pre-treatment EuroQol scores possibly might have restrained further 
improvement in quality of life. 
 It is difficult to relate this study to other studies, because to the authors’ 
knowledge no studies have been conducted on the costs and/or cost-
effectiveness of anxiety disorders in children. This study can only be related to 
studies on anxiety disorders in adults. However, after reviewing the literature, 
several differences were found. First, study populations consisted of adult 
patients with only one specific anxiety disorder (Heuzenroeder et al., 2004; 
McCrone et al., 2004). Second, treatment comparisons were made between CBT 
and drug interventions or optimal treatment (Issakidis, Sanderson, Corry, 
Andrews, & Lapsey, 2004; McCrone et al., 2004). Also the effectiveness 
measures differed from the ones used in our study (Heuzenroeder et al., 2004). 
Therefore, results from our study cannot be compared to results from the 
published literature. Future research on the cost-effectiveness of CBT treatments 
for clinically anxious children may use our results as a “benchmark”.   
 This cost-effectiveness study has some limitations that should be 
addressed. First, no care as usual condition was included in this cost-
effectiveness analysis. Care as usual in the Netherlands for childhood anxiety 
disorders is highly diverse but the field is moving rapidly towards applying 
CBT, although not always according to protocol. Moreover, in a meta-analysis 
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Weiss, Catron, Harris, and Phung (1999) evaluated the effectiveness of usual 
psychotherapy as provided to children in outpatient clinics. The overall effect 
size was -.08 indicating no effectiveness. In contrary, the overall effect size for 
CBT based on 21 randomized control trials was .84 (In-Albon & Schneider, in 
press). Hence, it is expected that a standardized CBT is more cost-effective than 
care as usual. 
 The time horizon in this study was only 15 months and therefore this 
study only provides an indication of the short-term cost-effectiveness of 
individual CBT. However, since the difference in efficacy and costs between 
individual and family CBT persisted over time, it seems likely that the superior 
cost-effectiveness of individual CBT will persist in time. Nevertheless, future 
follow-up assessments are necessary to establish the long-term cost-
effectiveness of individual CBT.  
 In conclusion, at short-term individual CBT is a cost-effective treatment 
for clinically anxious children seeking treatment. As health care costs associated 
with child anxiety are substantial (Polder et al., 2002), cost-effective treatments 
are necessary to reduce both anxiety and costs. Implementation of a 
standardized and efficacious individual CBT in daily practice seems therefore 
warranted. 
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Anxiety disorders are the most common psychiatric disorders in children, are 
often combined with comorbid disorders such as depression and externalising 
disorders, cause interference with daily functioning of the child and without an 
effective treatment may worsen and even continue into adulthood (Keller, et al., 
1992; Kendall, 1994). Hence, an effective treatment seems warranted. The 
majority of research shows that CBT is the only efficacious treatment for 
children with anxiety disorders (e.g. Cartwright-Hatton, Roberts, Chitsabesan, 
Fothergill, & Harrington, 2004; In-Albon & Schneider, in press).  
In this thesis a new family based CBT was evaluated (Bögels & 
Siqueland, 2006). Between January 2002 and December 2005, a randomized 
controlled trial was conducted to investigate effectiveness and cost-
effectiveness of family CBT versus individual CBT. In total, 146 families were 
included, of which 12 dropped-out before treatment and 6 were assigned to the 
waitlist condition and received treatment as usual afterwards. The remaining 
128 families were randomized to individual CBT (n = 64) or family CBT (n = 64).  
 
Main findings  
The main findings of this thesis are as follows. First, chapter 2 shows that the 
Dutch societal costs of illness in families with a clinically anxious child, using 
the bottom-up approach amounted to approximately 20.3 million euros. This is 
almost 21 times as high compared to a matched sample of families from the 
general population. Second, in chapters 3 and 4 it was found that the Screen for 
Child Anxiety Related Emotional Disorders (SCARED-71) child and parent 
version and the Children’s Automatic Thoughts Scale (CATS) differentiated 
between clinically anxious children and children from the general population, 
as a result, reliable cut-off scores were obtained. Third, chapter 5 reveals that 
there is growing evidence in the literature that parental involvement in child 
CBT is not more effective than solely individual CBT, but that the effects of 
family CBT have hardly been investigated. Fourth, the effectiveness study 
described in chapter 6 showed that, in contrast to the hypothesis, individual 
CBT was more effective than family CBT. Both treatments were less effective if 
parents suffered from anxiety disorders themselves and were more effective in 
younger children. Fifth, chapter 7 describes the cost-effectiveness study, in 
which the cost-effectiveness ratios, expressing incremental costs per anxiety-
free child and per Quality Adjusted Life Year (QALY), showed that individual 
CBT dominated family CBT, in that associated costs were lower and 
effectiveness was higher for individual CBT. In this chapter, the findings of each 
chapter are discussed and recommendations for clinical practice and future 
research are made. Finally, the overall conclusion will be provided.  
 
Cost-of-illness 
To the author’s knowledge, the cost-of-illness study, described in chapter 2 of 
this thesis, was the first study to examine costs in clinically anxious children. In 
addition to health care costs, non-health care costs (e.g. day care or informal 
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care), and out-of-pocket costs (own contributions), also indirect costs (school 
absence and productivity loss of parents) were assessed. Interestingly, the 
results showed that next to health care costs, productivity loss of the parents 
and school absence of the child contributed mostly to the total costs. This 
indicates, first, that children with a clinical anxiety disorder suffer from a highly 
disabling disorder that prohibits them from fully engaging in school activities. 
This might lead to future societal problems like entering the labour market later 
in life or even unemployment as an adult. Second, not only does anxiety hinder 
the child in its’ daily functioning, the parents also bear the consequences, in 
such a way that their presence at work diminishes due to the anxiety of the 
child.  
 Results in chapter 2 also indicated that bottom-up acquired total 
societal costs (health care, non-health care, out-of-pocket and indirect costs) for 
families of a clinically anxious child, referred for treatment, are 20.3 million 
euro in the Netherlands. Since anxiety disorders in children tend to last into 
adulthood (Newman et al., 1996), children probably continue to generate costs 
later in life due to their anxiety. Indeed, it was found that health care costs due 
to anxiety disorders in children and adults amounted to 180 million euro in 
1999 (Polder, Takken, Meerding, Kommer, & Stokx, 2002), whereas the health 
care costs in the cost-of-illness study described in chapter 2 amounted to 10.3 
million. Since the latter study showed that societal costs are twice as high, 
societal costs in children and adults are assumed to be even higher than 180 
million euros. Even more, costs associated with anxiety and other not anxiety 
related reasons are 21 times as high in families with clinically anxious children 
compared to families from the general population, indicating that societal costs 
for families with a clinically anxious child are huge. Therefore, an effective 
treatment for children with severe anxiety disorders seems warranted, not only 
to prevent future anxiety problems but also to reduce the corresponding high 
societal costs. 
A cost-of-illness study measures the magnitude of the societal costs 
related to a specific (mental) illness. To obtain an estimation of this magnitude, 
two methods can be used namely the bottom-up and the top-down approach. In 
this study, the bottom-up approach was used which acquires patient data by 
means of registrations or self-report measures like cost diaries. Multiplying the 
costs per patient by the prevalence rate results in the total cost-of-illness for a 
specific (mental) illness. However, the investigated sample used to measure the 
cost-of-illness has to be representative for the entire sample of children with 
anxiety disorders. Since this study only examined costs in families with 
clinically anxious children (9.7%; Verhulst, Van der Ende, Ferdinand, & Kasius, 
1997) referred for treatment (3.5%; Verhulst & van der Ende, 1997), thus 3.5% of 
9.7%, the results of our study cannot be generalised to all children with anxiety 
disorders, of whom many are not referred to mental health care. The latter 
group is estimated to be much larger (96.5% of 9.7%), suggesting that the total 
societal costs of children with anxiety disorders might be much higher. 
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Although the total societal costs might be higher if all anxious children were 
included in the cost of illness calculation, the annual societal costs per child 
might be lower compared to our estimation due to the high prevalence rate. On 
the other hand, the children with anxiety disorders that are not referred to 
mental health care may receive more other forms of help such as medical care, 
as the results of our top-down approach suggest. The costs of such care may be 
as high or even higher as that of mental health care. Future research should 
therefore investigate the costs of children with anxiety disorders in the whole 
range of the severity spectrum of anxiety disorders, whereby variation in use of 
mental health care and other facilities such as medical care can be determined.  
The costs of families with clinically anxious children were almost 21 
times as high compared to costs of families from the general population. A large 
part of this difference could be allocated to anxiety related costs, showing good 
discriminative validity of the cost diary. However, significant differences were 
also found on costs due to other reasons. This could be caused by the usage of 
the prospective diary, in which parents were asked to record the reasons for 
resource use and might mistakenly have attributed costs to other non-anxiety 
reasons. Therefore, as an alternative, costs could be obtained through 
retrospective cost interviews. This method allows the interviewer to ask 
exhaustive questions to be sure that all anxiety related costs are included and 
not ascribed to other reasons.  
Although good discriminative validity and convergent validity were 
established for the prospective cost diary used in the cost-of-illness study 
(chapter 2), the criterion validity of the cost diary was not established. Criterion 
validity would provide us with a conclusive answer regarding the true societal 
costs of illness of clinically anxious children. Criterion validity can be 
established by comparing actual resource use based on formal institutional 
registrations with reported resource use in the cost diaries. However, this 
would require a detailed inventory, by consulting the records of the 118 
clinically anxious children and their parents at general practitioners, hospitals, 
mental health institutions, schools and employers, which is very time 
consuming and difficult. Nevertheless, based on good discriminative validity 
and convergent validity, our cost of illness results obtained with prospective 
cost diaries seems a good approximation of the true costs in clinically anxious 
children in need of treatment. 
 
Effect measures: Anxiety and cognition measures 
Effectiveness studies usually use interviews and questionnaires to measure 
changes in anxiety symptoms and/or diagnostic status. In this thesis improved 
assessment methods for change in anxiety symptoms and cognition were used. 
In order to obtain these qualified measures, new questionnaires were 
developed. First, the existing 66-item Screen for Child Anxiety Related 
Emotional Disorders (Muris, Merckelbach, Schmidt, & Mayer, 1999) did not 
sufficiently measure social phobia, therefore this anxiety questionnaire was 
Chapter 8 
 116
enlarged by adding 5 extra social phobia items. The validity of this altered 
SCARED-71 as a screenings instrument is described in chapter 3. Second, the 
Child Automatic Thoughts Scale, (CATS; Schniering & Rapee, 2002) examined 
in chapter 4 was translated into a Dutch version to measure negative automatic 
thoughts. Cut-off scores for these two questionnaires were obtained by 
differentiating between clinically anxious children and children from the 
general population. These cut-off scores can be employed in prevention 
research for example to identify children at high risk and in effectiveness 
studies to determine whether the treatment has been successful in such a way 
that a child has reached a subclinical level of anxiety symptoms and negative 
automatic thoughts. Cut-off scores might be very relevant for clinical practice in 
such a way that therapists have a bench-mark to evaluate the end state 
functioning of the child by using a questionnaire instead of an elaborate 
interview. 
Unique was that the CATS was assessed to examine whether cognitions 
change as well after the child receives CBT. Earlier treatment studies often 
failed to investigate the change in cognitions. In the effect study described in 
chapter 6, moderate effect sizes were found for the CATS, indicating that both 
individual CBT and family CBT did change cognitions. Besides, 72% of the 
children in the individual CBT condition and 62% of the children in the family 
CBT condition fell into the normal range of having negative automatic thoughts 
after treatment. These results show that the CATS is able to detect change in 
cognitions after the treatment of an anxious child.   
 
Effectiveness 
The main effectiveness study, described in chapter 6, showed that individual 
CBT is more effective than family CBT. Also when reviewing the literature on 
parental involvement, the evidence grows that parental involvement is not 
more effective compared to treating the child alone (see chapter 5). It should be 
mentioned that both therapies are effective in treating children with anxiety 
disorders. At 3-month follow-up, only 5% (n = 3) of the children in the 
individual CBT condition and 17% (n = 11) of the children in the family CBT 
condition did not benefit from the treatment, in other words the severity of their 
primary anxiety disorder did not decline. It should also be mentioned that 19% 
(n = 12) of the families receiving family CBT dropped out, that is, did not 
complete the 12-session family CBT or exceeded the number of sessions as 
required by the protocol. Reasons for dropout during family CBT were; rapid 
improvement (1), lack of motivation (2), depressed and suicidal child (2), 
language problems (1), severe illness mother (1), dyslexia in mother and child 
(1), too much pressure on anxious father (1) and extra sessions due to severe 
child psychopathology (3). Based on reasons for dropout, it could be concluded 
that it is more difficult to get the family into family CBT due to 
psychopathology of the child and motivational problems. Due to the finding the 
family CBT is lees effective than individual CBT and the higher percentage of 
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treatment dropouts, it can be concluded that family CBT has quite a few 
catches.  
 To further investigate the reason for dropouts in de family CBT 
condition, pre-treatment differences between family CBT completers versus 
dropouts were carried out. The only difference was found on the percentage of 
broken homes, which was higher (36%, n = 4) in family CBT dropouts than in 
family CBT completers (14%, n = 7). Furthermore, in the family CBT dropout 
group, 73% (n = 8) of the mothers were housewives, which was significantly 
higher than the percentage of housewives in the completer group (28%, n = 14). 
It could be concluded that more complexity in families and less paid 
employment of mothers occurred to be associated with family treatment-
dropout. A highly speculative explanation is that being a housewife is 
associated with more overprotection of the anxious child and more resistance to 
change. More research is necessary to understand the association between 
broken homes and less paid employment of mothers with treatment-dropout 
during family treatment.    
 Furthermore, the influence of age and parental anxiety as moderators 
was investigated in chapter 6. The hypothesis that family CBT would be more 
effective in young children whereas child CBT would be more effective in 
adolescent children was not confirmed. However, a more general effect was 
found namely; CBT is more effective in 8- to 12-year-old children compared to 
13- to 17-year-old adolescents. First, this effect could be explained by the fact 
that the workbooks used during the treatments were not developmentally 
sensitive. That is, children aged 8 to 18 received the same workbook. 
Developmentally sensitive workbooks tailored to the child’s cognitive and 
emotional development might enhance the effects of future treatment. A second 
explanation for the age effect is that autonomy is very important for adolescents 
in other words they want to be independent of parents and other grown-ups. 
This may cause them to react against their parents as well as the therapist and 
to be less cooperative with the therapist, so therapeutic alliance is more difficult 
to establish (Hudson, Kendall, Coles, Robin, & Webb, 2002). Third, adolescents 
may have established more rigid and persistent negative cognitive and 
behavioural patterns (e.g. avoidance) due to the longer duration of anxiety 
symptoms in comparison with younger children. Therefore, it might be more 
difficult to change these patterns with CBT.  
 Whatever the explanation for the superior effects of CBT at a younger 
age, the results do suggest that it is better to treat children when they are 
younger (8-12). This finding may have important implications for prevention 
and treatment. As young children often do not self-refer for treatment, it is 
important that those who may refer children, such as general practitioners, 
school counsellors, and parents, are aware of the good results of treatment at a 
young age, and therefore do not postpone referral. Also, from a prevention 
point of view, it may be that the ideal age to offer children who are at risk for 
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developing anxiety disorders (or already have one) may be between 8-12 rather 
than later.  
Also, in contrast to the hypothesis, family CBT was not more effective 
when parents suffered from anxiety disorders themselves. In contrast, this 
study showed that CBT in general is less effective if parents suffer from anxiety 
disorders themselves. This indicates that anxious parents might hinder the 
child’s treatment. Hence, it could be suggested that anxious parents have to be 
treated for their own anxiety first, before the child can receive CBT in order to 
enhance treatment success. However, since anxiety disorders are also partially 
genetically transmitted (for a review and meta-analysis see Hettema, Neale, & 
Kendler, 2001), children of anxious parents might have an innate sensitivity 
which makes treatment more difficult to alter anxiety, while a child that 
acquired its’ anxiety through non-genetic causes, such as conditioning, might be 
more easily treated.    
Although the findings in this thesis indicate the superiority of 
individual CBT over family CBT, some precaution should be made before 
drawing this conclusion. The Task Force on Promotion and Dissemination of 
Psychological Procedures (1995) has proclaimed that in order to be a probably 
effective treatment, treatments must be efficacious in at least two randomized 
control trials in which the treatment is compared to a wait-list or control 
condition. Therefore, a second randomized control trial should be conducted in 
order to be able to conclude that both treatments are effective and to show 
superiority of individual CBT over family CBT. 
Also of importance is the patient preference, which was not obtained in 
our effectiveness study. In the effectiveness study described in chapter 6, 
families were randomized to either individual or family CBT. Perhaps families 
should decide themselves which treatment they want or prefer. From our study, 
it is unclear whether families would have preferred one treatment above the 
other. Future research should address this question.  
 
Cost-effectiveness 
In chapter 7 of this thesis, the first cost-effectiveness study in clinically anxious 
children was described. Until now, no study investigating the effects of CBT has 
taken costs into account as well. Results from our cost-effectiveness study 
showed that although costs and effects did not differ significantly between 
individual CBT and family CBT, cost-effectiveness ratios expressing 
incremental costs per anxiety-free child and incremental costs per Quality 
Adjusted Life Years (QALY), showed that individual CBT was dominant and 
hence more cost-effective than family CBT. Effectiveness was measured based 
on the percentage of anxiety free children and on the number of QALYs of the 
child.  
 Health related quality of life was measured with the EuroQol child and 
parent version (Stolk, Busschbach, & Vogels, 2000). This was the first study to 
assess health related quality of life by means of child self-report, maternal and 
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paternal report. Due to the high correlation between child and parent reported 
quality of life, only parent scores were aggregated and used in the cost-
effectiveness analysis. A literature study on 3,050 quality of life articles in 
children found that only in 9% of the articles, children were involved in the 
evaluation of quality of life (Wallander, Schmitt, & Koot, 2001). Thus usually 
only the proxy or parent report of the child’s quality of life is obtained because 
it is believed that children lack the language skills, cognitive abilities and a long 
term view of events to report their own quality of life (Stolk et al., 2000). 
However, adult studies have shown that proxy reports often underestimate 
quality of life of the patient. In addition, internalising disorders such as anxiety 
disorders are very subjective which makes it more difficult for a parent to 
report quality of life (Wallander et al., 2000). As a result, most studies have 
found that the parent-child agreement is low to moderate on both generic 
quality of life instruments (e.g. the EuroQol) and specific quality of life 
instruments (e.g. the SCARED). The high parent-child agreement found in 
chapter 7 is therefore remarkable. Given the inconsistency between the poor 
parent-child agreement in the literature and the high agreement found in 
chapter 7, future research should address this issue. It could be suggested that 
both child and proxy version have to be assessed to obtain more accurate and 
complete information about the quality of life of the child. If the agreement is 
high, either one utility score can be used in the cost-effectiveness analysis, if not, 
two different cost-effectiveness analyses should be performed.  
 Furthermore, this study is the first to measure change in generic health 
related quality of life in children after treatment. Until now, only 11 adult 
studies have been conducted that measured generic quality of life before and 
after treatment in patients with panic disorder (n = 8), social phobia (n = 2) and 
posttraumatic stress disorder (n = 1), however the majority of these studies 
concerned psychopharmacological interventions (Mendlowicz & Stein, 2000; 
Meltzer-Brody & Davidson, 2000). It is more than logical to obtain generic 
quality of life in psychopharmacological studies, since pharmaceuticals often 
have physical side effects, which can intervene enormously with quality of life. 
However, it is also useful to assess quality in life in CBT studies since generic 
quality of life questionnaires are commonly used in economic evaluations to 
obtain utility scores. Even more, our data show that generic quality of life 
improved after CBT in both groups. These improvements exceeded the 
minimally important difference, suggesting that the generic quality of life 
instrument used in our study, the EuroQol, is sensitive to changes in anxiety. 
Therefore, besides using specific quality of life questionnaires such as anxiety or 
psychopathology questionnaires, future studies should use generic quality of 
life instruments that cover all relevant aspects of health related quality of life 
before and after treatment.  
 Future research should address cost-effectiveness of treatment in 
children with anxiety disorders in general, since this study only showed the 
cost-effectiveness of individual CBT in clinically referred children. Perhaps, 
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offering an effective short-term intervention to all children with anxiety 
disorders might reduce societal costs and might prevent children from fully 
developing a clinical anxiety disorders. Especially since young children benefit 
more from CBT, this age group should be the target. As chapter 2 of this thesis 
shows, children with clinical anxiety disorders cost 21 times more than children 
from the general population, including nonclinically anxious children. Possible 
future costs of treatment and the consequences of clinical anxiety disorders 
might be saved by providing an effective treatment. Taken this even further, 
prevention programs might reduce costs of anxiety disorders as well. Children 
at risk for anxiety disorders can be traced with screening instruments and are 
offered a short intervention. This prevents children from developing a severe 
anxiety disorder that in the long term might cause high cost due to mental 
health and other facilities, as shown in our cost-of-illness study. A study by 
Simon, Bögels and Dirksen (personal communication) currently addresses the 
cost-effectiveness of a prevention program. This study uses the same 
assessments like the EuroQol and the prospective cost diary described in this 
thesis. Therefore, results of this study regarding the cost-effectiveness of the 
prevention program can be easily compared to our results, to see whether it is 
more cost-effective to provide a short intervention to children at risk than to 
offer effective treatments to children with a severe anxiety disorder who seek 
help in mental health care. Eventually, conclusions can be drawn on when and 
how anxious children should be treated to obtain optimum effectiveness and 
cost-effectiveness. 
 
Treatment implications 
 
How family CBT principles could be used: Modular CBT 
Although family CBT was found to be less effective than individual CBT, it 
could still have benefits in an altered form. It could be suggested that modules 
should be made, that can be used according to the needs of the family 
(component selection). These modules should be used in addition to individual 
CBT, which has proven to be very efficacious (see chapter 6). When there are 
problems concerning family functioning, extra modules should be provided by 
the therapists to address these problems. If parents are anxious they should be 
treated as well, using a specific module. However, if there are no family 
functioning problems or if the parents do not have any kind of 
psychopathology, the designated module should not be addressed. Individual 
CBT should therefore be complemented with several modules, which can be 
used according to the needs and problems of the family.  
In order to get insight in the problems and needs of families, an 
extended intake and elaborate assessment of family functioning should be 
obtained before entering treatment. Then, the therapist can decide which 
modules to use to address the specific family problems (therapist selection). It 
could also be suggested that families themselves choose the modules, according 
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to their own needs (patient selection). By means of tailoring individual CBT 
based on needs of the child and family, effectiveness may be increased. 
Preliminary support for a modular based treatment was found in a pilot study 
by Chorpita, Taylor, Francis, Moffitt and Austin (2004). Their modular CBT 
consisted of a combination of individualised scripted techniques matched to the 
child’s needs and strengths. Four core CBT elements were provided to all 7 
children that is self monitoring, psycho education, exposure and maintenance 
and relapse prevention. Additional modules were given based on decision rules 
provided in a flowchart and included, cognitive restructuring, social skills 
training, rewards, reinforcement strategies and time-out. Of the 7 referred 
anxious children, 6 were free of all anxiety disorders at 6-month follow-up. All 
7 were free of their primary diagnosis at 6-month follow-up. However, this 
latter study only used CBT modules and not more specific modules like family 
functioning. Furthermore, the sample size was small and no comparison was 
made with a more stringent or standard CBT. Future research could investigate 
whether a tailored and modular individual CBT, including family CBT 
elements, is more effective than standard individual CBT. 
 
Flexible number of sessions 
In the effectiveness study, it was found that immediately after CBT, 41% of the 
children still had an anxiety disorder. This could be due to the limited number 
of sessions that were obliged in the used protocol. Perhaps if more sessions 
were given, more children would be free of all anxiety disorders, since the 
therapist would have more time targeting the primary anxiety disorder more 
profoundly and other anxieties as well. Especially in family CBT, extra sessions 
might be necessary, since so many targets are set in this therapy; both the 
child’s anxiety and the parents’ anxiety is targeted, distorted cognitions of child 
and parents are identified and altered, family functioning is dealt with, and 
parents’ communication is improved. With extra sessions these themes can be 
fully exploited. This is confirmed by the fact that 3 families in family CBT 
needed more than 12 sessions and eventually were excluded because of 
protocol violation.  
More sessions could improve the percentage of children free of anxiety 
disorders but the reverse can also be effective; fewer sessions can be enough for 
some children. In the effectiveness study, one child dropped-out because after 4 
sessions it was free of anxiety disorders. Some other children also mentioned 
that they made so much progress they thought fewer sessions would be 
enough, however they completed the treatment because of the protocol 
requirements. Furthermore, Ost, Svensson, Hellström, and Lindwall (2001) 
showed that a 1-session exposure with or without the parent present was more 
effective than a waitlist condition in children with phobias, thus even one 
session makes a difference. Even more, a modular CBT by Chorpita et al. (2004) 
found that the sessions delivered to obtain effectiveness ranged from 5 to 17, 
thus also providing evidence for an effective individual CBT with flexible 
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number of sessions. However, long-term effects of short interventions have not 
been investigated yet. In conclusion, CBT could increase in effectiveness if the 
number of sessions is adapted to the needs of the child. This can be obtained by 
asking the child and parents if they want to continue (child or family 
preference) but could also be obtained by means of an objective standard. 
Examples of objective ways of assessing the need for further treatment are a 
short anxiety interview to re-assess the anxiety disorder status, or re-
administration of the SCARED to establish whether the child has reached an 
anxiety symptom level below the cut-off score. Such an objective assessment 
could be administered every session or every group of sessions.  
 Not only is a more flexible number of sessions ideal for the anxious 
child and its’ family, it may also be more cost-effective at the long term. If a 
treatment is terminated after 12 sessions, while the child is still anxious, the 
child might relapse or continue to have problems into adulthood, causing more 
costs. The reverse, when a child continues the remaining treatment sessions of a 
structured protocol, although the anxiety is already gone, is also cost inefficient. 
The sessions (and money), this latter child spares can be re-allocated to the 
anxious child who needs more sessions, which may cause an equilibrium. 
Hence, modifying the number of sessions to the child needs may be more cost-
effective in the long run. Future research should address this matter. 
 
Future research 
 
Moderators and mediators 
In the effectiveness study it was found that 52% (n = 66) of the children was free 
of all anxiety disorders and in 89% (n = 114) at least the primary anxiety 
disorder decreased in severity at 3-month follow-up. However, the anxiety 
disorders of 5 children that completed the treatment (2 individual CBT and 3 
family CBT) did not improve. Even more, it is assumed that 9 children that 
dropped-out of treatment did not improve as well, however last assessment 
carried forward was used due to lack of assessments, thus this could only be 
suggested based on oral therapist reports. It can be concluded that some 
children respond better to CBT than others. Insight in possible child or parental 
characteristics that are associated with the effectiveness of CBT, the so-called 
moderators, have the potential to further refine CBT and to enhance its’ 
effectiveness. Moderators are variables that influence the direction and/or 
strength of the relationship between an independent variable (having an 
anxiety disorder) and a dependant variable (treatment outcome) (see diagram 
1). Examples of moderators are socio-demographic factors like gender, ethnicity 
and age and diagnostic characteristics like primary anxiety disorder, severity 
and comorbidity. Also parental characteristics such as psychopathology, socio-
economic status and marital status could be related to success or failure of 
treatment. Studying moderators can lead to the finding; whom under which  
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circumstances is most responsive to treatment (Kazdin & Nock, 2003; Kraemer, 
Wilson, Fairburn, & Agras, 2002).  
Although, compared to individual CBT, family CBT was not more 
effective in younger children and if parents were anxious themselves (see 
chapter 6), family CBT could be more effective when investigating other 
moderators of influence. In other words, it could be suggested that for certain 
types of families, family CBT might possibly be more effective. For instance, 
family CBT seems an alternative for individual CBT when parents do not suffer 
from psychopathology.  
In contrast to our findings, Crawford and Manassis (2001) did not find 
that parental psychopathology influenced treatment outcome, however the 
moderators family dysfunctioning and clinician and child report of parental 
frustration predicted a poorer outcome of individual or group CBT with 
parental involvement. In case there are problems in family dysfunctioning, 
these families might benefit more from family CBT because this treatment 
focuses on family problems.  
Research on mediators is necessary to explain the possible association 
between child or parental characteristics and effectiveness. Mediators are 
mechanisms through which the independent variable (having an anxiety 
disorder) influences the dependant variable (treatment outcome) (see diagram 
2). In other words, through which process does the therapeutic change occur 
(Kazdin & Nock, 2003; Kraemer et al., 2002)? For example, age is considered as 
a moderator since it cannot be changed by treatment, however, the cognitive 
level that is associated with age is a mediator because CBT can influence the 
cognitive process and thereby can influence the outcome of treatment. Another 
mediator is therapeutic alliance. In Holland, a multi center study of the 
University of Amsterdam (Clinical child and youth psychology), Amsterdam 
Medical Centre (de Bascule) and Accare Child and youth psychiatry Groningen 
by Prins and de Haan, (personal communication) and a study by Heyne, van 
Hout, Maric, and Sauter (personal communication) in Leiden are currently 
conducting a research to investigate mediators and moderators in anxious 
children and children with school refusal respectively. 
In conclusion, child and parental characteristics can be used to adapt 
treatments. In case a child is at risk for treatment failure due to several 
characteristics and parental psychopathology, the therapist can anticipate on 
these factors. Future research should address moderators and mediators to  
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expand our knowledge of anxiety disorders and to enhance effective 
treatments. Methodological and statistical guidelines to study moderators and 
mediators can be found in Kazdin and Nock (2003) and Kraemer et al. (2002). 
 
Mechanisms of change 
A lot of research has been conducted on the effectiveness of several CBT 
programs. However, it is still unclear which component of CBT is the most 
effective part or which process causes therapeutic change. Kendall et al. (1997) 
executed a treatment study in which CBT was divided in two periods of 
sessions, a first part and a second part. The content of the parts was balanced 
between the two periods and included exposure based sessions and educational 
support based sessions. They found that if exposure was given in the second 
part of CBT, effects increased enormously compared to the educational support 
in the first part alone. If education support was given in the second part of 
treatment, the effects remained the same compared to the exposure sessions in 
the first part. The finding that exposure is indeed an important feature of CBT 
was confirmed by Ost et al. (2001). They found that a one-session exposure 
reduced anxiety complaints. However, an exposure based contingency 
management (child exposure and parental behavioural strategies) was less 
effective than an exposure based cognitive self-control (child exposure, 
cognitive strategies, self-evaluation and self reward and parental training on 
child’s self control skills) (Silverman et al., 1999). Last, Hansen and Franco 
(1998) and Silverman et al. (1999) both found that a non-active educational 
control condition was as effective as CBT. Due to these inconclusive results, 
future research is necessary to study the mechanisms of CBT that contribute to 
effectiveness. 
 
Care as usual and decision making 
In order to make a statement about whether individual CBT is most effective or 
cost-effective in general, it is necessary to compare individual CBT with other 
existing treatments for children with anxiety disorders such as 
psychopharmacological interventions, cognitive interventions, behavioural 
interventions, psychodynamic interventions, Eye Movement Desensitisation 
and Reprocessing (EMDR) and Relaxation Therapy. However, in clinical 
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practice a lot of variations and combinations of these aforementioned 
treatments are provided. Due to this diversity of treatments, it is impossible to 
refer to a treatment as “care as usual”.  However, care as usual for childhood 
anxiety disorders as it is currently given in the Netherlands is moving rapidly 
towards applying CBT, in multiple formats. However, so far, no study 
inventoried the range of existing treatments that are currently executed in 
clinical practice, thus it remains unclear what care as usual for children with 
anxiety disorders is.  
Concerning effectiveness, in a meta-analysis of Weiss, Catron, Harris, 
and Phung (1999) the overall effect size of usual psychotherapy as provided to 
children in outpatient clinics was found to be -.08 indicating no effectiveness. In 
contrary, the effect size for individual CBT found in chapter 6 was 1.39 for 
change in anxiety symptoms. So, it could be suggested that individual CBT is 
more effective than care as usual.  
Nevertheless, in order to provide an overall conclusion on effectiveness 
and cost-effectiveness, all possible alternative treatment types, including the 
diverse care as usual, should be included in the analysis. Although results of 
effectiveness and cost-effectiveness studies from randomised control trials are 
important and useful to determine effectiveness and cost-effectiveness for 
specific treatments, one RCT alone does not provide enough information about 
effectiveness and cost-effectiveness along all existing treatments. Therefore, the 
clinical and economic evaluation of treatment in children with anxiety disorders 
should be examined within a broader framework in which all evidence of 
available RCT’s is accumulated and evaluated. This model can than generate a 
statement about effectiveness and cost-effectiveness which can lead to more 
profound decision making and resource allocation (Sculpher, Claxton, 
Drummond, & Mcabe, 2006). 
 
Long-term follow-up 
A long-term follow-up study is necessary to investigate whether the 
conclusions drawn in this thesis still stand at 5 to 10 years from now. Our 
follow-up data suggest that results concerning effectiveness and cost-
effectiveness are stable throughout 3-month and 12-month follow-up, 
suggesting a stable pattern over time. Other effectiveness studies have shown a 
prolonged effect of CBT after 5 to 9 years follow-up (Barrett, Duffy, Dadds, & 
Rapee, 2001; Kendall, Safford, Flannery-Schroeder, & Webb, 2004). For example, 
Kendall et al. (2004) showed that of the 91% of the original sample, 90% of the 
children was (still) free of their primary diagnosis 5.5 to 9.3 years after 
treatment according to the child interview, which is quite a high percentage. 
However, no studies have addressed cost-effectiveness of CBT yet and therefore 
long term cost-effectiveness is also not examined yet. Future follow-up research 
should, beside effects, investigate the long-term costs as well.  
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Overall conclusion 
Overall, it can be concluded that, given our results, individual CBT seems the 
best choice for treating children with clinical anxiety disorders, not only from 
the child’s perspective (more effective), but also from a societal perspective 
(cost-effective). Also when reviewing the literature on parental involvement, 
the evidence grows that parental involvement is not more effective compared to 
treating the child alone. 
Given the large effect size for individual CBT (see chapter 6), the high 
percentage of children free of anxiety disorders for individual CBT (see chapter 
6) and the favourable results regarding the cost-effectiveness of individual CBT 
(see chapter 7), it can be concluded that for now, implementation of individual 
CBT in clinical practice seems warranted. However, given the many 
recommendations and suggestions for future research, it can be suggested that 
in the meanwhile, other research has to be done to investigate moderators, 
mediators, mechanism of change of CBT and long term effects and cost-
effectiveness regarding the full range of possible treatment options, in order to 
be able to optimize effectiveness and cost-effectiveness of treatments for 
children with anxiety disorders. 
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Tussen januari 2002 en december 2005 is er een grootschalig onderzoek 
uitgevoerd naar de kosten-effectiviteit van gezins cognitieve gedragstherapie en 
individuele of kind cognitieve gedragstherapie bij gezinnen met een klinisch 
angstig kind.  Dit houdt in dat er gekeken werd welke van de 2 behandelingen 
(individuele of gezins cognitieve gedragstherapie) beter werkt (effectiever is) en 
welke therapie, relatief gezien, het goedkoopst is in het behandelen van klinisch 
angstige kinderen. Klinisch angstige kinderen zijn kinderen die zo angstig zijn 
dat hun leven erdoor beïnvloed wordt en een behandeling nodig hebben. 
Cognitieve gedragstherapie is een behandeling waarbij angstige gedachten 
veranderd worden in minder angstige gedachten. Ook leert het kind dat het 
angstige situaties of dingen die het vermijdt juist moet gaan opzoeken en zo 
gaat wennen aan de angst totdat de angst weg is.  In totaal hebben 128 gezinnen 
meegedaan aan dit onderzoek die gelijkmatig werden verdeeld over de 
individuele en de gezins cognitieve gedragstherapie.  
 Naast kosten-effectiviteit is ook onderzocht hoeveel geld gezinnen met 
een klinisch angstig kind, de maatschappij kosten. Daarbij zijn kosten van de 
gezondheidszorg en kosten buiten de gezondheidszorg zoals opvang gemeten. 
Bovendien zijn indirecte kosten, zoals kosten die ouders maken als ze niet naar 
hun werk kunnen omdat ze bij het angstig kind moeten blijven, en eigen 
gemaakte kosten, zoals reisgeld, in kaart gebracht. Deze kosten zijn door de 
gezinnen opgeschreven in een kostendagboek. Opgeteld komen de totale 
kosten voor alle gezinnen in Nederland met een klinisch angstig kind uit op een 
bedrag van 20.3 miljoen euro. Deze kosten zijn bijna 21 keer zoveel als de 
kosten van gezinnen uit de algemene bevolking zonder een angstig kind. Naast 
gezondheidzorgkosten, zijn de kosten voor ouders die niet naar hun werk 
kunnen door de angsten van het kind en schoolverzuim van het angstig kind, 
het hoogst. Deze kosten zouden misschien bespaard kunnen worden als 
angstige kinderen een goede behandeling krijgen.  
Om te kijken of de behandeling goed werkt, zijn voor en na 
behandeling interviews afgenomen bij de gezinnen om te bepalen of er een 
angststoornis aanwezig was. Ook zijn er een aantal nieuwe of vertaalde 
vragenlijsten afgenomen zoals de CATS die mogelijke veranderingen in 
negatieve gedachten bij kinderen meet voor en na therapie. De CATS is in het 
Nederlands vertaald. Een andere vragenlijst, de SCARED meet angstklachten 
bij kinderen. De oorspronkelijke SCARED is uitgebreid met 5 sociale angst 
vragen zodat sociale angst beter in beeld gebracht kon worden. Door de 
uitkomsten op deze vragenlijsten te vergelijken met kinderen uit de algemene 
bevolking zonder angsten, kunnen zogenaamde afkappunten bepaald worden. 
Deze afkappunten kunnen in de behandelstudie gebruikt worden om te kijken 
of klinisch angstige kinderen onder het afkappunt zitten en dus ongeveer 
dezelfde hoeveelheid angstklachten en negatieve gedachten hebben als andere 
kinderen.  
In de behandelstudie is aangetoond dat individuele cognitieve 
gedragstherapie beter werkt dan gezins cognitieve gedragstherapie. Dit wil 
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zeggen dat er meer kinderen vrij van hun angststoornis waren na de 
individuele behandeling dan na de gezins behandeling. Ook uit de literatuur 
kan geconcludeerd worden dat het betrekken van ouders bij de behandeling 
van het angstig kind niet beter werkt dan wanneer het kind alleen behandeld 
wordt. Bovendien is gevonden dat cognitieve gedragstherapie beter werkt bij 8 
tot 12 jarige angstige kinderen dan bij 13 tot 17 jarigen. Verder laten de 
resultaten zien dat cognitieve gedragstherapie minder goed werkt bij angstige 
kinderen van wie de ouders zelf ook angstig zijn.   
Uiteindelijk is de kosten-effectiviteit studie uitgevoerd. Dit is de eerste 
studie ter wereld die gekeken heeft naar de kosten van cognitieve 
gedragstherapie bij angstige kinderen. Resultaten tonen aan dat individuele 
cognitieve gedragstherapie beter werkt en goedkoper is dan gezins cognitieve 
gedragstherapie.   
De conclusie is dat individuele cognitieve gedragstherapie de beste 
keus is om klinisch angstige kinderen te behandelen omdat het beter werkt en 
goedkoper is. Nieuwe onderzoeken moeten laten zien of de gevonden 
resultaten ook gelden op langere termijn bijvoorbeeld over een paar jaar. Ook 
zal er onderzocht moeten worden welk gedeelte van de cognitieve 
gedragstherapie het best werkt en waarom. Bovendien zou gekeken moeten 
worden of het niet beter en goedkoper is om kinderen, die een verhoogd risico 
hebben om angstig te worden, preventief te behandelen dus voordat ze ernstige 
angstklachten krijgen. Dan kan bepaald worden of het beter en goedkoper is om 
vroegtijdig kinderen met angstklachten te behandelen of dat ze pas behandeld 
moeten worden als ze een ernstige angststoornis hebben.  
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Between January 2002 and December 2005, a randomized control trial was 
conducted to investigate the cost-effectiveness of family Cognitive Behavioural 
Therapy (CBT) versus individual CBT. In total 128 families were randomized to 
individual CBT (n = 64) or family CBT (n = 64). Before investigating the cost-
effectiveness, the costs of families with clinically anxious children referred for 
treatment were examined, which was never been done before. The Dutch 
societal costs of illness in clinically anxious children and their families, using 
the bottom up approach by means of a prospective cost diary amounted to 
approximately 20.3 million euros, which is almost 21 times as high compared to 
families from the general population. Besides, health care costs, productivity 
loss of the parents and school absence of the child contributed mostly to the 
total costs. These high costs can be saved by providing an effective treatment to 
families with clinically anxious children.  
Effectiveness was measured by means of a semi-structures interview to 
obtain diagnostic status and with several newly developed or translated 
questionnaires including the Child Automatic Thoughts Scale (CATS; 
Schniering & Rapee, 2002) and the Screen for Child Anxiety Related Emotional 
Disorders (Muris et al., 1999). The CATS was translated into a Dutch version to 
measure change in cognition, which is sporadically assed in previous 
effectiveness studies. The existing 66-item SCARED did not sufficiently 
measure social phobia, therefore this questionnaire measuring anxiety 
symptoms was expanded by adding 5 extra social phobia items. Cut-off scores 
for these two questionnaires were obtained by differentiating clinically anxious 
children from children from the general population. These cut-off scores are 
important in the effectiveness study to determine whether a child reached a 
normal level of anxiety symptoms and negative automatic thoughts after 
treatment.  
In contrast to expectations, the effectiveness study showed that 
individual CBT was more effective than family CBT. Also when reviewing the 
literature on parental involvement, the evidence is growing that parental 
involvement has no additive value. Also contrary to our hypothesis, family CBT 
was not more effective in young children. A more general effect was found 
namely; CBT is more effective in 8- to 12-year-old children compared to 13- to 
17-year-old adolescents. Again, in contrast to the hypothesis, family CBT was 
not more effective when parents suffered from anxiety disorders themselves. 
The more general finding that CBT is less effective if parents suffer from anxiety 
disorders themselves was found.  
Finally, the cost-effectiveness study was conducted. Previous studies on 
CBT in anxious children only investigated effectiveness. This was the first study 
also taken into account the costs of CBT in anxious children. Results show that 
although costs and effects did not significantly differ between individual CBT 
and family CBT, cost-effectiveness ratios, expressing incremental cost per 
anxiety-free child and per QALY, indicated that individual CBT was more cost-
effective than family CBT.  
Abstract 
 
 146
In conclusion, individual CBT seems the best choice for treating 
children with clinical anxiety disorders, in terms of effectiveness and cost-
effectiveness. Future studies should investigate moderators and mediators, 
mechanisms of change of CBT, the long-term term cost-effectiveness, cost-
effectiveness in children with anxiety disorders in general and cost-
effectiveness in prevention of anxiety disorders to enhance the effectiveness of 
CBT for children with anxiety disorders, to reduce the costs associated with 
anxiety disorders in clinically referred children and as a result to obtain 
optimum cost-effectiveness. 
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